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Abstract 
Noroviruses are positive-sense single-stranded RNA viruses which, in humans, cause rapid 
onset diarrhoea and vomiting. There is an estimated 21 million cases of noroviral 
gastroenteritis in the United States per year. 
The work in this thesis has focused on two noroviral proteins, the viral protein genome-linked 
(VPg), and the viral RNA dependent RNA polymerase (NS7pol). The VPg protein is covalently 
linked to the 5' end of the noroviral genome and is a key component of translation and 
replication initiation in noroviruses. Using Nuclear magnetic resonance spectroscopy (NMR) we 
have analysed the murine norovirus (MNV) and a human norovirus VPg (Lordsdale virus (LDV)) 
proteins. The VPg protein of both viruses has a small structured helical core with extensive N 
and C-terminal flexible regions.  
We has also determined the structure of the MNV NS7pol as well as two high fidelity mutants 
(P72S and E75S) using X-ray crystallography. The NS7pol protein has a very similar “right 
drinking hand” structure to other RNA dependent RNA polymerases. The fidelity mutants were 
structurally identical to the wild type protein but had subtle changes in local hydrogen bonding 
networks. This is consistent with similar studies performed with picornaviral polymerases.  
In addition we used NMR and surface plasmon resonance to characterise the interaction of the 
MNV VPg protein with the NS7pol protein. The interaction between full length VPg and MNV 
NS7pol is weak, (KD ~160 μM). In addition the NS7pol interacts with both the full length VPg and 
the core domain of this protein.  
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1. Introduction 
1.1. The Caliciviridae 
 
The Caliciviridae are a diverse family of single stranded positive sense RNA viruses. They have a 
non-enveloped virion of 25-40 nm in diameter which is characterised by surface depressions. 
These depressions gave rise to the family name: calici is derived from the Latin root calyx, 
meaning cup (Green, 2006).  
The Calicivirdae have been divided into four genera of viruses: noroviruses, lagoviruses, 
sapoviruses and vesiviruses.  The vast majority of noroviruses and sapoviruses that have been 
characterised cause gastroenteritis in humans, although members of these genera have been 
found recently in mice, cows, pigs and dogs (Karst et al., 2003; Oliver et al., 2003; Sugieda and 
Nakajima, 2002; Martella et al., 2008). The prototypic members of the lagovirus genus are 
rabbit hemorrhagic disease virus (RHDV) and European brown hare syndrome virus which 
cause haemorrhagic disease in rabbits and hares respectively. The prototypic members of the 
vesivirus genus are feline calicivirus (FCV), which causes a respiratory syndrome in cats, and 
San Miguel sea lion virus, which causes a vesicular disease of sea lions. While the lagoviruses, 
sapoviruses and vesiviruses are closely related, the norovirus genus is a much more distantly 
related member of the family (Fig. 1-1) (Wobus et al., 2006). In the phylogenetic tree the 
norovirus genus has been further subdivided into five genogroups (GGI-V). All the pandemic 
strains of human norovirus are of genogroup II (GGII) (reviewed by Bull and White, 2011). 
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Figure 1-1: Phylogeny of the Caliciviridae 
Taken from Wobus et al., 2006. The tree is based on the protein sequence of the major capsid 
protein VP1. The numbers under branches are bootstrap values greater than 50%.  
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1.2.Norovirus and human disease 
 
Evidence for non-bacterial gastroenteritis dates back to the 1940s, with the discovery that 
diarrhoea could be transmitted by oral inoculation of fecal filtrate samples (Gordon et al., 1947; 
Jordan et al., 1953).  norovirus was first discovered by transmission electron microscopy on 
infectious stool filtrate following a gastroenteritis outbreak in Norwalk, Ohio in 1968 (Kapikian 
et al., 1972).   
Gastroenteritis caused by norovirus and sapovirus is characterised by acute and rapid onset 
nausea, vomiting, diarrhoea, abdominal cramping and fever; these symptoms typically last two 
to three days (reviewed in Glass et al., 2009). Transmission is via the faecal oral route and the 
infectious dose is between 18 and 1000 virions (Teunis et al., 2008).  There are an estimated 21 
million cases of noroviral gastroenteritis in the United States per year, making norovirus the 
most prevalent etiological agent of gastroenteritis (Scallan, et al., 2011). In England and Wales it 
is estimated that norovirus kills between 60 and 80 elderly people per year (Harris et al., 2008). 
Despite its medical importance, the precise mechanism underlying the gastrointestinal 
pathology remains poorly defined. Biopsies of the small intestine in volunteer studies have 
demonstrated broadening and flattening of intestinal villi and reduction in concentration of 
small intestine enzymes trehalase and alkaline phosphatase (Agus et al., 1973). More recent 
human biopsy experiments have shown reduced electrical resistance, increased apoptosis and 
reduced tight junction protein expression in the duodenum of norovirus patients. Therefore, it 
was suggested that leakiness of the gut epithelium is responsible for the diarrhoeal component 
of the disease (Troeger et al., 2009). There also appears to be delayed gastric emptying during 
the course of infection (Meeroff et al., 1980). 
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1.3.The Caliciviral genome 
 
The calicivirus genome is ~ 7.5 kilobases (kb) in length. Most caliciviral genomes encode three 
open reading frames (ORFs). ORF2 and ORF3 encode the structural proteins VP1 and VP2, 
respectively, which make up the viral capsid (Jiang et al., 1992; Glass et al., 2000). ORF1 encodes 
a large non-structural polyprotein which is cleaved into functional units by the viral protease 
(Green, 2006). The final polyprotein cleavage products, vary slightly depending on the virus but 
typically include: the RNA-dependent RNA polymerase (NS7po l); the viral protease (NS6pro); the 
viral protein genome linked (VPg); two proteins which disrupt cellular protein trafficking (NS4 
& NS1/2) and an ATPase (NS3) (Fig. 1-2) (Green, 2006; Sharp et al., 2010; Ettayebi and Hardy, 
2003). 
Two forms of calicivirus RNA are transcribed in cells and packaged into virions (Neill and 
Mangeling, 1988; Carter, 1990; Neill, 2002). These two forms are genomic RNA, containing all 
the ORFs, and sub-genomic RNA, which contains just ORF2 and ORF3. Both genomic and sub-
genomic RNA of caliciviruses are covalently linked at their 5 ′ ends to the VPg protein (Herbert et 
al., 1997; Schaffer et al., 1980). As will be described in detail, VPg has essential roles in viral 
translation, transcription and possibly also in virus encapsidation.   
Murine norovirus (MNV) encodes an extra reading frame, ORF4. This is encoded as an 
alternative reading frame overlapping ORF2 (Thackray et al., 2007). The ORF4 protein, 
virulence factor 1 (VF1), is thought to disrupt innate immune signalling through alteration of 
mitochondrial morphology (McFadden et al., 2011). The roles of these proteins will be 
discussed in the context of the virus life cycle below. 
The Caliciviridae are related to the Potyviridae, a family of plant viruses, and the Picornaviridae, 
a family of mammalian viruses. These viruses share many aspects of their biology including the 
production and cleavage of a large polyprotein, a VPg protein covalently linked to the 5′ end of 
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the genome, and some aspects of their genome structure (Racaniello, 2006). Throughout this 
introduction parallels will be drawn between the Caliciviridae and these two other viral families.  
 
 
 
Figure 1-2: Norovirus genome and proteome 
The positive sense RNA of norovirus is translated early after cell entry.  Most noroviruses have three 
open reading frames (ORFs) termed ORF1, ORF2 and ORF3. Murine norovirus encodes fourth ORF 
termed ORF4. These give rise to four protein products. ORF2 and ORF3 encode the capsid proteins 
VP1 and VP2 respectively. ORF4 encodes the innate immune regulator VF1. ORF1 encodes the non-
structural polyprotein. The non-structural polyprotein is further cleaved into functional units by 
NS6pro. The cleavage junctions are marked by lines in the polyprotein. 
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1.4.Cell culture and model systems 
 
Despite significant effort, no cell culture model has yet been developed for human norovirus 
(HuNV) (Duizer et al., 2004). HuNV replication has, however, been studied to a very limited 
extent in cell culture using replicon systems. Two replicon systems have been developed for 
HuNV. One system involves transfection of HuNV DNA under the control of a T7 promoter into 
cells which have a modified vaccinia Ankara virus expressing the T7 polymerase (Asanaka et al., 
2005). The other system involves transfection of in vitro translated HuNV RNA into cells (Chang 
et al., 2006). Both systems can express viral proteins and replicate viral RNA in cells but are 
limited in that they cannot produce viral particles capable of infecting other cells in the culture. 
Because of these obvious limitations, many of the details of norovirus biology have been 
characterised by using other caliciviruses as models of norovirus infection.  Reverse genetics 
systems, which allow recovery of genetically defined viruses, and cell culture systems are 
available for RHDV and FCV (Liu et al., 2008; Sosnovtsev and Green., 1995). However, these are 
not closely genetically related to HuNV and the pathology of these viruses does not mimic the 
human disease very well.  A cell culture system and reverse genetic model are also available for 
a porcine sapovirus (PoSV) (Flynn and Saif, 1988; Parwani et al., 1991; Chang et al., 2005). This 
virus is also a poor model in terms of genetic relatedness to human norovirus although the virus 
causes gastroenteritis with similar pathology to the human disease (Guo et al., 2001). 
 Much of the recent work on norovirus biology has been carried out using murine norovirus 
(MNV). This virus was discovered due to its lethality in immunocompromised mice (Karst et al., 
2003). The virus is more closely related to HuNVs than FCV, RHDV and PoSV.  Several members 
of the MNV genogroup have now been described. The first MNV member to be discovered 
(MNV-1) induces encephalitis, vasculitis of the cerebral vessels, meningitis, hepatitis, and 
pneumonia in immunocompromised mice (Karst et al., 2003; Ward et al., 2006). However very 
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recently an MNV virus was discovered (MNV-3) which induces acute gastroenteritis in these 
mice (Kahan et al., 2011).  
In addition, three different reverse genetics systems have now been described for MNV (Ward et 
al., 2007; Chaudry et al., 2007; Yunus et al., 2010). Reverse genetics is an approach whereby the 
function of a protein is probed by introduction of a mutation into the nucleic acid sequence 
encoding that protein. In the context of RNA viruses, it has been used extensively to characterise 
viral proteins. The approach utilises a plasmid that can be genetically manipulated to introduce 
any desired mutation into the viral genome encoded by the plasmid. The viral nucleic acid can 
then be introduced into a cell by either transfection of viral RNA which has been in vitro 
transcribed from the reverse genetics plasmid, or by transfection of the reverse genetics 
plasmid into cells. The latter approach requires the plasmid to be transcribed by either a host 
cell polymerase or an exogenous polymerase (such as the T7 polymerase) which has been 
previously transfected into the host cell. In either case, once the viral message has been 
introduced into the host cell the system should mimic a natural infection and allow viral 
message translation followed by viral replication, packaging and egress. This enables genetically 
modified virions to be obtained. These virions can then be phenotypically analysed in a variety 
of in vitro and in vivo virus assays. The major drawback to this system is that if the introduced 
mutation prevents one or all of the steps required to produce virions, infectious virus can never 
be recovered from the system.   
With these developments in virus culture systems, animal model systems and reverse genetics 
systems correlation between structure, function and pathology for noroviruses is now possible. 
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1.5.Roles of viral proteins and RNA in the virus life cycle 
 
 The calicivirus life cycle can broadly be broken down into the following stages: entry and 
attachment, genome translation, proteolytic cleavage of the virus non-structural polyprotein, 
virus replication, virion assembly and egress.  Each of these stages will be introduced in 
chronological order with emphases on the current state of knowledge of structural and 
molecular biology of calicivirus infection.   
1.5.1. Viral capsid: structure and its role in attachment and entry 
The norovirus capsid is made up of 90 dimers of the VP1 protein and has icosahedral symmetry 
as determined by X-ray crystallography (Prasad et al., 1999). The VP2 protein is also thought to 
be part of the capsid as determined by western blotting of purified HuNV virions (Glass et al., 
2000). The number of copies of VP2 in the capsid is not known accurately but has been 
estimated as one or two for FCV (Sosnovtsev and Green, 2000). Each VP1 protomer in the capsid 
has three domains: the N-terminal shell, the protruding domain 1 (P1) and the protruding 
domain 2 (P2).  The shell domain is an antiparallel β-sandwich. The interactions between shell 
domains form the closed inner shell of the virion. P1 and P2 are also β rich domains. 
Interactions between these domains form the open outer shell of the virion which gives it its 
characteristic cup-like depressions (Fig. 1-3).  
The first near-atomic resolution structures of norovirus virions were solved long before 
knowledge of the attachment and entry mechanisms of norovirus virions began to emerge.  
Several lines of evidence have linked cellular attachment of HuNV virions to binding of various 
different human histo-blood group antigens (HBGAs) on the surface of cells. HBGAs are 
carbohydrates present on the outermost part of human glycolipids and glycoproteins. They are 
complex antigens which are made by simple sugar addition to a galactose N-acetylglucosamine 
disaccharide precursor. The link between HBGAs and HuNV virions was first demonstrated 
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when it was shown that Norwalk virus, a genogroup I norovirus, binds to saliva which is 
secretor positive but not secretor negative. Secretor positive cells express one or more of the 
non-Lewis A antigens (Marionneau et al., 2002). Saliva binding assays using a variety of 
different HuNV virus-like particles (VLP) demonstrated that different HuNVs bind a wide 
variety of HBGA (Huang et al., 2003; Huang et al., 2005).  FCV and MNV virions have also been 
shown to bind carbohydrate receptors, glycoprotein α2, 6-linked sialic acid and ganglioside 
GD1a α2, 3-linked sialic acid respectively (Taube et al., 2009; Stuart and brown, 2007).  
X-ray crystallography has been used to investigate the capsid carbohydrate interaction at 
atomic resolution for the HuNVs. Co-crystal structures of the protruding domain (P1 and P2 
together) or the P2 domain alone with carbohydrate have shown that different HBGAs bind 
distinct sites of the outer most surface of the P2 domain (Fig. 1-3) (Chen et al., 2011; Bu et al., 
2008; Sankaran et al., 2011; Choi et al., 2008; Cao et al., 2007; Hansman et al., 2011). While no 
full virion structure has been solved in the presence of HBGAs the liganded and unliganded 
structures of the full protruding domain and P2 sub-domain are remarkably similar suggesting 
that ligand binding does not induce the conformational change that leads to viral uncoating (Cao 
et al., 2007).  
A proteinaceous receptor, feline junctional adhesion molecule 1 (fJAM1), has also been found for 
FCV. FCV infection can be partially blocked in cells by the addition of anti fJAM1 antibodies 
(Makino et al., 2006). In addition transfection of fJAM1 DNA into some non-permissive cell lines 
renders them permissive to FCV infection (Makino et al., 2006). Cryo-electron microscopy 
(cryo-EM) reconstructions of the FCV virion in an unbound state and bound to fJAM1 suggest 
that major structural alterations of the capsid occur upon binding, which led the authors to 
speculate the fJAM1 interaction may be required for viral uncoating (Bhella et al., 2008; Bhella 
and Goodfellow, 2011).  The precise roles of both the carbohydrate receptor and the 
proteinaceous receptor in calicivirus uptake are not yet fully determined.  
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Figure 1-3: Structure of the major capsid protein of human norovirus 
A. The X-ray crystal structure of human Norwalk virus VP1 dimer. Prasad et al., 1999 (PDB 1IHM). B 
The X-ray crystal structures of two different human norovirus P2 domain dimers bound to 
carbohydrate ligand two different human histo-blood group antigens (shown as sticks)  Chen et al., 
2011 (PDB 3PUN) Shanker et al., 2011 (PDB 3SLD).  
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What little is known about virus entry has been derived from a series of cell-based assays using 
inhibitors of possible mechanisms of viral entry coupled with siRNA knock-down, and 
dominant-negative over-expression of proteins involved in entry pathways. These experiments 
showed that FCV up take is by clathrin-mediated endocytosis while MNV uptake is by 
cholesterol and dynamin II-dependent endocytosis (Stuart and Brown, 2006; Perry and Wobus, 
2010; Gerondopoulos et al., 2010). The entry mechanisms for the two viruses also differ in their 
requirement for endosome acidification. MNV entry is unaffected by inhibitors of endosome 
acidification, bafilomycin A1 and chloroquine, while FCV entry is significantly reduced in the 
presence of these inhibitors (Stuart and Brown, 2006; Perry et al., 2009). Given that norovirus is 
primarily an enteric virus, the fact that it is unaffected by acid is unsurprising: given it has to 
traverse the stomach to get to its site of infection. FCV, which is primarily a respiratory virus, is 
unlikely to face the same pH stress as norovirus until it is in the cell. A similar situation has been 
observed for the picornaviruses whereby poliovirus (PV), an enteric picornavirus, is 
bafilomycin A1-resistant (Perez and Carrasco, 1993) while human rhinovirus, a respiratory 
picornavirus, is bafilomycin A1-sensitive (Suzuki et al. 2001).  
 
1.5.2. m7G cap mediated translation initiation 
The next step in the norovirus life cycle is viral RNA translation.  Caliciviruses use a novel 
pathway of translation initiation which is poorly characterised. This mechanism will be 
discussed following an introduction of the currently well characterised pathways of translation 
initiation, and a key viral protein, VPg.  
There are two well characterised pathways of translation initiation of mRNA in eukaryotic cells. 
The first is the canonical pathway used by the majority of eukaryotic transcripts. The canonical 
pathway utilises an m7G cap-binding complex, the eIF4F complex, and a bridging complex, the 
eIF3 complex, to connect the mRNA to the 40S subunit of the ribosome. The eIF4F complex is a 
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heterotrimeric protein complex which includes a cap binding protein, eIF4E, a bridging protein 
eIF4G and an ATP dependent RNA helicase, eIF4A.  eIF4E binds the 5′ end of RNA transcripts via 
π-π stacking interactions between two tryptophan residues  on a flexible loop of eIF4E and the 
guanosine base of the m7G cap (Fig. 1-4) (Marcotrigiano et al., 1997). In humans there are two 
eIF4G homologues eIF4GI and eIF4GII; these share 46% amino acid identity. Both eIF4G 
proteins interact with eIF4E, on a site distant from that used for m7G cap binding, using an 
eIF4G YxxxxLφ motif (φ being any hydrophobic residue) (Marcotrigiano et al., 1999). The 
binding site and mode of binding is identical to that of a family of proteinaceous translation 
inhibitors, which inhibit the eIF4E-eIF4G interaction, the 4EBP family of inhibitors 
(Marcotrigiano et al., 1999) (Fig. 1-4). In addition to binding to eIF4E, eIF4G also binds to eIF4A 
via two distinct sites on the eIF4G molecule (Imataka and Sonenberg, 1997).  Both the eIF4A 
binding sites are located on HEAT (Huntingtin, elongation factor 3 (EF3), protein phosphatase 
2A (PP2A), and the yeast kinase TOR1) repeat domains in the structure. HEAT repeat domains 
are domains made up of pairs of repeating antiparallel helices. There are three known HEAT 
domains in the eIF4G protein. The structures of all three have been determined by X-ray 
crystallography (Marcotrigino et al., 2001; Bellsolell et al., 2006).  No structural information is 
currently available for the mammalian eIF4A-eIF4E interaction. However, a structure of yeast 
eIF4A bound to eIF4G has been determined by X-ray crystallography. Yeast eIF4G has only one 
HEAT domain which contains both eIF4A binding sites (Fig. 1-4) (Schutz et al., 2008). eIF4G also 
interacts with a component of the eIF3 complex, eIF3E. The eIF3 complex is an 800 kDa protein 
complex which interacts with the 40S ribosome and has multiple roles in translation initiation 
and ribosome assembly (Emanuilov et al., 1978; Siridechadilok et al., 2005; Le Febvre et al., 
2006; reviewed by Hinnebusch, 2006).  
eIF4G also interacts with the poly (A) binding protein (PABP) which in turn interacts with the 
poly (A) tail of mRNA (Tarun and Sachs., 1996).  This interaction causes mRNA to form closed 
loops that have been observed by atomic force microscopy (Wells et al., 1998). It has been 
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shown that the poly (A) tail of mRNA enhances translation by more than an order of magnitude 
(Gallie, 1991). Thus, it has been postulated that mRNA circularisation increases the efficiency of 
translation (reviewed in Gallie, 1998). 
 
 
Figure 1-4: eIF4G domain structure and binding partners 
A. Schematic of the longest isoform of eIF4G1 (Genbank accession NP_937884). Figure adapted from 
Jackson et al., 2010. B. The structure of the cap binding protein eIF4E in complex with m7G and the 
peptide inhibitor 4EBP2 (Unpublished PDB 3AM7). C. Yeast eIF4G HEAT interaction with eIF4A 
helicase. The C and N-terminal domains of the latter are abbreviated as CTD and NTD respectively. 
Schutz et al., 2008 (PDB 2VSO). 
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1.5.3. IRES-mediated translation initiation 
The second well characterised mechanism of translation initiation is internal ribosome entry 
site (IRES) meditated translation initiation. Internal ribosome entry sites at located at the 5′ end 
of transcripts and drive translation in an m7G cap-independent manner. They were first 
discovered in the 5′ untranslated region (UTR) of picornavirus RNA (Jang et al., 1988; Pelletier 
and Sonenberg, 1988). Internal ribosome entry sites have extensive secondary structure and 
bind to one or more translation initiation factors, allowing RNA to be coupled to the 40S 
ribosomal subunit without some or even most of the canonical translation initiation machinery. 
There are currently four distinct mechanisms of IRES-mediated translation characterised based 
on their different requirements for initiation factors, associated proteins and the secondary 
structure of the IRES RNA (reviewed by Jackson et al., 2010). In type one and type two IRES-
mediated translation initiation an IRES stem-loop binds to an eIF4G proteolytic cleavage 
product. This allows eIF4E independent translation initiation (reviewed by Jackson et al., 2010). 
In type three IRES-mediated translation initiation, an IRES stem-loop binds to eIF3 allowing 
coupling of the RNA message to the ribosome in the absence of the eIF4F complex (reviewed 
Jackson et al., 2010). In type four IRES-mediated translation mechanism no canonical 
translation initiation factors are required: an IRES stem-loop substitutes for the AUG/Met-tRNA 
and this binds to the 40S subunit directly (Pestova and Hellen, 2003; Wilson et al., 2000; Schuler 
et al., 2006). A model of type one IRES-mediated translation initiation alongside the canonical 
mechanism is shown in Figure 1-5. 
The strategy of internal ribosome entry is common among positive sense RNA viruses. The use 
of such a strategy is often accompanied by shutting down the canonical pathway of translation 
initiation to give the virus an advantage in protein expression. For example in the case of PV 
eIF4GI and eIF4GII are cleaved by the viral 2A protease such that the eIF4E binding site is 
separated from the eIF3 binding site (Gradi et al., 1998). In addition PABP is cleaved by the viral 
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proteases 2A and 3C. Both of these events have been correlated, at least in vitro, to translational 
repression of m7G capped mRNA (Gradi et al., 1998; Joachims et al., 1999). 
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Figure 1-5: Schematic representation of mechanisms of translation initiation 
A. Cap-mediated translation initiation. The m7G cap is shown as a black dot. B. Type I IRES-mediated 
translation initiation. C. Possible mechanism of translation initiation in noroviruses. The VPg of 
noroviruses has been shown to interact with eIF4G. It has also been reported that this protein 
interacts with eIF4E and eIF3 although whether all VPg proteins interact with all of these ligands is 
unknown. The asterisk indicates that PABP is cleaved by the viral protease. This inhibits the canonical 
mechanism of mRNA circularisation.  
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1.5.4. Caliciviral translation: VPg  
VPg proteins were first discovered attached to the 5′ end of the PV genome (Lee et al., 1977; 
Ambros and Baltimore 1978). They were subsequently discovered attached to the RNA 
genomes of several viral families. The best characterised VPg proteins are that of the 
Picornaviridae, Caliciviridae and Potyviridae. 
The VPg proteins of piconaviruses, caliciviruses and potyviruses are proteins of approximately 
2 kDa, 15 kDa and 22 kDa respectively.  The evolutionary relationship of these VPg molecules is 
difficult to determine based upon sequence identity.  The calicivirus and potyvirus VPg proteins 
share approximately 13% sequence identity but neither protein appears to share amino acid 
identity with picornavirus VPg. All of these proteins are covalently attached to their respective 
genomes via a hydroxyl group on a conserved tyrosine (Murphy et al., 1991; Murphy et al., 
1996; Ambros and Baltimore 1978; Belliot et al., 2003; Mitra et al., 2004; Anindya et al., 2005). 
In the case of picornaviruses and caliciviruses this is known to be via a phosphodiester linkage 
(Ambros and Baltimore 1978; Belliot et al., 2003).  
Nuclear magnetic resonance (NMR) spectroscopy structures have been determined for the 
picornaviral (PV) and caliciviral (FCV) VPg proteins. Two structures of the 22 residue PV VPg 
polypeptide have been determined; one with a stabilising agent, trimethyl amine N-oxide 
(TMAO), and one without. In the presence of stabilising agent the C-terminal six resides form an 
α-helix which packs against the N-terminal 15 residues which form an ordered loop structure. 
Central to the packing of the two structural motifs is tyrosine 3 which is the conserved genome 
linked tyrosine (Fig. 1-6) (Schein et al., 2006; Rothberg et al., 1978; Ambros and Baltimore, 
1978).  In the absence of TMAO VPg forms a much less ordered molten globule-like structure 
with little or no secondary structure elements (Schein et al., 2006).  
 
 Introduction 
 
28 
 
FCV VPg is 111 residues in length. It has a structured core which extends from residue 10 to 
residue 80. The core is formed of a tight three α-helix bundle with each helix consisting of just 
over three turns (Fig. 1-6) (Kwok et al., unpublished). Tyrosine 24, the conserved genome-
linked tyrosine, does not pack into the hydrophobic core. Instead it is highly surface-exposed, 
jutting out of helix-1 (Mitra et al., 2004).  
 
Figure 1-6: Two views of NMR structure ensembles of poliovirus and feline calicivirus VPg 
Nucleotide accepting tyrosines are shown as sticks. A. Overlay of the 10 conformers of poliovirus 
VPg structure deposited in the protein data bank (PDB 2BBL) (Schein et al., 2006). B. The 10 lowest 
energy conformers of the FCV VPg structure (Kwok et al., unpublished) 
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1.5.5. Caliciviral translation: VPg  
Caliciviruses, like picornaviruses, do not have a 5′ m7G cap-due to the covalent linkage of VPg to 
the 5′ end of the genome.  Unlike the picornaviruses, the caliciviruses do not have an IRES; 
suggesting that caliciviral translation initiation must be by a mechanism that is both m7G cap 
and IRES-independent.  
It has been known since the 1970s that FCV genomic RNA which has been proteinase K treated 
is not infectious when transfected into cells (Burroughs and Brown, 1978). In the mid 1990s it 
was shown that m7G-capped calicivirus genomic RNA is infectious, suggesting a role for VPg in 
translation initiation (Sosnovtsev and Green, 1995). This observation was solidified by the 
demonstration that proteinase K treatment of viral transcripts specifically prevents translation 
of viral proteins in in vitro translation assays (Herbert et al., 1997).  These observations, taken 
together, suggest that VPg plays the role of an m7G cap by coupling the viral message to the 40S 
ribosomal subunit.  
The mechanism of VPg mediated translation remains poorly characterised. One of the reasons 
for this is that two separate groups have proposed three different binding partners for VPg, all 
of which could mediate translation initiation.  A study using a HuNV (GI Norwalk virus) VPg has 
shown an interaction between VPg and eIF3D by yeast two-hybrid assay (Daughenbaugh et al., 
2003). Pull-down experiments with purified eIf3 complex and VPg also demonstrated an 
interaction between VPg and the eIF3 complex (Daughenbaugh et al., 2003). This work also 
demonstrated that eIF4GI, eIF4E and the 40S ribosomal protein S6 were also associated with 
VPg in cell lysate. This suggests that VPg alone can mediate the recruitment of translation 
initiation factors and the 40S ribosomal subunit. Using truncated VPg proteins, the region of VPg 
required for interaction with translation initiation factors was narrowed down to the C-terminal 
half of the protein (Daughenbaugh et al., 2003). 
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Daughenbaugh et al also found that VPg is capable of inhibiting in vitro translation of m7G 
capped mRNA and mRNA with a type four IRES (Daughenbaugh et al., 2003).  As a type four 
IRES does not require any translation initiation factors, it is likely that VPg is locking the 40S 
ribosomal subunit into a conformation that is inhibitory to type four IRES-mediated translation.  
This may also be the mechanism of VPg inhibition of m7G capped mRNA translation. However, 
VPg may also sequester translation initiation factors required in m7G cap-mediated translation.  
Viral RNA translation via direct interaction with eIF3 is not without precedence. Type three 
IRES such as that of hepatitis C virus (HCV) can bind to the eIF3 complex to initiate translation 
as evidenced by RNA toe printing assays, RNase protection assays and cryo-EM reconstruction 
of an HCV IRES eIF3 binary complex (Sizova et al., 1998; Pestova et al., 1998; Siridechadilok et 
al., 2005).  
Another study by Daughenbaugh and colleagues which extended their translation initiation 
work into the MNV model showed an almost identical pattern of translation initiation factors 
pulled down by MNV VPg from cell extracts to that previously seen for HuNV (Daughenbaugh et 
al., 2006).  In addition, they showed that eIF4GI and eIF4E interact with MNV VPg in cells, as 
determined by pull-down using cells infected with MNV. However, the authors did not 
investigate interaction between eIf3 and VPg during the course of infection (Daughenbaugh et 
al., 2006).  Using purified protein in pull down assays preliminary data from our laboratory 
suggest that MNV VPg interacts with eIF4GI. This strategy has also demonstrated that the most 
N-terminal HEAT domain of eIF4GI is sufficient to mediate the VPg-eIF4G interaction. This data 
is supported by collaborators who have demonstrated the VPg-eIF4G interaction using whole 
cell lysate based pull down assays. This approach has also showed that a single amino acid 
mutation at the extreme C-terminus of VPg, F123A, is enough to disrupt the interaction (Chung 
et al., unpublished). 
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In addition to eIF3 and eIF4GI, previous studies have shown a direct interaction between 
purified eIF4E and VPg proteins of MNV, LDV and FCV using an ELISA-based assay (Goodfellow 
et al., 2005; Chaudhry et al., 2006). However, the functional relevance of this interaction for 
MNV is unclear given that MNV translation in vitro is not sensitive to eIF4E depletion or 
disruption of the eIF4E-eIF4G interaction by 4EBP1 addition (Chaudhry et al., 2006). FCV 
translation, however, is sensitive to both eIF4E depletion and 4EBP1 addition indicating that the 
VPg-eIF4E interaction is more likely than its MNV counterpart to play a role in translation in 
vivo (Chaudhry et al., 2006).  
From the above studies it is clear that calicivirus VPg interacts with the cellular translational 
initiation machinery.  However, it is not yet clear weather all calicivirus VPg proteins interact 
with eIF4GI, eIF4E and eIF3D or whether VPg interacts with a subset of these in a genus or 
species dependent manner.  
The potyvirus VPg has also been shown to interact with Arabidopsis thaliana eIF4E and its 
homologue eIF(iso)4E and can inhibit m7G cap-mediated translation by competing for the cap 
binding site (Wittmann et al., 1997; Miyoshi et al., 2006; Leonard et al., 2000; khan et al., 2006; 
Khan et al., 2008). In picornaviruses the VPg protein does not have a role in translation as 
protease digestion of the PV VPg protein does not affect infectivity (Nomoto et al., 1977). In 
addition, the picornavirus 5′ UTR of the RNA genome is sufficient to drive translation of a 
downstream ORF (Jang et al., 1988; Pelletier and Sonenberg, 1988).  
 
 
 
 
 
 Introduction 
 
32 
 
1.5.6. Caliciviral polyprotein processing 
Once translated, the large non-structural polyprotein must be cleaved into its functional units. 
The polyprotein is approximately 200 kDa, but in cells this is not observed most likely due to 
the proteolytic processing being co-translational (Sosnovtseva et al., 1999; Sosnovtsev et al., 
2006). The protein responsible for proteolytic processing is the 3C like protease, NS6pro  
(Sosnovtseva et al., 1999). This is a cysteine protease which adopts a chymotrypsin-like fold 
(Zeitler et al., 2006; Nakaamura et al., 2005; Leen et al., 2012).  The NS6pro fold consists of five 
antiparallel β-strands which form a truncated β-barrel domain. This packs against an anti-
parallel six-stranded complete β-barrel domain. The active site, which consists of a cysteine, 
histidine and glutamic acid/aspartic acid catalytic triad, is at the interface of the β-barrel 
domains (Fig. 1-7). 
 
 
 
 
 
 
 
 
Figure 1-7: X-ray crystal structure of murine norovirus NS6pro 
The active site triad is composed of cysteine, histidine and aspartic acid residues. In this structure 
the cysteine has been mutated to an alanine.  The active site triad is shown in sticks. In addition the 
N-terminal domain including the β-barrel is shown in green while the C-terminal domain is shown in 
orange. A disordered loop missing from the structure is shown as a dashed line (Leen et al., 2012) 
(PDB 4ASH). 
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Combined strategies of western blotting of polyprotein cleavage products, N-terminal 
sequencing of those products and mutation has led to identification of all cleavage sites in the 
calicivirus polyprotein (Belliot et al., 2003; Liu et al., 1999; Seah et al., 2003; Sosnovtsev et al., 
2002; Sosnovtsev et al., 2006).  There are small differences in the final cleavage products of the 
four different genera. The norovirus polyprotein is cleaved into six protein products. One 
cleavage site present at the extreme N-terminus of the other viral genera is absent from the 
norovirus polyprotein (Fig. 1-8). The FCV polyprotein is also cleaved into six protein products, 
but in this case the NS6pro NS7po l cleavage junction has been mutated (Fig. 1-8). The roles of 
these seven caliciviral non-structural proteins will be discussed in more detail in the viral 
replication section (Section 1.5.8).  
Figure 1-8: Cleavage map of the non-structural polyprotein of feline calicivirus (FCV) and murine 
norovirus (MNV) 
Final cleavage products are shown as black boxes. The residue number and sequence of each 
junction are shown above the boxes.  
 
The 3C-like protease of FCV has also been implicated in cleaving the PABP and the N-terminal 
region of eIF4G (Kuyumcu-Martinez et al., 2004; Wilcocks et al., 2004). Cleavage of the PABP 
and eIF4G may have the effect of inhibiting translation of poly (A)-tailed messages by disrupting 
the circularisation of the mRNA molecule and (or) inhibiting binding of translation initiation 
factors which bind to the PABP. It has been postulated that PABP and eIF4G cleavage is one of 
the mechanisms which mediates a host translation shut off which has been observed in FCV 
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infected cells beginning five hours post-infection (Kuyumcu-Martinez et al., 2004; Wilcocks et 
al., 2004). Since caliciviral messages are poly (A)-tailed, these observations suggest that there 
must be a mechanism by which caliciviral messages escape PABP cleavage-mediated shutoff.  
 
1.5.7. Caliciviral replication: Setting up viral replication factories 
The next step in the virus life cycle is genome replication. Ultrastructural analysis of the 
replication of a diverse group of positive sense RNA viruses has demonstrated that cells infected 
with these viruses undergo large-scale membrane rearrangements several hours post-infection. 
This rearrangement involves the formation of membranous vesicles which over time fill up with 
paracrystalline arrays of virus like particles (Matern and Daniel, 1965; Stohlman et al., 1975; 
Welsch et al., 2009; Love and Sabine, 1975; Wobus et al., 2004).  Viral RNA synthesis has been 
correlated to the formation of these membrane vesicles (Bienz et al., 1980).  Thus, it is likely 
that these vesicles serve as factories for both genome replication and virion assembly.  
Recent work, primarily using fluorescent microscopy of infected cells or cells transfected with 
virus protein expression vectors, has begun to unravel the mechanisms underlying genome 
factory production in the Caliciviridae. In MNV infection, replication complexes are visible six 
hours post-infection (Hyde et al., 2009). These structures were found to be associated with 
proteins from the endoplasmic reticulum (ER), trans-Golgi network and endosomes suggesting 
that these vesicles are derived from the secretory pathway in cells (Hyde et al., 2009). All of the 
non-structural proteins and viral RNA co-localise with these structures (Hyde et al., 2009). 
Expression of viral proteins in cells showed that NS1/2 and NS4 interact with components of 
the secretory pathway, suggesting that these proteins may be important in setting up virus 
factory structures (Hyde and Mackenzie, 2010). In FCV, expression of viral proteins in cells 
demonstrated that NS2, NS3 and NS4 all localise to the ER and both NS3 and NS4 cause large 
ultrastructural changes in the ER (Bailey et al., 2010). Previously, a yeast two-hybrid study 
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looking at association between FCV viral proteins found that NS2 interacts with NS3, NS4 and 
NS6pro/NS7po l and that NS6pro/NS7pol interacts with VPg (Keiser et al., 2006). Taken together, 
these data suggest that NS2, NS3 and NS4 can both subvert the host secretory pathway for virus 
factory production and recruit the key viral proteins required for replication to these structures.  
 
1.5.8. Calicivirus replication: NS7pol 
The calicivirus NS7pol enzyme is an RNA-dependent RNA polymerase (RDRP) which is 
homologous to the polymerases of other positive sense RNA viruses such as the 3Dpo l of the 
Picornaviridae. Structures have been determined of the 3Dpol of several picornavirus species 
such as foot and mouth disease virus (FMDV) and PV (Ferrer-Orta et al., 2004; Ferrer-Orta et al., 
2006; Ferrer-Orta at al., 2010; Hansen et al., 1997; Marcotte et al., 2007; Gong and Peerson, 
2010). In addition, several caliciviral NS7pol structures have been solved including HuNV, 
Sapovirus, and Lagovirus (Ng et al., 2002; Ng et al., 2004; Zamyatkin et al., 2008; Zamyatkin et 
al., 2009; Fullerton et al., 2007). All polymerases share a common “right hand” fold with thumb, 
fingers and palm domains. In addition to these domains, RDRPs including those of the 
Picornaviridae and Caliciviridae have another structural motif called the “fingertips” motif, 
which connects the thumb and fingers domains causing the polymerase to have a closed central 
cleft (Fig. 1-9). This central cleft is the RNA-binding cleft, which positions the template strand 
and newly synthesised daughter strand to facilitate correct nucleotide addition by the active site 
of the polymerase. 
 The active site of the polymerase is contained within the palm domain and is characterised by 
two aspartic acid residues which co-ordinate two divalent cations. The presence of this two 
metal ion coordination in crystal structures led Tom Steitz to propose a two metal ion 
mechanism of nucleotide addition for all polymerases (Steitz, 1993). This mechanism was 
modified subsequently by Cameron and colleagues to include a general acid which protonates 
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HuNV NS7pol PV 3D
pol
E. coli Klenow
HIV RT
the pyrophosphate leaving group (Castro et al., 2007). The basic mechanism is that one of the 
metals (A) reduces the pKa of the free 3′ hydroxyl group of the daughter strand. This induces 
deprotonation of the free 3′ hydroxyl group, allowing it to nucleophilically attack the α 
phosphate of the incoming nucleotide triphosphate (NTP). This, in turn, causes the transient 
formation of a pentavalent α phosphate intermediate which is resolved by the breaking of the 
bond between the α phosphate and an oxygen of the β phosphate. The second metal ion (B) 
stabilises the pentacovalent intermediate and the leaving phosphate groups. Finally the leaving 
group is protonated by a conserved lysine.  This is shown diagrammatically in Figure 1-10.  
 
 
 
 
 
 
 
 
 
Figure 1-9: Conservation of polymerase architecture across classes 
Two RNA dependent RNA polymerases (RDRPs); Human norovirus (HuNV) NS7pol (PDB 1SH0)(Ng et 
al., 2004) and poliovirus (PV) 3Dpol (PDB 1RA6) (Thompson and Peersen, 2004), as well as a DNA 
dependent DNA polymerase, the Klenow fragment of E. coli  (PDB 1QSL) (Brautigam et al., 1999) and 
a RNA dependent DNA polymerase, the human immunodeficiency virus (HIV) reverse transcriptase 
(RT)(PDB 2HVT) (Smeardon et al., 1994). Fingers, palm and thumb domains are shown in yellow, 
green and blue respectively. The finger tips domains of the RDRPs are shown in cyan. 
 
Fingers 
   Palm 
 Thumb 
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Figure 1-10: The catalytic mechanism of all polymerases 
The mechanism consists of six steps. These are numerically listed in the above figure. Briefly two 
metal ions, labelled A and B, are coordinated by two aspartic acid residues. Metal ion A lowers the 
pKa of the 3′ OH of the ribose sugar of the daughter strand. This causes deprotonation of the 3′ OH 
(1). The 3′ oxygen then nucleophilicly attacks the α phosphate of the incoming nucleotide 
triphosphate (NTP) (2). The α phosphate is then transiently pentacovalently coordinated (3) (this 
step is not shown graphically above). This intermediate is resolved by breaking the bond between 
the α phosphate and the oxygen of the β phosphate (4). The pyrophosphate leaving group is then 
protonated by a general acid (5). And the leaving group exits the active site (6). Figure was made 
using the Norwalk virus polymerase, RNA and NTP co-crystal structure (PDB 3BSO) (Zamyatkin et al., 
2008). 
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In addition, structural studies have also defined several subdomains which have important roles 
in both catalysis and stabilisation of the incoming nucleotide and stabilisation of the RNA 
duplex. These sub-domains and their roles in polymerase function are summarised in Fig. 1-11. 
 
 
 
 
 
 
 
 
 
Figure 1-11: RNA dependent RNA polymerase motifs and their role in catalysis 
A. X-ray crystal structure of the poliovirus RNA dependent RNA polymerase with RNA and NTP (PDB 
3OL6) (Gong and Peersen, 2010). The model is coloured according to motifs. The motifs and their 
roles in catalysis are documented in B. 
Motif Function Colour in above 
figure 
A Co-ordination of divalent cation and interaction with the 2′ OH of incoming 
NTP. Forms the catalytic centre along with C. 
Pink 
B Interaction with template strand and 3′ OH of incoming NTP. Cyan 
C Co-ordination of divalent cation and interaction with the 3′ OH of incoming 
NTP. Forms the catalytic centre along with C. 
Orange 
D Interacts with the γ phosphate of incoming NTP. Contains the general acid 
which protonates the phosphate leaving group.  
Gray 
E Interacts with newly added base pairs of daughter strand.  Brown 
F Positions the template strand upstream of the catalytic site along with G 
forms the template strand entry tunnel.  
Green 
G Positions the template strand upstream of the catalytic site along with F 
forms the template strand entry tunnel.  
Red 
I Interacts with the major groove of newly formed RNA duplex. Blue 
II Interacts with the phosphate backbone of the template.  Yellow 
III Interacts with the minor groove of newly formed RNA duplex.  Black 
A 
B 
C 
D 
E 
F 
G 
I 
II 
III 
A 
B 
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1.5.9. Calicivirus replication: NS7pol initiation of RNA synthesis 
The replication of positive sense RNA viral RNA must proceed first by the production of a 
negative-sense strand which serves as a template for the production of positive sense genomic 
RNA for new virions. This is effectively a double transcription reaction to make multiple copies 
of the parent strand. RNA synthesis itself can be thought of as three distinct processes. The first 
step is initiation; this is the addition of the first nucleotides of the daughter strand. The second 
step, elongation, is the addition of nucleotides to the nascent strand in a template-dependent 
manner until near the end of the template. Finally, termination is the mechanism by which the 
polymerase ceases nucleotide addition to the daughter strand and the RNA synthesis complex of 
template RNA, daughter RNA and polymerase, disassociates. For RDRPs, elongation and 
termination are poorly characterised. Because of this, replication initiation is the only stage that 
will be discussed in detail.  
There are a multitude of mechanisms by which transcription initiation occurs in RNA viruses. 
However, these can be broadly categorised into either de novo or primed initiation mechanisms. 
In de novo initiation, an incoming NTP base pairs with the 3′ end nucleotide of the template. A 
second NTP base-pairs with the nucleotide immediately 5′ to the 3′ end nucleotide of the 
template. Effectively, the first nucleotide acts as a single nucleotide primer providing a free 3′ 
hydroxyl group which attacks the α phosphate of the second NTP forming a dinucleotide 
(reviewed in Van Dijk et al., 2004). The primed mechanisms can be divided into three main 
groups: polynucleotide-priming, copy back-priming and protein-priming. Polynucleotide-
priming is the use of a short stretch of RNA to provide a free 3′ hydroxyl group. An example of 
this is the cap snatching mechanism of influenza which uses an ~11 nucleotide primer derived 
from host mRNA to make viral RNA (reviewed in Van Dijk et al., 2004).  Copy back-priming is 
the use of a looping mechanism in the template strand whereby the 3′ end of the template 
strand serves as the primer for daughter strand synthesis. This strategy is used by the 
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bacteriophage phi6 (Laurila et al., 2005). Finally, protein-priming is the use of a hydroxyl group 
on an amino acid side chain as the free 3′ hydroxyl as a primer (reviewed in Van Dijk et al., 
2004). The best studied example of protein-priming is the picornaviral VPg. A model has been 
proposed for the mechanism of nucleotidylation of the picornaviral VPg. Firstly VPg or a 
cleavage precursor is nucleotidylated by the 3Dpo l in a template-dependent manner to produce 
VPg-pUpU (dinucleotide form). The template used for primer synthesis, at least for negative-
strand synthesis, is a stem-loop structure called the cis-acting replication element (CRE) 
(Goodfellow et al., 2000; Goodfellow et al., 2003). VPg-pUpU in turn binds to the 3’ end of both 
the genomic and anti-genomic RNA to initiate synthesis of the negative and positive sense RNA 
respectively.  There are several lines of evidence for this model. Firstly VPg can be 
nucleotidylated in vitro by using poly (A) or CRE as a template (Paul et al., 1998; Paul et al., 
2003a). Secondly, all picornavirus sequences start with UU and when this motif is deleted, at 
least in the case of PV, using reverse genetics the only virus recoverable from cell culture has 
reverted to wild type for the UU motif (Harmon et al., 1991). Thirdly, a mutation in 3Dpol which 
causes a specific defect in the formation of VPg-pUpU but not VPg-pU has a replication defect in 
cell culture despite having WT levels of processivity in vitro (Korneeva and Cameron, 2007).  
Finally, mutations which render VPg resistant to nucleotidylation kill the virus (Cao and 
Wimmer, 1995; Paul et al., 2003b). This model of picornavirus nucleotidylation is shown in 
Figure 1-12. 
In vitro, two types of assays have been used to characterise the priming mechanism used by 
NS7pol. The first assay, a nucleotidylation assay, measures nucleotide addition to VPg by NS7pol 
using nucleotide radiolabelled at the α-phosphate position. The second assay is an in vitro NS7po l 
based RNA synthesis assay. This uses a variety of templates, including heteropolymeric RNA 
(e.g. ATAGA) and homopolymeric RNA (e.g. AAAAA) as well as a variety of primers and attempts 
to determine which priming mechanisms allow RNA synthesis to occur. In the case of HuNV, one 
laboratory has found that synthesis using a homopolymeric template is primer dependent 
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(Royham et al., 2006a, Royham et al., 2006b). This laboratory has also shown that when poly (A) 
RNA is used as template and VPg used as a primer, that VPg can be nucleotidylated to form VPg-
pU (mononucleotide form) and this can be elongated to VPg-polyU. VPg nucleotidylation was 
found to be strictly template-dependent. Given that negative-strand synthesis is likely to start at 
the 3′ poly (A) tail of the genomic RNA, these data suggest that negative-strand synthesis is 
template-dependent and VPg can act as this primer. The same group using the same assay but 
this time using anti-sub-genomic RNA as template found that positive-strand synthesis was 
possible without added primer and that the product formed was two RNA molecules of sub-
genomic size (Royham et al., 2006a, Royham et al., 2006b). From their data, Royham and 
colleagues proposed that negative sense RNA synthesis was VPg primed while positive-strand 
synthesis was primed de novo. However, they did not look into the possibility of primer-
dependent positive-strand synthesis by an oligonucleotide primer or by VPg. Nor could they 
exclude the possibility that negative-strand synthesis was being primed by an oligonucleotide 
rather than VPg.   
Previously, Fukushi and colleagues had shown that HuNV NS7pol can initiate transcription de 
novo using both homopolymeric and heteropolymeric templates (Fukushi et al., 2004). This 
directly contradicts the Royham studies and opens the possibility that initiation of both positive 
and negative-strand transcription occurs de novo. Complicating the matter even further, work 
with the HuNV NS6proNS7pol precursor suggests that this protein can nucleotidylate VPg in a 
template-independent manner. However, a region near the 3′ end of the genomic RNA was 
found to enhance the nucleotidylation of VPg by NS6proNS7pol (Belliot et al., 2008). While the 
RNA sequence responsible for this has not yet been determined, it may be equivalent to the CRE 
stem-loop found to enhance VPg nucleotidylation in PV (Goodfellow et al., 2000). In addition, 
NS6proNS7pol of both RHDV and HuNV was found to be able to synthesise anti-sub-genomic RNA 
using a copy back priming mechanism (Belliot et al., 2005; Vazquez et al., 2001). 
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Figure 1-12:  Model of picornaviral genome replication 
VPg is first nucleotidylated by 3Dpol to form VPg-pUpU. The template for the reaction is the cis-acting 
replication element (CRE). VPg-pUpU acts as a primer for negative-strand synthesis by base pairing 
with the poly (A) tail of genomic RNA. VPg-pUpU also acts as a primer of positive-strand synthesis by 
base pairing with the first two bases of the anti-genomic RNA.  
 
Given the number of different mechanisms proposed for transcription initiation, it is likely that 
not all of them are relevant in vivo. It may be that in vitro, given non-physiological levels of 
particular components, that the polymerase is much more versatile than is possible in vivo. It is 
also possible that macromolecules in replication complexes cause the polymerase to favour one 
initiation mechanism over others.  
As caliciviral RNA extracted from cells is covalently coupled to VPg, the possibility of positive 
sense RNA being synthesised by a de novo mechanism raises an interesting question: how does 
VPg become covalently attached to genomic RNA if it does not act as a primer for its synthesis? 
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1.5.10. Calicivirus replication: VPg nucleotidylation 
There is no current model of VPg nucleotidylation for caliciviruses. However, near-atomic 
resolution structures have been determined for two different picornaviruses in complex with 
VPg. These include a binary complex of FMDV 3Dpol with VPg, a ternary complex of FMDV 3Dpol, 
VPg and uridine-5'-triphosphate (UTP) prior to catalysis and a binary complex of FMDV 3Dpol 
and uridylylated VPg (Ferrer-Orta et al., 2006). The structure of a binary complex of coxsackie B 
virus (CBV) 3Dpol with VPg has also been determined (Gruez et al., 2008). FMDV and CBV VPg 
proteins have two distinct binding sites on the polymerase. FMDV VPg traverses the RNA 
binding tunnel (Fig. 1-13). Its nucleotide accepting tyrosine (Y3) is positioned in the active site 
pocket normally occupied by the incoming NTP. Based on the structural evidence it is likely that 
VPg can be productively nucleotidylated in this position.  CBV VPg, on the other hand, binds at 
the base of the thumb domain (Fig. 1-13). The N-terminal six residues of VPg, including Y3, were 
absent in the structure. However, the distance between the active site of the polymerase and the 
most N-terminal residue of VPg in the structure precludes the possibility of VPg being 
productively nucleotidylated by the 3Dpol it is interacting with. It is also very unlikely in this 
crystal form that the VPg can interact with the base of the thumb of one 3Dpol and the active site 
of another. Thus, the physiological relevance of this mode of binding is unclear.  
What is also unclear is the relevance of either of these modes of binding to caliciviral VPg 
nucleotidylation.  The structures of the picornaviral 3Dpol and the caliciviral NS7po l are both very 
similar. However, the caliciviral nucleotide-accepting tyrosine is more than 20 residues from the 
N-terminus of the protein. It is also located in a helical region of the protein. This suggests that if 
the mode of binding of the calicivirus VPg mimics that of FMDV, then the protein would have to 
unfold and its N-terminus translocate more than 20 residues through the RNA binding tunnel of 
the polymerase.  While this seems unlikely, no work has been carried out to characterise the 
caliciviral NS7pol-VPg interaction. 
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Figure 1-13: Picornaviral 3Dpol VPg interaction 
X-ray co-crystal structures have been solved for both foot and mouth disease virus (FMDV) and 
coxsackie B virus (CBV). The VPg proteins are shown in green, the polymerase proteins in blue. 
FMDV (PDB 28FE) (Ferrer-Orta et al., 2006). CBV (PDB 3CDW) (Gruez et al., 2008). 
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1.5.11. Calicivirus replication: polymerase fidelity 
The fidelity of genome replication in positive sense RNA viruses has emerged as a very 
important topic over the last two decades. Polymerase proteins of this viral group lack the 
exonuclease activity associated with multisubunit polymerases and thus have comparatively 
high error rates (Arnold and Cameron, 2004). This error rate is typically 10-3 to 10-5 mutations 
per site per genome replication event, depending on the virus (reviewed in Castro et al., 2005).  
A small increase in this error rate can lead to significant decrease in viral fitness, an effect that is 
termed error catastrophe (Holland et al., 1990; Lee et al., 1997). Induction of error catastrophe 
is the mechanism by which the antiviral purine analogue ribavirin triphosphate works (Crotty 
et al., 2001).  
Viral RDRPs have a six-step elongation cycle. 1) the RDRP RNA complex binds an incoming NTP, 
2) conformational change leading to closure of the active site, 3) the nucleotidyl transfer 
catalytic step, 4) post catalysis stabilisation of the reaction products and relaxation of the active 
site to the open conformation, 5) release of the diphosphate group and 6) translocation of the 
polymerase along the template strand by one nucleotide (Gong and Peerson, 2010).  These steps 
are summarised in Figure 1-14.  Theoretically, fidelity checkpoints could occur at any of the 
steps from two to five in this cycle. These checkpoints would influence the rate constants of the 
forward or reverse reaction at one or more steps in the cycle.  Surprisingly, kinetic  studies have 
shown that there is little or no energetic difference at the NTP binding step of the catalytic cycle 
(Arnold and Cameron, 2004; Arnold et al., 2004). This suggests that initial binding of the NTP is 
mediated by the triphosphate moiety of the NTP.  These studies have also shown that the 
primary energetic barriers for incorrect nucleotide addition are at the pre-catalysis closure of 
the active site and the nucleotidyl transfer catalytic step (Arnold and Cameron, 2004; Arnold et 
al., 2004).  
 
 Introduction 
 
46 
 
 
 
Figure 1-14: The catalytic cycle of RNA dependent RNA polymerases 
The steps involved the elongation cycle of RNA dependent RNA polymerases are:  1) the RDRP RNA 
complex binds to an incoming NTP, 2) conformational change leading to closure of the active site, 3) 
the nucleotidyl transfer catalytic step, 4) post catalysis stabilisation of the reaction products 
relaxation of the active site to the open conformation, 5) release of the diphosphate group an d 6) 
translocation of the polymerase along the template strand by 1 nucleotide . The closed polymerase 
conformation is marked NS7pol*. 
 
It is always difficult to assign conformations seen in structural studies to those predicted by 
kinetic studies, as demonstrated by the continuing controversy of whether a large domain 
movement in DNA polymerases corresponds to an active site closure predicted by kinetic 
studies (Joyce and Benkovic, 2004). However, recent X-ray crystallographic studies have 
convincingly demonstrated an active site rearrangement in the 3Dpo l of PV, albeit post-catalysis, 
correlates well to the predicted closed conformation. This rearrangement includes several key 
side chains, including D233, N297, D238, K61 and S288, which were predicted by kinetic 
analysis to have a role to play in polymerase fidelity (Gohara et al., 2000).  These side chains 
form a hydrogen bond network which interacts with the 2′ and 3′ hydroxyl group of the 
incoming NTP (Fig. 1-15). From the kinetic model of Arnold and colleagues it is also predicted 
that the closed conformation would re-orientate the triphosphate of the incoming NTP to a 
catalytically competent position (Arnold and Cameron, 2004; Arnold et al., 2004). However, as 
this conformation has been captured post-catalysis it is impossible to determine whether or not 
this is truly the closed conformation.  
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The importance of active site closure to polymerase fidelity has been shown by biochemical and 
structural characterisation of 3Dpol proteins with altered fidelity characteristics. The G64S 
mutant of PV 3Dpol was isolated as a PV ribavirin triphosphate escape mutant in cell culture. 
This mutant increases the fidelity of 3Dpol thus decreasing the amount of ribavirin triphosphate 
incorporated into new virus genomes relative to the wild type polymerase (Pfeiffer and 
Kirkegaard, 2003; Arnold et al., 2005). The only difference between wild type and mutant 
polymerase in terms of the kinetics of the elongation cycle is that the rate of polymerase active 
site closure prior to catalysis for G64S is three times slower than wild type (Arnold et al., 2005). 
X-ray crystallographic studies of WT and G64S mutant 3Dpol have shown that G64 is involved in 
a hydrogen bond network connecting position 64 in the fingers domain to the polymerase N-
terminus which in turn interacts with residue 237 of motif A. This residue is very likely to have 
a role to play in active site closure given its proximity to D238 which has a significant side chain 
reorientation upon active site closure (Fig. 1-15). The equivalent mutation in FMDV 3Dpol is 
G62S. Unlike the PV equivalent, this mutation has never been selected as a ribavirin 
triphosphate escape mutant and an increase in polymerase fidelity has never been 
demonstrated for this mutant. X-ray crystallographic studies of WT and G62S mutant FMDV 
3Dpol complexed with NTP and duplex RNA have shown that S62 does not contribute any extra 
hydrogen bonds which could stabilise the interaction between the N-terminus and motif A of 
the polymerase, unlike G64S of PV. However, there is a large deviation between WT and G62S in 
the loop between β strand-9 and α helix-11 (β9α11 loop). This loop in PV contains S288 which 
also re orientates to form the closed conformation of the polymerase.  
A mutation which has been selected as a FMDV ribavirin triphosphate escape mutant in cell 
culture, M296I, is located on the β9α11 loop. However, unlike G64S, this mutant has reduced 
fidelity in comparison to the WT 3Dpol (Arias et al., 2008). X-ray crystallographic studies of WT 
and M296I mutant 3Dpol complexed with NTP and duplex RNA has shown a deviation in the 
position of the β9α11 loop relative to the wild type polymerase.  This deviation prevents base-
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pairing of ribavirin triphosphate with a pyrimidine due to steric hindrance (Ferrer-Orta et al., 
2010). The only other picornavirus polymerase mutant which has been shown to have 
decreased fidelity is PV N297E. While structural studies have not been published on this 
mutation this residue also participates in stabilisation of the closed conformation of the 
polymerase (Korneeva and Cameron, 2007) (Fig 1-15). Thus both kinetic and structural 
evidence points to a closure of the active site prior to catalysis as the key fidelity checkpoint for 
viral RDRPs.  
The understanding of fidelity of polymerases may have an important role in the development of 
new antiviral compounds that exploit the error catastrophe effect in a similar manner to 
ribavirin triphosphate. An alternative strategy that is being developed is the use of high fidelity 
polymerases in attenuated live virus vaccines. A PV virus vaccine containing G64S has been 
shown to have reduced capacity to mutate to higher fitness genotypes relative to vaccines with 
WT polymerases in a mouse model (Vignuzzi et al., 2008).  
 
Figure 1-15: Open versus closed conformation of the poliovirus 3Dpol active site 
 RNA and residue side chains important for active site closure are shown as sticks. The template RNA 
strand is shown in green and the daughter strand shown in yellow. Important interactions involved 
in closure are shown as dashes. (PDB 3OL6 open, 3OL7 closed)(Gong and Peersen, 2010). 
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1.5.12. Caliciviral assembly and egress 
The final step in the virus life cycle is assembly and egress. Little is known about the process of 
capsid assembly in caliciviruses. Expression of the VP1 protein in eukaryotic cells causes the 
production of viral like particles which are morphologically and antigenicly similar to native 
virions (Jiang et al., 1995; Geissler et al., 1999; Jiang et al., 1995). Thus, the VP2 is not required 
for the assembly process. However, there is some evidence that VP2 stabilises VP1 and at least 
in a baculovirus expression system, increases VP1 expression levels (Bertolotti et al., 2003). In 
addition, yeast two-hybrid and co-immunoprecipitation studies have demonstrated an 
interaction between VP1 and VP2 (Kaiser et al., 2006; Glass et al., 2003). However, given the fact 
that only one or two VP2 molecules are present per virion and 180 VP1 molecules are present 
there must be a mechanism for regulating the stoichiometry of the components in viral 
assembly.   At least in the case of RHDV, a single copy of both genomic RNA and sub-genomic 
RNA is thought to be packaged into the virion (Meyers et al., 1991). The mechanism of genome 
packaging is currently unknown. Other viruses typically have packaging signals such as the ψ 
sequence in the 5′ UTR of Retroviridae genomic RNA (Mann et al., 1983; Mann and Baltimore, 
1985). Yeast two-hybrid analysis has suggested that VPg binds to VP1 (Kaiser et al., 2006).  This 
is a very tentative observation but it may be that VPg acts as the packaging signal for the 
caliciviral genome. A recent X-ray crystal structure of an infectious FCV virion failed to show 
density for the VP2 proteins, VPg proteins or the viral RNA (Ossiboff et al., 2010). This, however, 
maybe unsurprising, given the symmetry of the virion and the relative stoichiometry of the 
components.  There are no publications on the topic of calicivirus egress.   
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2. Aims 
 
The aim of this PhD project is to extend our work on FCV VPg into MNV. This involves cloning, 
expression, purification and structural characterisation of MNV VPg. Beyond this the aim was to 
begin to understand the mechanism of VPg nucleotidylation preferably at atomic resolution.  
This involves first structural characterisation of the MNV VPg, then characterisation of the MNV 
VPg interaction followed by crystallisation trials with an optimised MNV VPg construct with the 
MNV NS7pol.  
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3. Materials and Methods 
 
3.1.Construction of expression vectors 
 
3.1.1. Bacterial cells and plasmids used for cloning and expression 
 
E. coli XL1-Blue cells were used for routine genetic manipulation due to their ability to maintain 
plasmids at a high copy number. pETM11 and a modified pETM11 (pETM11_m) were used as 
expression vectors for protein production (Zou et al., 2003). Both of these plasmids belong to 
the pET family of vectors and are very similar, the only change being the NcoI site of pETM11 in 
the 5′ multiple cloning site has been mutated to a BamHI site in pETM11_m. These vectors 
possess a kanamycin resistance gene, thus pET positive cells were selected for using 25 µg/ml 
kanamycin.  pET vectors possess the genetic elements, T7 promoter and T7 terminator.  These 
elements drive the transcription of an ORF ligated between them using the phage T7 
polymerase.  pET vectors also express LacI; this binds to the Lac operon promoter and 
represses transcription driven by this promoter. LacI, however, is allostericly inhibited by 
allolactose and the allolactose analogue isopropyl β-D-1-thiogalactopyranoside (IPTG). 
Expression cells used in this project were positive for the DE3 genetic element which encodes 
the T7 polymerase under the control of the lactose promoter.  Induction of protein expression is 
by the addition of IPTG; this allows expression of the T7 polymerase which in turn transcribes 
the ORF ligated between the T7 promoter and terminator.  A schematic representation of 
pETM11 is shown in Figure 3-1. A schematic representation of the VPg and NS7pol constructs 
made with pETM11 during the project is shown in Figure 3-2. DNA ligated into pETM11 is 
expressed as a fusion protein with a six histidine (his) tag at its N-terminus. This tag can be 
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cleaved using the tobacco etch virus (TEV) NIa protease. Cleavage leaves a GS or GAM sequence 
N-terminal to the native protein sequence in pETM11_m and pETM11, respectively. The 
bacterial strains used for protein expression were E. coli BL21 (DE3) (Stratagene) and E. coli 
Rosetta (DE3) cells (Novagen). Rosetta (DE3) cells contain a plasmid which expresses tRNA for 
rare codons in E. coli. This plasmid contains a chloramphenicol resistance gene. Thus, Rosetta 
(DE3) cells were routinely maintained with 35 µg /ml chloramphenicol. 
Expression vectors were transformed into cells using the heat shock method. Briefly this 
involved mixing 10-100 ng of vector with 50 µl of chemically competent E. coli cells on ice. This 
mixture was kept on ice for 30 minutes prior to incubation at 42°C for 45 seconds. The mixture 
was then incubated on ice for 10 minutes prior to recovery. Recovery involved the addition of 
450 µl of lysogeny broth (LB) and incubation of the mixture at 37°C shaking (220 RPM) for 60 
minutes. The cells were then centrifuged at 5,000xg for 10 minutes. 450 µl of supernatant was 
discarded and the cells were re-suspended in the remaining 50 µl of supernatant. This 
suspension was spread on LB agar and allowed to grow overnight at 37°C.  
 
 
 
 
 
 
Figure 3-1: Schematic representation of pETM11 
Open reading frames are shown in blue. Plasmid control elements are shown in black. The 
expression is driven by the T7 promoter (T7 prom). The tobacco etch virus (TEV) NIa protease 
cleavage site marked as TEV. The position of the His tag is marked by 6xHis. The positions of the 
restriction enzymes NcoI, EcoRI and HindIII used during the course of the project are marked by red 
arrows. The NcoI site is mutated to a BamHI site in pETM11_m.   
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Figure 3-2: Schematic representation of proteins used in the course of the project 
The His tag and most of the linker is removed by after cleavage by tobacco etch virus (TEV)  NIa 
protease. The sequence at the N-terminus of the native sequence shown as single letter code in an 
orange or red box is a remnant of the linker sequence connecting the protein to the 6x His tag that is 
left post TEV cleavage. The 6x his tag is underlined in red.  
 
 
3.1.2. PCR amplification 
 
The polymerase chain reaction (PCR) was used to amplify DNA sequences for subsequent 
ligation into expression vectors. The KOD hot start polymerase kit (Novagen) was used for all 
PCR reactions.  Typical cycling parameters were 95°C for 2 minutes, followed by 31 cycles of 
95°C for 20 seconds, 55°C for 20 seconds, and 72°C for approximately 1 minute per kb of target 
DNA. Reactions were performed in 25 µl or 50 µl volumes. The following is the reaction mixture 
for a 50 µl reaction. KOD Buffer (120 mM Tris.HCl pH8, 10 mM KCl, 6 mM (NH4)SO4, 0.1% triton 
X-100, 0.001% BSA), 1 mM MgSO4, dNTPs (0.2 mM each), 10-50 ng of template DNA, 300 nM 
forward and reverse primers, and 0.02 U/µl KOD hot start polymerase. The template used in 
most of the PCR reactions was the MNV1 CW1 (NCBI accession number DQ285629.1) reverse 
genetic system plasmid pT7:MNV-G (Chaudhry et al., 2007).  For ligation of NS7po l mutants, P72S 
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and E75S, into pETM11_m pT7:MNV-G which was mutated at these positions was used. 
Restriction enzyme sites for ligation into expression vectors were designed into the primers. All 
VPg PCR primer sets had an NcoI site in the forward primer and a HindIII site in the reverse 
primer. This enabled directional ligation of the PCR product into pETM11. The equivalent sites 
for NS7pol ligation were a BamHI site in the forward primer and an EcoRI site in the reverse 
primer. This enabled directional ligation of the PCR product into pETM11_m. The primer sets 
used in PCR are shown in Table 3-1.  
 
Table 3-1: PCR primers used in construction of expression vectors 
All primers are written 5′ to 3′.  The 5′ CATCAT sequence was added to each primer to facilitate 
restriction enzyme (RE) binding to the PCR products. Restriction enzyme recognition sites are 
underlined in bold and introduced stop codons are marked in red. 
 
3.1.3. Ligation of PCR products into pETM11 
 
Following PCR the products were purified using the QIAquick PCR purification kit (Qiagen) as 
per the manufacturer’s instructions. The PCR product was cleaved using restriction enzymes 
(NEB) appropriate for its ligation (Section 1.1.2). Typically this involved using 20 U of each 
enzyme, 1x concentration of the appropriate NEB reaction buffers, and the PCR product in a 40 
µl reaction volume incubated at 37°C for 2 hours. Post reaction the cleaved PCR product was run 
on a 1% agarose gel. The PCR product was then purified using the QIAquick gel extraction kit 
Virus Protein Residue start/End Sequece
MNV VPg 1 Forward catcatccatgggaaagaagggcaagaacaagaaggg
MNV VPg 11 Forward catcatccatggggcgacccggagtcttcaga
MNV VPg 62 Reverse catcataagcttactcctcctcgtcccgctccag
MNV VPg 85 Reverse catcataagcttacagtttggctctctctgccttg
MNV VPg 124 Reverse catcataagcttactcaaagttgatcttctcgcc
LDV VPg 1 Forward catcatccatgggcaagaaggggaagaacaagact
LDV VPg 11 Forward catcatccatgggcaagaaacacacagccttttc
LDV VPg 80 Reverse catcataagcttagaaaatcctttgccgaa
LDV VPg 66 Reverse catcataagcttagtcctcctcggtcgccc
LDV VPg 94 Reverse catcataagcttaaagagaggccctctcttcctt
LDV VPg 133 Reverse catcataagcttactcaaagttgatcttctcgcc
MNV NS7 1 Forward catcatggatccggaccccccatgcttccccgc
MNV NS7 510 Reverse catcatgaattctcactcatcctcattcacaaaga
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(Qiagen). pET vectors were linearised with the appropriate restriction enzymes for ligation with 
their respective inserts. A typical restriction enzyme digest consisted of 15 µg of DNA, 80 U of 
each enzyme and 1x concentration of the appropriate NEB buffer in a total volume of 160 µl. 
This was incubated at 37°C for approximately 4 hours. The vector backbone was isolated by 
running the products on a 1% agarose gel and cutting out the vector band. The DNA was eluted 
from the agarose gel using the QIAquick gel extraction kit (Qiagen).  
Ligations were performed using the Roche rapid ligation kit. The mass of vector used in the 
reaction was 50-100 ng. Typically 3 ligation reactions were set up containing different 
insert:vector molar ratios. These ratios were 1:1, 3:1 and 6:1. The reactions were allowed to 
proceed for 60 minutes at room temperature. Following this, the reaction products were 
transformed into E. coli XL1-blue cells as per Section 3.1.1 with a two small changes. Firstly, 10 
µl of ligation product was mixed with 90 µl of XL1-blue cells. Secondly, the cells were recovered 
using 900 µl of LB. Single colonies were grown up overnight in 5 ml of LB at 37°C shaking (220 
RPM). Purified plasmid was obtained using the QIAprep spin miniprep kit (Qiagen). The 
sequence of the ORF to be expressed was determined prior to use for all plasmids (MWG 
operon).  
 
3.1.4. QuikChange mutagenesis 
 
QuikChange is a method for introducing mutations into plasmid DNA. It involves the use of two 
complimentary oligonucleotides which both contain the mutation(s) of interest. These are used 
in a PCR reaction thus incorporating the mutation(s) into the plasmid. WT template DNA is 
digested with the restriction enzyme DpnI which is a frequent cutter of methylated DNA 
(template) but does not cut unmethylated DNA (product).  
The KOD hot start polymerase kit (Novagen) was used for all QuikChange reactions. Typical 
cycling parameters used were 95°C for 2 minutes, followed by 17 cycles of 95°C for 30 seconds, 
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55°C for 60 seconds, and 68°C for approximately 0.5 minutes per kb pair of target DNA. 
Reactions were performed in 50 µl volumes.  The reaction mixture was as follows. Buffer (120 
mM Tris.HCl pH8, 10 mM KCl, 6 mM (NH4)SO4, 0.1% triton X-100, 0.001% BSA), 1 mM MgSO4, 
dNTPs (0.2 mM each), 10-50 ng of template DNA, 2.5 ng/µl forward and reverse primers, and 
0.008 U/µl KOD hot start polymerase. The primer sets used in QuikChange are shown in Table 
3-2. The template used for the MNV VPg QuikChange was MNV VPg 1-124 ligated into pETM11 
as described in Section 3.6.3. The template used for the production of FCV VPg mutants was FCV 
VPg 1-111 (full length) in pETM11. Following PCR 20 U of DpnI was added to the product. This 
was incubated overnight at 37°C. The reaction products were transformed into E. coli XL1 blue 
cells as per Section 3.1.3. Clonal purified plasmid DNA was obtained and sequenced as per 
Section 3.1.3. 
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Table 3-2: Primers used in QuikChange mutagenesis of MNV 1-124 and FCV VPg 1-111 
All primers are written 5′ to 3′. Underlined and in bold are mutations introduced by the QuikChange 
primers. 
 
 
 
 
 
 
 
MNV Y26A For gtgggctcacggatgaggaggccgatgagttcaagaagcgc
MNV Y26A Rev gcgcttcttgaactcatcggcctcctcatccgtgagcccac
MNV Y26F For gggctcacggatgaggagttcgatgaatttaagaagcgc
MNV Y26F Rev gcgcttcttaaattcatcgaactcctcatccgtgagccc
MNV R32D For cgatgaatttaagaaggaccgcgagtctagggg
MNV R32D Rev cccctagactcgcggtccttcttaaattcatcg
MNV Y40A For gcgagtcccggggcggcaaggcctccattgatgattacctc
MNV Y40A Rev gaggtaatcatcaatggaggccttgccgccccgggactcgc
MNV Y40F For gagtcccggggcggcaagttctccattgatgattacctc
MNV Y40F Rev gaggtaatcatcaatggagaacttgccgccccgggactc
MNV Y45A For cccggggcggcaagtactccattgatgatgccctcgctgaccgcga
MNV Y45A Rev ctcgcggtcagcgagggcatcatcaatggagtacttgccccccggg
MNV Y45F For aagtactccattgatgatttcctcgctgaccgcgagcga
MNV Y45F Rev tcgctcgcggtcagcgaggaaatcatcaatggagtactt
MNV D48R For gatgattacctcgctcgtcgcgagcgagaagaag
MNV D48R Rev cttcttctcgctcgcgacgagcgaggtaatcatc
FCV Y24A For ctgactgatgacgaggcagatgagtggcgcgaac
FCV Y24A Rev gttcgcgccactcatctgcctcgtcatcagtcag
FCV F43A For gatttgtcagtggaggatgccttaatgttgcgccatc
FCV F43A Rev gatggcgcaacattaaggcatcctccactgacaaatc
FCV R47E For ggatttcttaatgttggagcatcgtgccgctctagg
FCV R47E Rev cctagagcggcacgatgctccaacattaagaaatcc
FCV F62A For cgacaatgatgcagtaaaagcacggtcgtggtggaattccag
FCV F62A Rev ctggaattccaccacgaccgtgcttttactgcatcattgtcg
FCV R69E For gtcgtggtggaattccgaaaccaaaatggccaatg
FCV R69E Rev cattggccattttggtttcggaattccaccacgac
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3.2.Protein production and purification 
 
 
3.2.1. Protein production 
 
For routine expression of VPg proteins, Rosetta cells were transformed as per Section 3.1.1 with 
the appropriate expression vector. A single colony was picked and used to inoculate fresh LB 
which was grown overnight at 37°C shaking (220 RPM). 50 ml of this overnight culture was 
used to inoculate 1 L of fresh LB media. The cells were grown at 37°C shaking (220 RPM) to an 
optical density at 600 nm (OD600) of 0.6. The cells were chilled on ice for 10 to 15 minutes and 
then induced using 1 mM IPTG for four hours at 20°C prior to harvesting by centrifugation 
(5,000xg for 20 minutes). Cell pellets were stored at -80°C prior to processing.  
For production of [15N, 13C]-labelled protein (MNV VPg 11-85) using rich media (E. coli OD 2 CN 
Silantes), the starter culture was grown as described for routine expression. This time, the 50 ml 
of starter culture used to seed the 1 L culture was first washed with 50 ml phosphate-buffered 
saline (PBS) by centrifugation (3,000xg for 20 minutes) resuspension in fresh PBS and re-
centrifugation. The cells were then resuspended in 50 ml of [1 5N, 1 3C]-labelled media prior to its 
addition to 950 ml of [15N, 13C]-labelled media. Expression was performed as above with the 
exception that the induction time was extended to 16 hours.  
 For production of   [15N, 13C]-,or 15N,-labelled protein using minimal media, 50 ml of the LB 
overnight starter culture was added to 1 L of fresh LB. This was allowed to grow at 37°C shaking 
(220 RPM) to an optical density at 600nm (OD600) of 0.6. The cells were then centrifuged, at 
3,000g for 20 minutes, the supernatant was poured off and the pellet resuspended in 250 ml of 
minimal media, prepared as described in Table 3-3.  The cells were allowed to grow in the 
minimal media for two hours at 20°C prior to induction by addition of 1 mM final IPTG. The cells 
were grown at 20°C for 15-18 hours, post induction, prior to harvesting by centrifugation 
(5,000xg for 20 minutes). Pellets were stored at -80°C prior to processing.  
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NS7pol expression was performed using BL21 (DE3) cells (Stratagene). A 25 ml starter culture 
was grown overnight and this was used to inoculate 500 ml of fresh LB media. Cells were grown 
at 37°C until an OD600 of approximately 0.6 was reached. The cells were induced with a final 
concentration of 1 mM IPTG and were allowed to grow for a further 15-18 hours at 37°C post 
induction prior to harvesting by centrifugation (5,000xg for 20 minutes). Cell pellets were 
stored at -80°C prior to processing. 
Expression of all proteins was monitored by taking the equivalent of 100 µl of cells at OD600 0.6 
pre-induction and post-induction.  These cells were centrifuged at 13,200xg for ten minutes. 
The supernatant was removed and the pellet resuspended in 40 µl 2x sodium dodecyl sulfate 
(SDS) loading buffer. 10 µl of the pre- and post-induction samples were then analysed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 15% acrylamide and 
12% acrylamide was used for VPg and NS7po l respectively. 
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Na2PO4  50 mM 
KH2PO4  25 mM 
NaCl 20 mM 
NH4Cl 0.194 % w/v 
1 M MgSO4  0.2% v/v 
1 M CaCl2  0.02% v/v 
0.01 M FeSO4  0.1% v/v 
Glucose   1% w/v 
1000x vitamin solution* 1 ml 
1000x micronutrient solution** 1 ml  
  *1000x vitamin solution Conc (g/L) 
Choline chloride 0.4 
Folic acid 0.5 
Pantothenic acid 0.5 
Nicotinamide 0.5 
Myo-Inositol  1 
Pyridoxal HCl 0.5 
Thiamine HCl 0.5 
Riboflavin 0.05 
Biotin 1 
  **1000x micronutrient solution Conc (M) 
Amm Molybdate 3x10
-6
  
H3BO3  4x10
-4
  
CoCl2  3x10
-5
  
CuSO4  1x10
-5
  
MnCl2  8x10
-5 
  
ZnSO4  1x10
-5
  
 
  
Table 3-3: Composition of minimal media 
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3.2.2. Protein purification: VPg 
 
 
VPg proteins from two caliciviruses, MNV and Lordsdale virus (LDV), were purified for several 
different experiments. While the methodology was very similar for all VPg proteins purified 
there were some differences. First the method of purification of NMR-labelled MNV VPg will be 
outlined. Then all other purification methods will be outlined with reference to this.  
In the case of NMR-labelled MNV VPg cell pellets were resuspended using 30 ml of buffer A. 
Buffer A was composed of 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM dithiothreitol 
(DTT), 0.1% v/v triton-X 100 and 0.1 mM phenylmethanesulfonyl fluoride (PMSF). Cell walls 
were disrupted using 2 mg /ml chicken egg lysozyme. This suspension was incubated for 
approximately 10 minutes on ice prior to sonication.  The lysate was sonicated for 15 seconds 
on 15 seconds off until the viscosity of the solution was similar to that of water. Typically this 
took 5-10 minutes.  The solution was clarified by centrifugation at 30,000xg for 20 minutes 
followed by the addition of 1 mg /ml protamine sulphate, and re-centrifugation at 30,000g for 
20 minutes. The clarified lysate was incubated with TALON cobalt affinity beads (Clontech) for 
45-60 minutes. Typically 1 ml bed volume of beads was used per 250 ml of minimal media or 1 
L of rich media.  Following the incubation the beads were washed sequentially with buffer B 
containing 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM DTT with increasing 
concentrations of  imidazole per wash (0 mM, 5 mM, 10 mM, 100 mM and 500 mM). The beads 
were washed with 50 ml of 0 mM, 10 mM and 100 mM and with 25 ml of 5 mM and 500 mM 
imidazole. 5 µl of each fraction was analysed by SDS-PAGE. Fractions containing VPg were 
incubated with 0.25-0.5 mg of His tagged TEV NIa protease and dialysed overnight into buffer B 
using Snakeskin 3,000 Da molecular weight cut off (MWCO) dialysis tubing (Pierce). TEV NIa 
protease was removed by reapplication of the solution to TALON beads as above. Sequential 
washing of the TALON beads was performed as above with the exception that the buffer B 
contained 0 mM, 5 mM, 100 mM, or 500 mM imidazole. The 0 mM fraction was 50 ml; all other 
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fractions were 25 ml. Each fraction was analysed by SDS-PAGE as previous. Pure fractions were 
concentrated using a 3,000 MWCO Vivaspin centrifugal concentrator (Sartorius).  
Protein used for backbone resonance assignment, side chain assignment resonance, nuclear 
Overhauser effect spectroscopy (NOESY), and amide heteronuclear NOE (hetNOE) NMR 
experiments was further purified using size exclusion chromatography (SEC) with a 16/60 
Superdex 75 column and an Äkta purifier (GE healthcare) at room temperature. The SEC 
running buffer was buffer B. 5µl of each peak fraction was analysed by SDS-PAGE.  Pure VPg 
fractions were pooled and concentrated (3,000 MWCO Vivaspin). Protein concentration was 
determined using the predicted extinction coefficient, calculated using protparam on the 
ExPASy bioinformatics resource portal, and the protein sample absorbance at 280 nm 
(Gasteiger et al., 2005).  The protein was snap frozen in liquid nitrogen and stored at -80°C.  
MNV VPg 11-62 and MNV VPg 1-124 used in the characterisation of MNV VPg truncated 
constructs by 1H-15N HSQC spectroscopy were not SEC purified. MNV VPg 1-124 used in surface 
plasmon resonance (SPR) was not TEV NIa protease cleaved, re-applied to TALON or SEC 
purified. 
In the case of LDV VPg purification for initial 1H-15N HSQC experiments, LDV VPg 11-66, 11-80 
and 1-133 was purified exactly as per the SEC purified MNV VPg samples. LDV VPg 11-94 and 1-
133 which were used in backbone and side chain assignment experiments were purified as 
previously but with a slightly different SEC buffer: 150 mM NaCl, 50 mM sodium phosphate pH 
5.5 and 1 mM Tris-HCl(2-carboxy- ethyl)phosphine (TCEP).  
The MNV VPg mutant proteins, used to characterise the stability of VPg by 1D NMR, were 
purified in a manner similar to that of NMR-labelled VPg protein. The differences were that 
buffer A was 50 mM Tris.HCl pH 7, 300 mM NaCl, 2 mM β-mercaptoethanol, 0.1% v/v triton x-
100 and 0.1 mM PMSF. Buffer B was 50mM Tris.HCl pH 7, 300 mM NaCl and 2 mM β-
mercaptoethanol. The protein was dialysed overnight into 4 L of buffer B. No TEV was added to 
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the overnight dialysis and the protein was not rebound to TALON post dialysis. Rather it was 
simply concentrated (3,000 MWCO Vivaspin), snap frozen in liquid nitrogen and stored at -80°C. 
The exceptions to this protocol were in the purification of Y24F, Y40F and Y45F. These were 
dialysed overnight into 4 L of buffer containing 50mM Tris.HCl pH 7, 150 mM NaCl and 2 mM β-
mercaptoethanol. The protein was then concentrated, snap frozen and stored as per the other 
MNV VPg proteins. Prior to recording spectra Y24F, Y40F and Y45F were buffer exchanged into 
50mM Tris.HCl pH 7, 300 mM NaCl and 2 mM β-mercaptoethanol by dilution and re-
concentration. 
The WT and mutant FCV VPg proteins were purified as per MNV VPg Y24F, Y40F and Y45F with 
the exception that the samples were not buffer exchanged prior to recording the 1D NMR 
spectra. 
3.2.3. Protein purification: NS7pol 
 
Protein used in X-ray crystallography and NMR titrations was purified by two step affinity 
chromatography and SEC similar to NMR-labelled VPg. The differences were primarily in the 
buffer used in purification. Buffer A consisted of 200 mM NaCl, 50 mM Tris.HCl pH8, 5% v/v 
glycerol, 0.1% v/v triton x-100, and 0.1 mM PMSF.  Buffer B consisted of 200 mM NaCl, 50 mM 
Tris.HCl pH8 and 5% v/v glycerol. The SEC buffer consisted of 200 mM NaCl, 50 mM Tris.HCl 
pH8, 5% v/v glycerol and 2 mM NaN3.  The SEC column used was a 16/60 Superdex 200. SEC 
purification was performed at 4°C. The protein was concentrated using a 30,000 MWCO 
Vivaspin concentrator. NS7pol protein used in SPR experiments was purified as per the X-ray 
crystallography and NMR samples except they were not subjected to SEC.  
 
3.3. MNV NS7pol X-ray crystallography 
 
Crystallisation trials were set up using MNV NS7po l WT at 10 mg/ml in SEC buffer (Section 
1.1.2). JCSG (Qiagen) and PACT (Qiagen) commercial screens were set up using the sitting drop 
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vapour diffusion method. The drops contained a 100 nl reservoir solution mixed with 100 nl 
protein solution. Crystallisation plates were incubated at 18°C. An initial hit, JSCG solution 57 
(0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5, 1.6 M MgSO4), was scaled up to 
drops containing 1000 nl reservoir solution mixed with 1000 nl protein solution. These were 
incubated at room temperature. Crystals were soaked in cryo-buffer (20% v/v glycerol, MES pH 
6.5, 1.75 M MgSO4) for approximately 5 minutes prior fishing using nylon loops and freezing in 
liquid nitrogen. Looped crystals were stored in liquid nitrogen. Initial characterisation of the 
crystals was performed using a Rigaku MicroMax-007 HF-M high-flux generator (wavelength 
1.54 Å) with a Saturn 944+ CCD detector. The crystals were kept at 100 K during the collection 
process by a cryostream of cooled nitrogen. Data were collected to a resolution of 3.15 Å. The 
data were indexed using iMosflm (Leslie, 2006) and scaled with SCALA (Evans, 2006).  The 
structure was phased by molecular replacement with an ensemble of HuNV NS7pol structures 
(PDB 1SH0, 1SH3 and 2B43) using Phaser (Ng et al., 2004; Hogbom et al., 2009; McCoy et al., 
2007). A random 5% of reflections were set aside to check the model against unrefined data. 
Positional and B-factor refinement was performed using the remaining 95% of reflections using 
Crystallography & NMR System (CNS) v1.2 (Brunger et al., 1998). The electron density maps 
were readily interpretable. The model was manipulated manually between rounds of positional 
and B-factor refinement using the molecular visualisation package O (Jones et al., 1991). Higher 
resolution data to 2.3 Å were collected at Diamond synchrotron beamline I03 (Oxford, UK). The 
data were indexed and scaled as previous. 3.15 Å model was used as a starting point. The phases 
were extended to 2.3 Å. Positional and B-factor refinement was performed by CNS v1.2 and 
phoenix v1.6 (Adams et al., 2010).  The model was manipulated manually between rounds of 
positional and B-factor refinement using the molecular visualisation package Coot (Emsley et 
al., 2010).  Water molecules were automatically added to the model using the collaborative 
computer project 4 (CCP4) water pick program. The positions of the water molecules were 
checked using Coot. Models were validated using MolProbity (Chen et al., 2010). 
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MNV NS7pol P72S and E75S mutants crystallised in the same condition as WT MNV NS7po l. The 
crystal manipulation, data generation, data processing and model building were done as per the 
WT high resolution data set. NS7pol P72S was collected to 2.7 Å resolution while the E75S 
mutant was collected to 2.35 Å resolution. The model used for phasing was the high resolution 
MNV NS7pol WT model. Positional and B-factor refinement was also performed with a model 
lacking the mutated residue as well as several residues N and C-terminal to it. This was 
performed to demonstrate that the phases of the input model were not adversely biasing the 
electron density maps at the sites of mutation.  
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3.4.MMR assignment and structure calculation 
 
3.4.1. NMR instruments, samples and basic data handling  
 
NMR data were collected on one of two instruments, a Bruker Avance II 800 MHz (1H frequency 
800.32 MHz) or a Bruker Avance III 600 MHz (1H frequency 600.50 MHz). 10% v/v D2O was 
used as the field frequency lock for all protein samples in non-deuterated buffer. Protein 
concentration and buffer concentrations quoted for experiments are prior to the addition of 
10% D2O. For all 2D and 3D NMR experiments data were processed using NMRPipe software 
and analysed using NMRView5 (Delaglio et al., 1995; Johnson, 2004).  
 
3.4.2. LDV and MNV VPg NMR assignment experiments  
 
The protein concentration, buffer composition and instruments used in assignment experiments 
are given in Table 3-4. All NMR assignment experiments were performed at a temperature of 
303 K. Before and after all assignment experiments the protein sample quality was determined 
using 1D and 1H-15N HSQC experiments. Resonance assignment experiments can be broken into 
sequential assignment experiments and side chain assignment experiments. Sequential 
resonance assignment is the assignment of the backbone nuclei Cα, Hα, CO, NH as well as the 
side chain Cβ and Hβ to a particular chemical shift value. Side chain assignment is the 
assignment of all other nuclei of the protein to a particular chemical shift value. MNV VPg 11-85, 
LDV VPg 1-133 and LDV VPg 11-94 were all sequentially assigned while side chain assignment 
was performed on MNV VPg 11-85. The sequential side chain experiments performed were as 
follows HN(CA)CO, HNCO, CBCA(CO)NH, HNCACB, HBHA(CBCACO)NH and a high resolution 1H-
15N HSQC experiment. MARS, an automated backbone assignment tool was used to partially 
assign the protein backbone (Jung and Zweckstetter, 2004). Manual assignment of nuclei was 
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required to complete the sequential assignment for all three proteins. In the case of MNV VPg 
11-85 the sequential assignment was checked using the carbon and 1H-15N NOESY experiments.  
Side chain nuclei can be divided into aromatic and aliphatic nuclei. Different experiments are 
required to assign these two types of nuclei. The aliphatic side chain experiments used were 
HCCH total correlation spectroscopy (TOCSY), (H)CCH TOCSY, (H)CC(CO)NH TOCSY, 
H(CCCO)NH TOSCY and high resolution 1H-13C HSQC spectroscopy. The aromatic side chain 
experiments used were (HB)CB(CGCD)HD, (HB)CB(CGCGCDCE)HE and high resolution aromatic 
1H-13C HSQC. All non-amide correlated side chain assignment experiments were recorded in a 
buffer containing D2O as the solvent instead of H2O. In order to make this protein sample H2O 
had to be first removed. This was done by snap freezing the sample and freeze drying overnight 
at -40°C. The dried sample was then resuspended in D2O.  Side chain assignment of aliphatic 
nuclei was primarily completed using the amide correlated side chain experiments and the 
nitrogen and 1H-13C NOESY experiments. Aromatic side chain assignments were completed 
using the (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE coupled to the 1H-15N and 1H-13C NOESY 
experiments. The Cα, Hα, CO, Cβ and N chemical shift values were used to calculate the ψ and φ 
dihedral angles of MNV VPg 11-85 using the TALOS+ program (Shen et al., 2009). These were 
used as restraints in the structure calculation.  
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Table 3-4: Protein concentration, buffer composition and NMR magnet used in assignment, 
structure calculation or dynamics measurements of VPg proteins 
The compositions of buffers listed above are A: 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 
mM DTT. B: 50 mM sodium phosphate pH 6.5, 360 mM NaCl, 1.2 mM DTT, 1.2x cOmplete PI (Roche), 
0.1% NaN3. C: 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM DTT, 1x complete PI (Roche), 2 
mM NaN3. D: 50 mM sodium phosphate pH 6.5, 300 mM NaCl, 1 mM DTT, 2mM NaN3. E: 50 mM 
sodium phosphate pH 5.5, 150 mM NaCl, 1 mM TCEP, 100 µM leupeptin, 10 µM pepstatin, 50 µM 
PMSF,2 mM NaN3. F: 50 mM sodium phosphate pH 5.5, 150 mM NaCl, 1 mM TCEP, 2 mM NaN3, 1x 
cOmplete PI (Roche). 
 
 
 
Protein Experiment Protein Conc (µM) Buffer Magnet
MNV VPg 11-85 HN(CA)CO 590 A Bruker Avance II (800 mHz)
HNCO 590 A Bruker Avance II (800 mHz)
CBCA(CO)NH 590 A Bruker Avance II (800 mHz)
HNCACB 590 A Bruker Avance II (800 mHz)
HBHA(CBCACO)NH 590 A Bruker Avance II (800 mHz)
HCCH TOCSY 710 B Bruker Avance II (800 mHz)
(H)CCH TOCSY 710 B Bruker Avance II (800 mHz)
(H)CC(CO)NH TOCSY 590 A Bruker Avance II (800 mHz)
 H(CCCO)NH TOSCY 590 A Bruker Avance II (800 mHz)
C HSQC 710 B Bruker Avance II (800 mHz)
C aromatic HSQC 590 A Bruker Avance II (800 mHz)
NH HSQC 590 A Bruker Avance II (800 mHz)
N NOESY 590 A Bruker Avance II (800 mHz)
C NOESY 710 B Bruker Avance II (800 mHz)
hetronuclear NOE 590 C Bruker Avance III (600 mHz)
(HB)CB(CGCD)HD 710 B Bruker Avance II (800 mHz)
(HB)CB(CGCDCE)HE 710 B Bruker Avance II (800 mHz)
MNV VPg 1-124 hetronuclear NOE 420 D Bruker Avance III (600 mHz)
LDV VPg 1-133 HN(CA)CO 310 E Bruker Avance III (600 mHz)
HNCO 310 E Bruker Avance III (600 mHz)
CBCA(CO)NH 310 E Bruker Avance III (600 mHz)
HNCACB 310 E Bruker Avance III (600 mHz)
HBHA(CBCACO)NH 310 E Bruker Avance III (600 mHz)
NH HSQC 310 E Bruker Avance III (600 mHz)
hetronuclear NOE 310 E Bruker Avance III (600 mHz)
LDV VPg 11-94 HN(CA)CO 960 F Bruker Avance III (600 mHz)
HNCO 960 F Bruker Avance III (600 mHz)
CBCA(CO)NH 960 F Bruker Avance III (600 mHz)
HNCACB 960 F Bruker Avance III (600 mHz)
HBHA(CBCACO)NH 960 F Bruker Avance III (600 mHz)
NH HSQC 960 F Bruker Avance III (600 mHz)
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3.4.3. MNV structure calculation 
 
The 1H-13C NOESY heteronuclear multiple quantum correlation (HMQC) and 1H-15N NOESY 
HSQC experiments were used as the primary distance restraint generating experiments. These 
were recorded with a mixing time of 125 ms.  The 1H-13C NOESY HMQC spectrum was recorded 
in deuterated buffer as per Section 3.4.2.  The protein concentration, buffer composition and 
magnet used in NOESY experiments are given in Table 3-4. Before and after all NOESY 
experiments the protein sample quality was determined using 1D and 1H-15N HSQC 
experiments. 
Dihedral angle restraints and chemical shift values for each assigned atom as well as 1H-13C 
NOESY and 1H-15N NOESY peak lists and intensities were submitted to ARIA (ambiguous 
restraints for iterative assignment) for structure calculation (Habeck et al., 2004).  
TALOS+ ψ and φ dihedral angles restraints were implemented, for residues in secondary 
structure, with an error tolerance of +/- 25°. The frequency tolerance window for assigning 1H-
13C NOESY peaks was 0.04, 0.06 and 1 part per million (PPM) in direct proton, indirect proton 
and carbon dimensions respectively. In the case of the 1H-15N NOESY this window was 0.04, 0.06 
and 0.5 PPM in direct proton, indirect proton and nitrogen dimensions respectively.  Due to 
overlap within the spectra network anchoring was implemented in the calculation up until, and 
including, iteration 4 of the structure calculation.  
Two slow cooling stages were used in each calculation. These had a cumulative number of 0.003 
ps dynamics cooling steps of 50,000. A total of 100 conformers were calculated on the final 
structure calculation. The lowest energy 20 of these were water refined. An ensemble of water-
refined structures was submitted to MolProbity NMR for structural validation (Chen et al., 
2010). 
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3.5.Validation of MNV VPg 11-85 and determination of the LDV VPg core 
3.5.1. Characterisation of MNV VPg solution conditions  
 
The effects of temperature, pH and NaCl concentration on protein structure were determined 
using amide HSQC and 1D NMR experiments. Spectra were recorded on the Bruker Avance III 
600 MHz magnet for all samples. The pH and NaCl concentration experiment spectra were 
recorded at a temperature of 303 K. For the pH titration a universal buffer (MMT) was used. 
This is composed of Malic acid, MES and Tris-HCl at a molar ratio of 1:2:2. The pH of the 
solutions was adjusted using concentrated NaOH (6 M) or HCl (11.6 M) where appropriate. MNV 
VPg 1-124 was aliquoted, then dialysed using 3,500 MWCO GeBaflex dialysis tubing (Geba) into 
a buffer containing 300 mM NaCl, 1 mM DDT, and 50 mM MMT at whole number pH values 
between 4 and 8 inclusive. The VPg concentration was approximately 100 μM. For the NaCl 
titration MNV VPg 1-124 aliquots were dialysed, as per pH characterisation, into a buffer 
containing 50 mM sodium phosphate pH 6.5, 1 mM DTT, and either 300 mM, 250 mM, 150 mM 
or 50 mM NaCl. The VPg concentration used in the NaCl titration was approximately 40 μM in 
each sample. The VPg temperature titration was performed using MNV VPg 11-85 at 5 K 
intervals between 278 K and 303 K. The protein concentration used was approximately 590 μM.  
3.5.2. Characterisation of LDV VPg solution conditions  
 
The effect of solution conditions on LDV VPg was determined by NMR using the same 
instrument and experiments as per 3.5.1. For the pH titration LDV VPg 1-133 was aliquoted and 
exchanged into a buffer containing 300 mM NaCl, 1 mM DDT, and 50 mM sodium phosphate at 
pH values of 5.5, 6.5 or 7.5. The pH of the solutions were adjusted using concentrated NaOH (6 
M) or HCl (11.6 M) where appropriate. In addition an LDV VPg 1-133 aliquot was exchanged 
into a buffer containing 100 mM NaCl, 1 mM DDT, and 50 mM sodium phosphate at pH 6.5. 
Buffer exchange was performed using Vivaspin 20 3,000 MWCO concentrators.  The VPg 
concentration for all but the pH 6.5, 100 mM NaCl sample was approximately 170 μM. The 
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concentration of the pH 6.5, 100 mM NaCl sample was approximately 270 μM. A temperature 
titration was performed on LDV VPg 11-94 at a concentration of 960 μM in a buffer containing 
50 mM sodium phosphate pH 5.5, 150 mM NaCl, 1 mM TCEP, 1x complete protease inhibitor 
(PI) (Roche), 2 mM NaN3. Spectra were recorded at 5 K intervals between 278 K and 303 K. 
Additional spectra were collected at 310 K and 313 K.  
 
3.5.3. Characterisation of truncated MNV VPg constructs 
 
Amide HSQC spectroscopy and 1D NMR were used to compare the structured regions of MNV 
VPg 1-124, 11-85 and 11-62. The buffer conditions were 50 mM sodium phosphate pH 6.5, 300 
mM NaCl and 1 mM DDT. Spectra were recorded on the Bruker Avance III 600 MHz magnet at 
303 K for all samples. The approximate concentration of each protein was 250 μM for VPg 1-
124, 590 μM for VPg 11-85 and 670 μM for VPg 11-62. Both VPg 11-62 and full length VPg used 
in this experiment were not SEC-purified but were at least 90% pure as determined by SDS-
PAGE.  
 
3.5.4. Characterisation of LDV VPg truncated constructs 
 
Amide HSQC spectroscopy and 1D NMR were used to compare the structured regions of LDV 
VPg 1-133, 11-80 and 11-66. The protein concentrations were as follows: VPg 1-133, 110 μM; 
VPg 11-80, 420 μM; and VPg 11-66, 1 mM.  All samples were in a buffer composed of 300 mM 
NaCl, 1 mM DDT, 50 mM sodium phosphate at pH 6.5. 11-66 spectra were recorded on the 
Bruker Avance III 600 MHz magnet.  LDV VPg 1-133 and 11-80 spectra were recorded on the 
Bruker Avance II 800 MHz magnet.  All spectra were recorded at 303 K.  
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3.5.5. Amide hetNOE experiments of MNV and LDV VPg constructs  
 
Amide heteronuclear NOE (hetNOE) experiments were performed on LDV VPg 1-133, MNV VPg 
1-124 and MNV VPg 11-85. The protein concentrations, buffer conditions and magnets used are 
given in Table 3-4.  Only amide cross peaks which were assigned and clearly not overlapped 
were analysed. The determination of the peak intensities was performed automatically using 
the jitter function of NMRview5. 
 
3.5.6. 1D NMR of MNV and FCV VPg mutants 
 
1D NMR was used to analyse WT and mutant MNV proteins. The following are the proteins and 
concentrations of the proteins analysed. MNV VPg WT (146 µM), MNV VPg Y26A (179 µM), MNV 
VPg R32D (143 µM), MNV VPg Y40A (142 µM), MNV VPg Y45A (141 µM), MNV VPg D48R (99 
µM) and MNV VPg R32D D48R (137 µM). The buffer conditions were 300 mM NaCl, 50 mM Tris-
HCl pH 7, 2 mM β-mercaptoethanol. All spectra were recorded on the Bruker Avance III 600 
MHz magnet at a temperature of 298 K. These conditions were also used for FCV VPg 1-111 and 
mutants thereof with the exception that 150 mM NaCl was used. The protein concentration used 
was ~45 µM for FCV VPg. 
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3.6.Analysis of VPg-NS7pol interaction 
 
3.6.1. Titration of MNV NS7pol into 15N labelled MNV VPg constructs 
 
Titrations of unlabelled MNV NS7pol into 15N-labelled MNV VPg 11-62 or MNV VPg 1-124 were 
performed as follows. Both NS7pol and VPg proteins were dialysed into a buffer containing 50 
mM Tris-HCl pH 8, 200 mM NaCl, 3 mM DTT, 2 mM NaN3 and 5% glycerol. Dialysis was 
performed using 3,500 MWCO GeBaflex dialysers (Geba). The titrations were monitored using 
1H-15N HSQC and 1D NMR experiments. Spectra were recorded on the Bruker Avance III 600 
MHz magnet at 303 K for all samples. In the case of the VPg 1-124 titration, 300 µM NS7pol and 
100 µM VPg were used. Reference spectra of 100 µM VPg 1-124 were recorded. Spectra were 
also recorded with this VPg sample plus 0.29, 0.87 and 3.50 molar equivalents of NS7pol. The 
3.50 molar equivalent sample was concentrated, using a Vivaspin 6 (3,000 MWCO), down to the 
volume at which the VPg 1-124 reference spectra were recorded.  1H-15N HSQC and 1D NMR 
spectra were then acquired for this concentrated sample.  The MNV VPg 11-62 titration was 
performed in a very similar way.  Spectra were recorded for the 100 µM VPg reference sample 
and this sample plus 0.39, 0.73 and 3.67 molar equivalents of NS7pol. The 3.67 molar equivalent 
sample was concentrated as previously down to the volume at which the VPg 11-62 reference 
spectra were recorded. Finally NS7pol was added to this concentrated sample up to 11.82 molar 
equivalents of NS7pol. A 1H-15N HSQC spectrum was recorded of this sample overnight. 1H-15N 
HSQC and 1D NMR spectra were also acquired for this concentrated sample.   
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3.6.2. MNV VPg-NS7pol interaction monitored by SPR  
 
Neither the NS7pol or VPg protein used in this experiment was SEC purified but both were 
greater than 90% pure as determined by SDS-PAGE. NS7pol was diluted 285-fold to 50 µg /ml in 
a pre-concentration buffer containing 40 mM sodium acetate at pH 4.5. This solution was used 
to immobilise NS7pol to a CM-5 BIAcore chip (GE healthcare) using the BIAcore amine coupling 
kit (GE healthcare). The level of immobilisation achieved was 1875 response units (RUs).  
The running buffer contained 50 mM sodium phosphate, 250 mM NaCl, 1 mM β-
mercaptoethanol, 0.05% tween-20.  MNV VPg was buffer exchanged into a buffer identical to the 
Biacore running buffer except that it did not contain tween-20. MNV VPg was injected over the 
immobilised NS7po l chip in a dilution series containing the VPg concentrations 636 µM, 318 µM, 
160 µM, 80 µM and 40 µM. Each concentration was injected onto the chip in duplicate. A blank 
(unimmobilised) surface was used as a control for non-specific VPg binding to the CM-5 chip 
surface. The flow rate used in the experiment was 20 µl/min, injection time 2.5 min. 
Regeneration of the chip surface was achieved by allowing the running buffer to flow (30 
µl/min) over the surface for 13 minutes post injection. All experiments were performed at room 
temperature on a BIAcore 3000 (GE healthcare).  
In addition to using MNV VPg 1-124 as analyte, MNV VPg 11-62 was also used. Regeneration 
conditions for this analyte could not be found. The attempted regeneration schemes are 
summarised in Table 3-5.  
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Table 3-5: Regeneration conditions tried for MNV VPg 11-62 
Regeration conditon  1 Regneration condition 2 Flow rate (µl/min) Time (s)
10 mM Hepes pH 7, 1 M NaCl                        - 30 30
10 mM Hepes pH 7, 3.6 M KCl                        - 30 30
5 mM NaOH                        - 30 30
50 mM NaOH                        - 30 30
0.0014 % triethylamine                        - 30 30
10 mM Hepes pH 7, 1 M NaCl 5 mM NaOH 30 30
3.33 mM HCl 5 mM HCl 80 30
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4. Results and Discussion: NS7pol 
 
The X-ray crystal structures of many viral RNA dependent RNA polymerases have now 
been determined, including the NS7pol proteins of two different HuNV strains. They all 
have a very similar right hand fold with a closed RNA binding cleft. This chapter 
describes the X-ray crystal structure of MNV NS7pol and the structure of two high fidelity 
NS7pol mutants, P72S and E75S.  
4.1.Expression and purification of wild type MNV NS7pol  
MNV and HuNV NS7pol proteins share approximately 60% amino acid identity as 
determined by an amino acid sequence alignment (Fig. 4-1). The crystal structures of 
the NS7pol of human sapovirus, RHDV and two strains of HuNV were determined using 
full length constructs (Ng et al., 2002; Ng et al., 2004; Fullerton et al., 2007; Hogbom et 
al., 2009). MNV full length (1-510) WT NS7pol as well was P72S and E75S mutants were 
cloned into a modified pETM11 expression vector as described in Materials and 
Methods. The proteins expressed to high levels in E. coli cells as determined by SDS-
PAGE (data not shown). The cells typically reached OD600 values of 1.5 after overnight 
induction with 1 mM IPTG.  
The protein purity at each stage of purification was assessed by SDS-PAGE (Fig. 4-2). 
After clarification of the cell lysate a large proportion MNV NS7pol was present in the 
soluble fraction (Fig. 4-2). Up to 25% of MNV NS7pol eluted from the TALON beads in the 
10 mM imidazole fractions. This was observed for both WT and mutant MNV NS7pol 
purifications (Fig. 4-2). The 10 mM and 100 mM imidazole fractions were pooled after 
the initial TALON purification. The molecular weight of NS7pol bands decreased after 
 Results and discussion: NS7pol 
 
 77 
 
overnight incubation with, His tagged TEV NIa protease (Fig. 4-2). Thus, the poly-
histidine tag could be readily cleaved off by the TEV NIa protease. TEV NIa protease was 
purified away from NS7pol by a secondary TALON purification step. The protein was 
finally purified, to near homogeneity, by SEC (Fig. 4-2). Typical protein yields varied 
from 7.5 to 15 mg/l of LB media.  The protein was soluble to a concentration of at least 
30 mg/ml. 
MNV_NS7   GPPMLPRPSGTYAGLPIADYGDAPPLSTKTMFWRTSPEKLPPGAWEPAYLGSKDERVDG- 59 
NW_NS7    GG----DSKGTYCGAPILGPGSAPKLSTKTKFWRSSTAPLPPGTYEPAYLGGKDPRVKGG 56 
          *      ..***.* ** . *.** ***** ***:*.  ****::******.** **.*  
 
MNV_NS7   PSLQQVMRDQLKPYSEPRGLLPPQEILDAVCDAIENRLENTLEPQKPWTFKKACESLDKN 119 
NW_NS7    PSLQQVMRDQLKPFTEPRGKPPKPSVLEAAKKTIINVLEQTIDPPDKWSFAQACASLDKT 116 
          *************::****  *  .:*:*. .:* * **:*::* . *:* :** ****. 
 
MNV_NS7   TSSGYPYHKQKSKDWTGSAFIGDLGDQATHANNMYEMGKSMRPIYTAALKDELVKPDKIY 179 
NW_NS7    TSSGHPHHMRKNDCWNGESFTGKLADQASKANLMFEEGKNMTPVYTGALKDELVKTDKIY 176 
          ****:*:* :*.. *.*.:* *.*.***::** *:* **.* *:**.********.**** 
 
MNV_NS7   GKIKKRLLWGSDLGTMIRAARAFGPFCDALKETCIFNPIRVGMSMNEDGPFIFARHANFR 239 
NW_NS7    GKIKKRLLWGSDLATMIRCARAFGGLMDELKTHCVTLPIRVGMNMNEDGPIIFERHSRYR 236 
          *************.****.***** : * **  *:  ******.******:** **:.:* 
 
MNV_NS7   YHMDADYTRWDSTQQRAILKRAGDIMVRLSPEPDLARVVMDDLLAPSLLDVGDYKIVVEE 299 
NW_NS7    YHYDADYSRWDSTQQRAVLAAALEIMVKFSSEPHLAQVVAEDLLSPSVVDVGDFTISINE 296 
          ** ****:*********:*  * :***::*.**.**:** :***:**::****:.* ::* 
 
MNV_NS7   GLPSGCPCTTQLNSLAHWILTLCAMVEVTRVDPDIVMQESEFSFYGDDEVVSTNLELDMV 359 
NW_NS7    GLPSGVPCTSQWNSIAHWLLTLCALSEVTNLSPDIIQANSLFSFYGDDEIVSTDIKLDPE 356 
          ***** ***:* **:***:*****: ***.:.***:  :* ********:***:::**   
 
MNV_NS7   KYTMALRRYGLLPTRADKEEGPLERRQTLQGISFLRRAIVGDQFGWYGRLDRASIDRQLL 419 
NW_NS7    KLTAKLKEYGLKPTRPDKTEGPLVISEDLNGLTFLRRTVTRDPAGWFGKLEQSSILRQMY 416 
          * *  *:.*** ***.** ****   : *:*::****::. *  **:*:*:::** **:  
 
MNV_NS7   WTKGPNHQNPFETLPGHAQRPSQLMALLGEAAMHGEKYYRTVASRVSKEAAQSGIEMVVP 479 
NW_NS7    WTRGPNHEDPSETMIPHSQRPIQLMSLLGEAALHGPAFYSKISKLVIAELKEGGMDFYVP 476 
          **:****::* **:  *:*** ***:******:**  :* .::. *  *  :.*::: ** 
 
MNV_NS7   RHRSVLRWVRFGTMD-AETPQERSAVFVNEDE-- 510 
NW_NS7    RQEPMFRWMRFSDLSTWEGDRNLAPSFVNEDGVE 510 
          *:..::**:**. :.  *  :: :. *****    
 
Figure 4-1:  Amino acid sequence alignment of Norwalk and MNV NS7pol proteins 
Alignment was performed using clustalW using the MNV1 CW1 strain NS7pol sequence (NCBI 
accession number DQ285629.1) and NW NS7pol sequence (NCBI accession number 3BSN_A ). 
Norwalk virus is a HuNV strain.  
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Figure 4-2:  Wild type MNV NS7pol purification 
Purification was performed firstly by  poly-histidine tag purification using TALON resin, then cleavage 
of the poly-histidine tag by TEV NIa protease. The TEV NIa protease was purified away by re-
application of the protein to TALON resin. Finally the protein was further purified by size exclusion 
chromatography (SEC) using a Superdex S200 16/60 highload column. A) Initial TALON resin 
purification monitored by SDS-PAGE. 1) Whole cell lyste, 2) soluble fraction post 30,000xg 
centrifugation, 3) soluble fraction post 1 mg/ml protamine sulphate addition an 30,000xg 
centrifugation, 4) flow fraction following application of protein to TALON resin, 5) 0 mM Imidazole 
wash 1, 6) 0 mM Imidazole wash 2, 7) 5 mM imidazole wash, 8) 10 mM imidazole wash 1, 9) 10 mM 
imidazole wash 2, 10) 100 mM imidazole wash 1, 11) 100 mM imidazole wash 2, 12) 500 mM 
imidazole wash. B) Monitoring TEV NIa cleavage of the poly-histidine tag by SDS-PAGE. 1) pre-TEV 
NIa cleavage, 2) post TEV NIa cleavage. C) Reapplication of the protein to TALON resin monitored by 
SDS-PAGE. 1) Flow through following re-application of the protein to TALON resin, 2) 0 mM 
imidazole wash, 3) 5 mM imidazole wash, 4) 100 mM imidazole wash, 5) 500 mM imidazole wash. D) 
SEC purification monitored by absorbance at 280 nm and SDS-PAGE. Fractions analysed by SDS-PAGE 
are marked by crosses on the x-axis of the chromatogram.  
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4.2.Crystallisation of wild type MNV NS7pol  
 
Crystallisation trials of MNV NS7pol full length were set up immediately following purification, at 
a concentration of 10 mg/ml.  Crystal hits appeared after 4 days in several JCSG conditions. 
These included JSCG condition 20 (0.2 M magnesium chloride, 0.1 M Tris pH 7, 10% w/v PEG 
8000), JCSG condition 29 (0.8 M sodium phosphate, 0.1 M HEPES pH 7.5), JCSG condition 52 (0.2 
M lithium sulfate, 0.1 M Tris pH 8.5, 1.26 M ammonium sulfate), JCSG condition 56 ammonium 
phosphate dibasic,, 0.1 M sodium acetate and JCSG condition 57 (0.1 M MES pH 6.5, 1.6 M 
magnesium chloride). JCSG solution 29 produced large cuboid crystals with approximate 
maximum dimensions of 200 µm x 30µm x 20 µm (Fig. 4-3). Solution 52 also produced large 
crystals, this time plates with multiple overlapping lattices, the largest of which had dimensions 
of approximately 70 µm x 70µm x 20 µm (Fig. 4-3). JCSG solutions 57, 20 and 56 produced much 
smaller cuboid, needle and plate crystals respectively (Fig. 4-3). Larger, single lattice, plate 
crystals of up to 200 µm x 200 µm x 20 µm in size were obtained in JCSG condition 57 by scaling 
up the drop volume to 2000 nl and the reservoir volume up to 125 µl. An example of these 
crystals is shown in Figure 4-4.  
 
 
 
 
 Results and discussion: NS7pol 
 
 80 
 
 
Figure 4-3: Initial crystal hits for full length MNV NS7pol 
The red scale bar is approximately 200 µm in length. The crystallisation conditions are as follows: 
JSCG condition 20 (0.2 M magnesium chloride, 0.1 M Tris pH 7, 10% w/v PEG 8000), JCSG 
condition 29 (0.8 M sodium phosphate, 0.1 M HEPES pH 7.5), JCSG condition 52 (0.2 M 
lithium sulfate, 0.1 M Tris pH 8.5, 1.26 M ammonium sulfate), JCSG condition 56 
ammonium phosphate dibasic,, 0.1 M sodium acetate and JCSG condition 57 (0.1 M MES 
pH 6.5, 1.6 M magnesium chloride).  
 
 
 
 
 
 
4.3. Wild type NS7pol: data collection, phasing and model building  
 
Data were initially obtained at 3.15 Å resolution on a Rigaku MicroMax-007 HF-M high-flux 
generator with a Saturn 944+ CCD detector. The data were indexed and scaled using iMOSFLM 
and SCALA respectively.  The asymmetric unit had 3 molecules in an orthorhombic unit cell. The 
crystal was of the space group C212121. The data were phased using an ensemble of HuNV NS7pol 
structures (PDB 1SH0, 1SH3 and 2B43) using Phaser (Ng et al., 2004; Hogbom et al., 2009; 
McCoy et al., 2007).  The log likelihood gain score of the phaser solution was 3,339, indicating 
that the molecular replacement solution was of good quality.  
The resulting electron density map was readily interpretable (Fig. 4-5). The HuNV NS7pol 
structure (PDB 1SH0) was used as the initial model; this model was manipulated using the 
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molecular graphics program O to fit the electron density map (Ng et al., 2004). Data were 
acquired at Diamond light source synchrotron (I03 beamline) to extend the resolution of the 
map to 2.3 Å.  This map was very again readily interpretable, and contained density for many 
carbonyl and side chain groups which were absent in the lower resolution map (Fig 4-5). The 
low resolution model was manipulated using Coot to fit the high resolution electron density 
map. The final high resolution model contained residues 8 – 491.  The full length protein 
contains 510 residues.  Electron density of sufficient quality for model building was absent for 
the N-terminal 7 residues and C-terminal 19 residues of the protein. The final high resolution 
model had good stereochemical and refinement statistics (Table 4-1). Approximately 99% of 
residues in the model are in the allowed region of the Ramachandran plot. The residues in the 
disallowed region are all in one of three high B-factor regions of the protein. In these regions the 
electron density map is difficult to interpret, which is likely to result in some misinterpretation 
leading to a poor quality model. These high B-factor regions, residues 375-380, 435-440 and 
466-475, are also associated with high B-factors in other RDRP polymerase structures (Ng et al., 
2004; Hogbom et al., 2009; Zamyatkin et al., 2008). The three structures in the asymmetric unit 
show a good level of agreement with backbone root mean square deviation (RMSD) of 
approximately 0.2 Å. The greatest deviations between the structures are in three high B-factor 
regions. The data collection and model statistics are given in Table 4-1. The Ramachandran plot 
is shown in Figure 4-6. 
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Figure 4-4: Representative crystal and diffraction image of MNV NS7pol 
Both the image of the crystal A and diffraction pattern B were obtained at the I03 beamline of 
Diamond synchrotron.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-5: Initial and final MNV NS7pol electron density maps 
The electron density map is shown as blue mesh. The model in both the low resolution electron 
density map A and the high resolution electron density map B is the final model built using the high 
resolution electron density map.  
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Figure 4-6: Ramachandran plot for the wild type full length MNV NS7pol crystal structure 
Generated using MolProbity (Chen et al., 2010). 
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4.4.Wild type MNV NS7pol structure 
 
The structure of MNV NS7po l is very similar to the structure of all other positive sense RNA viral 
polymerases that have been determined. Alignment of the MNV NS7po l structure with an 
equivalent HuNV structure, that of Norwalk virus NS7pol (PDB 1SH0), shows that the two 
structures are very similar with a backbone RMSD of 0.8 Å. Like that of HuNV, the MNV NS7pol 
has a right hand fold with palm, fingers, thumb and fingertips domains (Fig. 4-7). This encircles 
a closed RNA binding cleft, into which the active site aspartic acid residues, D245 and D347, 
protrude. The palm domain consists of a central three stranded β-Sheet, which is stabilised by 4 
α-helices and a second three stranded β-Sheet (Fig. 4-7). This central β-Sheet contains D347. 
D245 is contained on a loop structure three residues C-terminal to the smallest strand in the 
central β-Sheet. The palm domain of MNV NS7po l aligns well to that of Norwalk virus NS7po l with 
a backbone RMSD of 0.5 Å between the two domains.  
The fingers domain is the largest domain in the protein; it consists of a seven α-helix bundle 
packed together with a three stranded β-sheet (Fig. 4-7).  This domain also aligns well with the 
HuNV NS7pol finger domain with a backbone RMSD of 0.5 Å between the two structures.  
 The thumb domain consists of approximately 100 residues at the C-terminus of the NS7pol 
protein; it is made up of four α-helices packed together with a small, 2 stranded, β-Sheet (Fig. 4-
7). The angle of the helices in the thumb domain differs slightly to that of HuNV. The result of 
this is that the thumb domains of Norwalk virus and MNV NS7po l proteins are the most divergent 
in terms of backbone RMSD of all the domains in the protein; the backbone RMSD of the two 
domains is 0.8 Å. Structural variability and flexibility in the thumb domain, however, has been 
previously observed in other structures. It is the most structurally divergent domain between 
the two non RNA-liganded HuNV NS7pol structures solved thus far, with a backbone RMSD of 0.6 
Å between the two domains (Ng et al., 2004; Hogbom et al., 2009). In addition, the thumb 
domain re-orientates significantly to accommodate duplex RNA. This reorientation results in the 
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backbone RMSD of the thumb domain, of the same NS7po l protein, with and without duplex RNA 
being 1.4 Å (Ng et al., 2004; Zamyatkin et al., 2008).  C-terminal to the thumb domain is the C-
terminal 20 residues of the protein; in the MNV NS7po l structure this C-terminal section is 
disordered. This is also the case for the RHDV and human sapovirus NS7pol proteins (Ng et al., 
2002; Fullerton et al., 2007). However, both unliganded HuNV NS7pol structures have structured 
C-termini which occupy slightly different positions in the RNA binding cleft (Hogblom et al., 
2009).  All but one of the side chains, N220, required for packing of the C-terminus into the RNA 
binding cleft is conserved between HuNV and MNV NS7pol proteins. A N220S mutation in MNV 
NS7pol may have a deleterious effect on C-terminus binding given that the functional group, at 
position 220, important for the interaction in HuNV NS7pol is a side chain amide. However, it 
must be noted that even though the two HuNV structures are identical for all residues important 
for the interaction of the C-terminus with the RNA binding cleft, both structures deviate in the 
position of the C-terminus in the RNA binding cleft. Thus, it is quite likely that the interaction is 
of low affinity and that the C-terminus is quite mobile in solution. However, given that the C-
terminus is at a crystallographic interface, this apparent mobility may be a result of the C-
terminus being forced into different positions by crystal packing. 
The fingertips domain consists of three long loop structures which close the RNA binding cleft. 
An N-terminal loop which stems from the fingers domain and interacts with the thumb domain, 
is the primary connection between the thumb and fingers domain (Fig. 4-7). This loop is 
stabilised via interactions with two other loops, one stemming from the thumb domain, and one 
from the fingers domain. Despite the fingertips domain being made up of loops it is quite well 
conserved structurally. The backbone RMSD between aligned MNV and Norwalk virus NS7pol 
fingertips domains is 0.5 Å.  
Unfortunately subsequent to solving this structure, a structure of MNV NS7po l was published, by 
another group, at a resolution of 2.7 Å (Lee et al., 2011). The published structure and our 
unpublished structure are very similar with a backbone RMSD of approximately 0.3 Å (Fig. 4-7).  
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The only large deviations between the two proteins are in high B-factor regions. Interestingly 
Lee and colleagues have not built model for the C-terminal 18 residues of the protein, backing 
up our observation that the C-terminus of MNV NS7pol is more mobile than its HuNV equivalent 
(Lee et al., 2011). 
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Figure 4-7: The structure of murine norovirus (MNV) NS7pol compared to human norovirus (HuNV) 
NS7pol and the published MNV NS7pol structure 
A. Two views of the MNV NS7pol structure are shown. The thumb domain is shown in light blue, the 
fingers domain in yellow, The fingertips domain is shown in cyan, apart from the central loop which 
connects the fingers and thumb domain. This loop is shown in orange. The palm domain is shown in 
green except for the central β-sheet of the domain which is shown in purple. B. The HuNV 
polymerase (PDB 1SH0) is predominantly shown in green with the C-terminus of the molecule shown 
in orange. MNV NS7pol is shown in light blue. C. The MNV NS7pol structure presented in this thesis is 
shown in light blue while the published structure is shown in orange (PDB 3NAH). 
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4.5.MNV NS7pol crystallographic interfaces  
 
PV 3Dpol forms large two dimensional lattice structures both in vitro and in vivo (Lyle et al., 
2002).  The formation of these lattices is important for RNA binding and elongation (Hobson et 
al., 2001; Spagnolo et al., 2010). The interactions between 3Dpol proteins of PV that allow these 
lattices to form have been captured in the crystal lattice of the PV 3Dpol crystal structure 
(Hansen et al., 1997; Lyle et al., 2002). More recently FMDV 3Dpol has been shown to form lattice 
structures, with RNA, in vitro (Bentham et al., 2012).   No evidence has yet emerged to support 
the formation of noroviral NS7pol lattice structures.  However, MNV NS7pol can exist as in a range 
of states from monomer to hexamer in solution (Lee et al., 2011).   
The published NS7pol structure has been indexed as being in the C2 space group with a 
monoclinic unit cell. The structure presented in thesis has been indexed being in the C212121  
space group and having an orthorhombic unit cell.  However, both published and unpublished 
MNV NS7pol structures have very similar crystal forms that share the same dimer and trimer 
interfaces. The MNV NS7pol asymmetric units are shown, along with the trimer and dimer 
interactions, in Figure 4-8.  
 It is tempting to speculate that the interfaces observed in the crystal structure mediate the 
oligomerisation of MNV NS7pol. Given that HuNV NS7po l has been shown to function in RNA 
elongation as a cooperative homodimer, it is also tempting to speculate that these 
crystallographic interfaces, much like those of PV 3Dpol, have important roles to play in viral 
replication (Hogbom et al., 2009).  However, given that very little is currently known about 
norovirus replication factories, it is likely that the role of NS7po l oligomerisation will not be fully 
understood until we have reliable structural models of the viral replication complex. 
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Figure 4-8: Crystallographic interfaces in the published and unpublished MNV NS7pol crystal  
structures 
Both structures have three molecules in the asymmetric unit. The published structure has both 
dimer (labelled 1 above) and trimer (labelled 2 above) interfaces within the asymmetric unit. The 
structure presented in this thesis has just a trimer interface in the asymmetric unit. The dimer 
interface joins adjacent asymmetric units in the crystal lattice.  
 Results and discussion: NS7pol 
 
 90 
 
4.6.MNV NS7pol fidelity  
 
In an attempt to produce a high fidelity NS7pol our collaborators, Dr Ian Goodfellow and 
colleagues, designed a panel of mutations in NS7po l. Their strategy was based on the ribavirin 
triphosphate resistance mutant G64S of PV 3Dpol. As this mutation increases the fidelity of the 
polymerase in PV, a structural alignment was performed between NS7pol and PV 3Dpol (Arnold et 
al., 2005). Mutations were made in a region of MNV NS7po l that structurally aligns close to G64 
of PV 3Dpol.  Characterisation of mutant polymerases was performed using live virus with 
mutant polymerases and a well characterised MNV mutant, A5941G (Bailey et al., 2008). This is 
a capsid protein mutation which is unstable, and reverts to WT in cell culture. The number of 
passages, in cell culture, required for the capsid mutant to revert to WT was used as a crude 
measure of polymerase fidelity. Reversion to WT at this position is monitored by sequencing of 
viral DNA at each viral passage. The viral nucleic acid was obtained from virus grown in non-
adherent Raw 264.7 cells.  Thus the sequencing data for position A5941 is averaged due to the 
quasispecies diversity of the culture. 
After this process two NS7pol mutants, P72S and E75S appeared to have higher fidelity than WT. 
Both of these mutations, like that of G64S of PV, are in the fingers domain at a site that is more 
than 15 Å away from the polymerase active site.  Because of its distance from the active site, the 
part of the fingers domain on which the fidelity substitutions are located will be called the 
“remote site” throughout the remainder of the chapter.  
P72S and E75S mutant MNV NS7po l were cloned into pETM11, expressed and purified as per WT 
NS7pol. The protein yield of both mutant polymerases was similar to that of WT. The purified 
protein was at least 95% pure, as determined by SDS-PAGE (data not shown). All the work for 
the P72S mutant up to, and including, crystallisation was performed by an undergraduate 
student Mr Robert Harrington, under my supervision. Crystallisation was performed as per the 
large scale crystallisation setup for MNV NS7po l protein. Crystals were very similar, in both size 
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and shape, to the WT crystals. Data were acquired at the Diamond synchrotron I03 beamline to 
2.7 Å and 2.35 Å resolution for P72S and E75S mutants respectively. The space group and unit 
cell parameters were as per the WT crystals. Models were manipulated for both mutant 
polymerases as per the high resolution structure of WT MNV NS7pol, with the exception that the 
high resolution structure of WT MNV NS7pol was used as the initial model.  
Final models had good stereochemical and refinement statistics. The data collection and model 
statistics are given in Table 4-1. The Ramachandran plots are shown in Figures 4-9 and 4-10. 
 Like WT NS7pol, the models start at residue 8 and extend to residue 491. Electron density was 
very difficult to interpret in the P72S model between residues 469 and 476. Thus, gaps of 
between 2 and 6 residues are present in this part of the model in each molecule in the 
asymmetric unit.  
Neither P72S nor E75S substitutions induce large scale rearrangement of the protein structure 
(Fig. 4-11). The backbone RMSD between both mutant NS7po l proteins and WT is approximately 
0.3 Å. The electron density for both mutated residues and the surrounding residues was readily 
interpretable; in all three chains in both P72S and E75S models the serine side chains could be 
unambiguously built into the electron density (Fig. 4-12). In addition the electron density at 
positions 72 in P72S and 75 of E75S were very different from the density at the equivalent 
positions of the WT polymerase. This electron density did not change significantly in omit maps. 
Omit maps were calculated using Phenix, with simulated annealing and without the mutated 
residue and several adjacent residues N and C-terminal to it in the input model. This suggests 
that the altered electron density observed in the mutant polymerases is not as a result of phase 
bias introduced by the input model.  
In the case of the P72S mutant the S72 hydroxyl group forms a hydrogen bond with the 
corresponding hydroxyl group of S251 (Fig. 4-11). This hydrogen bond is present in all three 
molecules in the asymmetric unit despite one of the S72 side chains adopting a different 
rotamer conformation to the other two residues. In addition, in one of the molecules in the 
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asymmetric unit, another hydrogen bond is present between a terminal amine of the 
guanidinium group of R248 and the backbone carbonyl group of Q69 (Fig. 4-11). While this 
hydrogen bond is not present in WT and E75S polymerase proteins, there is some electron 
density in all polymerase molecules to support the R248 rotamer conformation which allows 
this hydrogen bond to form, suggesting that the side chain may be occupying two 
conformations. However, in all but one molecule in the P72S mutant asymmetric unit, this 
hydrogen bond rotamer is a minority species.  
Thus, it appears that the only significant structural difference between the WT and P72S mutant 
polymerase is one, or at most, two extra hydrogen bonds between this remote site and motif A 
of the polymerase. In the wild type polymerase these two sites are already connected by a 
hydrogen bond network which principally centres on R77.  The terminal amines of the 
guanidinium group of R77 are hydrogen bonded with the carbonyl groups of S251 and Q253 of 
motif A as well as P72 and E75 of the remote site. These two sites are also connected by a 
hydrogen bond between the L79 carbonyl group and the side chain amide group of Q254.  
Motif A contains one of the aspartic acid residues (D245 in MNV NS7pol) which coordinates one 
of the active site divalent cations. It is known from the co-crystal structure of HuNV NS7pol with 
RNA and NTP that this cation stabilises the positioning of the incoming NTP by interaction with 
the phosphate groups (Zamyatkin et al., 2008). It has also been shown that motif A stabilises the 
position of the incoming NTP by firstly, interaction of the backbone amide group of R245 with 
the γ phosphate group of the NTP, and secondly, interaction between the backbone amide group 
of D247 and the 2ʹ  hydroxyl group of the NTP ribose sugar (Zamyatkin et al., 2008). The 
interactions between motif A of HuNV and the incoming NTP are shown graphically in Figure 4-
13.  
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Figure 4-9: Ramachandran plot for the P72S MNV NS7pol full length crystal structure 
Generated using MolProbity (Chen et al., 2010). 
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Figure 4-10: Ramachandran plot for E75S MNV NS7pol full length crystal structure                  
Generated using MolProbity (Chen et al., 2010). 
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 Wild-type P72S E75S 
Beamline I03 Diamond light 
source (UK) 
I03 Diamond light 
source (UK) 
I03 Diamond light 
source (UK) 
Space-group C2221  C2221  C2221  
a, b, c (Å) 123.89, 195.93, 
198.19 
122.55, 194.61, 
197.51 
122.99, 195.71, 
197.66 
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution range (Å) 45.19-2.30 55.28-2.67 44.96-2.35 
Independent reflections 105,335 66,931 98,517 
Multiplicity1 3.5 (3.6) 3.7 (3.7) 3.9 (3.9) 
Completeness1 (%) 98.9 (99.9) 99.8 (100)  99.6 (100)  
I/σ
I
 1 8.9(2.4) 10.3 (2.4)  12.5 (4.1)  
Rmerge (%)
1,2 7.5 (45.9)  7.8 (53.3)  6.3 (30.4)  
    
MODEL REFINEMENT    
No. of Nonhydrogen 
atoms/waters 
566 123 553 
Rmodel (%)
3 19.51 19.23 18.34 
Rfree (%)
4 23.97 25.26 22.60 
r.m.s bonds (Å) 0.007 0.008 0.008 
r.m.s bond angles (°) 1.040 1.116 1.097 
Ramachandran plot (% 
favoured/allowed) 
99.2 98.9 99.1 
 
 
 
 
Table 4-1: Data and refinement statistics for MNV NS7pol wild type, P72S and E75S  
1Values for the outermost resolution shell are given in parentheses. 2Rmerge = 100 x ∑h∑j|Ihj - 
Ih|/∑h∑jIhj where Ih is the weighted mean intensity of the symmetry related reflections Ihj
3. 
Rmodel = 100 x ∑hkl|Fobs - Fcalc|/∑hklFobs where Fobs and Fcalc are the observed and calculated structure 
factors respectively. 4Rfree is the Rmodel calculated using a randomly selected 5% sample of reflection 
data omitted from the refinement. 
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Figure 4-11: Structure of the P72S and E75S mutant NS7pol proteins in comparison to wild type 
(WT) 
A. Superposition of the structures of WT (blue) as well as P72S (green) and E75S (orange) mutant 
NS7pol proteins. B. Structure of WT NS7pol with motif A and the remote site, containing P72 and E75, 
shown in pink and yellow respectively. C-E. Hydrogen bond network connecting the remote site 
(yellow) and motif A (pink). Hydrogen bonds are shown as dashes.  
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Figure 4-12 Electron density maps for residues 72 and 75 in wild type (WT) as well as P72S and 
E75S mutant NS7pol proteins 
The electron density map is shown as blue mesh. The electron density maps are at 2.3, 2.7 and 2.35 
Å resolution for the WT, P72S and E75S NS7pol proteins respectively. The electron density maps are 
presented at 1 σ. Positions 72 and 75 in both WT and mutant polymerases are marked with a red 
asterisk. 
 
 
While polymerase fidelity is just beginning to be characterised in the noroviruses, much more 
work has been done on the picornaviral RDRP. It is likely that the P72S mutation of MNV NS7pol 
works in a similar manner to the G64S mutation of the PV RDRP. The interactions involved in 
motif A stabilisation in the G64S mutant 3Dpol are shown in Figure 4-14. This mutation also 
serves to stabilise the motif A of the PV polymerase active site, albeit through a slightly different 
mechanism to P72S of MNV NS7pol. The PV 3Dpol motif A is stabilised by a very intricate network 
of hydrogen bonds involving three sites remote from the active site. In this case the amide group 
of G1 functionally replaces the R77 interacting with the carbonyl groups of A239 and L241 of 
motif A and the side chain carbonyl of N65. The S64 hydroxyl group hydrogen bonds with the 
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E2 side chain thus stabilises the N-terminus of the protein which in turn is thought to help the 
stabilisation of motif A by G1 (Marcotte et al., 2007).   
How this stabilisation mechanistically affects the polymerase fidelity is currently being worked 
out for the PV RDRP. The steps involved in the nucleotide addition cycle of the picornaviral 
RDRP are outlined in Fig. 1-14.  In the case of PV RDRP the rate constants for each step have 
been determined empirically for each step in the presence of matched or mismatched NTP. In 
the presence of a mismatched nucleotide the rate constant for the pre-catalysis active site 
closure step is greatly reduced as is the phosphoryl transfer step (catalysis step)(Arnold et al., 
2004). A reduced rate of active site closure and catalysis increases the possibility of nucleotide 
disassociation from the complex as the NTP disassociation constant is unaffected by weather 
the nucleotide is mismatched or not (Arnold et al., 2004). Thus active site closure and 
phosphoryl transfer are key checkpoints of fidelity in viral RDRPs.   
Similar analysis with the PV G64S RDRP mutant demonstrated that relative to the WT 
polymerase the G64S mutant had a 3 fold slower rate for active site closure. The rate of 
phosphoryl transfer for both WT and the G64S mutant enzyme was very similar. This implicated 
the observed increase in fidelity in the G64S mutant to the pre-catalysis active site closure step. 
Molecular dynamics studies have shown that the G64S mutant has decreased conformational 
flexibility of the active site of the polymerase particularly that of motif A (Moustafa et al., 2011). 
It may be that the conformational rigidity in the G64S mutant of the PV RDRP increases the 
energy barrier for active site closure decreasing the likihood of mismatched nucleotide 
incorporation. The P72S mutation may have a very similar mechanism to the G64S mutation in 
terms of stabilisation of motif A of the polymerase based on the structural similaraties between 
the proteins. However, detailed biochemical analysis will be required to fully demonstrate that 
the P72S mutant of NS7po l is increasing fidelity in a way that is mechanistically similar to the PV 
RDRP. 
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The role of position 75 in modulating polymerase fidelity is difficult to determine based on our 
structural model for both the WT and E75S NS7po l. The S75 side chain does not appear to 
interact with any other residue, much like the E75 side chain in the WT polymerase. In addition, 
the hydrogen bond network between the remote site and motif A is identical in both E75S and 
WT polymerases (Fig. 4-11). It may be that in solution the side chain at position 75 interacts 
transiently with other residues and this transient interaction is not stable enough to be 
captured in the crystal structure.  Alternatively the side chain at position 75 may play a role in 
the nucleotide addition cycle which cannot be captured in an unliganded structure. E72 is the 
HuNV equivalent to E75 of MNV NS7pol; the E72 side chain of HuNV does not appear to interact 
with other residues in the RNA- and NTP-bound structures of HuNV. However, this does not 
exclude the possibility that the interaction is transient or that a serine at this position would 
interact with other residues. 
There may be a parallel between E75S of MNV NS7po l and G62S of FMDV 3Dpo l. The G62S 
mutation of FMDV 3Dpol is the equivalent to the G64S mutation of FMDV 3Dpol, however, this 
mutation has never been shown to increase polymerase fidelity. Two crystal structures of FMDV 
G62S 3Dpol in complex with duplex RNA and NTP have been determined (Ferrer-Orta et al., 
2010). While S62 does not contribute any hydrogen bonds to the stabilisation of motif A, the 
polymerase showed reduced conformational flexibility in a loop, the β9-α11 loop, near the 
active site of the polymerase.   
In order to confirm that P72S and E75S both alter fidelity by reducing the flexibility of the active 
site co-crystal structures of the polymerases with duplex RNA and NTP are required. This may 
have to be coupled with molecular dynamics simulations to full understand the dynamic 
interactions mediating reduced flexibility. 
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Figure 4-13: Interactions of the HuNV motif A with an incoming NTP 
The structure is the co-crystal structure of the HuNV NS7pol with RNA and CTP (PDB 3BSO). Motif A is 
shown in pink. The remote site is shown in yellow. The divalent cation (Mn2+) is shown in silver. CTP 
and side chains and main chains which interact with it are shown in sticks. Electrostatic interactions 
are shown as dashed lines.  
 
 
 
 
 
 
 
 
 
Figure 4-14: Hydrogen bond network stabilising motif A of G64S PV 3Dpol 
Motif A is shown in pink, residues 1-5 are shown in light blue, residues 58-68 in yellow, and residues 
281-287in green. Electrostatic interactions are shown as dashed lines. (PDB 2IFJ).  
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4.7.NS7pol  research: future perspectives 
 
The norovirus polymerase is a very well characterised enzyme; few interesting structures 
remain to be determined. Of these the main target is the polymerase bound to the protein 
primer of replication, VPg. This structure would provide the first insights into the structural 
basis of norovirus protein priming. The unliganded NS7po l structure was determined as a first 
step towards determining the structure of the NS7pol-VPg complex. 
What is of much interest is structural information about the arrangement of the norovirus 
replication complex. Any kind of reliable structural model of the replication complex is likely to 
require proteomic analysis to define the host and viral proteins present within the complex. 
This information may allow reconstitution of the complex or subunits of the complex, in vitro, 
which may permit structural determination, of at least part of the complex, by crystallography 
or electron microscopy. In the absence of a high resolution model of the replication complex a 
quasi-structural model could be built if the structure of all the components of the complex can 
be determined and the stoichiometry of the components and binding interfaces be defined. 
However, the structures of N-term, NS3 and NS4, all of which are likely to be involved in the 
replication complex, have yet to be determined.  
The characterisation of the mechanisms governing the fidelity of norovirus polymerases using 
mutant polymerases is interesting in and of itself, as fidelity is a very important concept for both 
viral evolution and antiviral drug development. Study of polymerase fidelity may also have an 
important application in the development of rationally attenuated vaccines with reduced 
capacity to revert to virulence. It may be that the structural characterisation of P72S and E75S 
polymerases with RNA and NTP will allow determination of the regions which have reduced 
conformational flexibility. Further mutation in these regions may allow reduced conformational 
flexibility, thus increased fidelity, in the absence of remote site mutations. Having two mutations 
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in distinct sites of the polymerase would provide a large mutational barrier for vaccine strains 
to overcome in order to revert back to a rapidly evolving virus.   
At the present, however, the primary issue for the development of live human norovirus 
vaccines is the absence of a working cell culture system; this prevents the possibility of 
production of live virus of any kind.  
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5. Results and Discussion: VPg 
 
The structure of FCV VPg has been determined previously (Kwok et al., unpublished). It is a 
tightly packed three helix bundle, as has been described in the introduction. This chapter 
describes the extension of this structural work into MNV and LDV.  It also describes preliminary 
attempts to characterise the interaction between MNV VPg and MNV NS7pol. 
5.1.Expression and purification: VPg proteins  
Expression constructs were made as described in the Materials and Methods. The coding 
regions of all constructs were sequenced prior to use. The following constructs were made for 
protein expression: MNV VPg 1-124 (full length), MNV VPg 11-85, MNV VPg 11-62, LDV VPg 1-
133 (full length), LDV VPg 11-94, LDV VPg 11-80, and LDV VPg 11-66. In addition, in the context 
of full length MNV VPg protein, the following mutations were made for protein expression: 
Y26A, Y26F, R32D, Y40A, Y40F, Y45A, Y45F, D48R and D48R/R32D double mutant.  In addition 
the following full length FCV VPg (1-111) proteins were expressed: WT, Y24A, F43A, R47E, 
F62A and F69E.  
All proteins expressed well in E. coli cells as determined by SDS-PAGE analysis of cell lysate pre- 
and post-induction (data not shown).  Using LB or rich media typical final OD600 values were 
between 1.0 and 2.0 for 4 hour or overnight inductions. Typical values for overnight expression 
using minimal media varied from OD600 of 5 to 13.  
Protein purification was monitored by SDS-PAGE. Figure 5-1 shows the purity of VPg at each 
stage of purification for MNV VPg 1-124. After cell lysis and clarification of the cell lysate by 
centrifugation all WT VPg proteins were present in the soluble fraction.  
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For most VPg purifications the protein was greater than 90% pure after a primary TALON resin 
purification step. In the case of MNV VPg 1-124 small contaminating bands were visible after 
TALON purification. The molecular weight of these bands decreased after addition, and 
overnight incubation with, His tagged TEV NIa protease. Thus, they are very likely to be the 
result of degradation of the protein at the C-terminus (Fig 5-1).  TEV NIa protease was readily 
purified away from VPg by a secondary TALON purification step (Fig. 5-1). After this step VPg 
was typically the only band visible by SDS-PAGE for all proteins except MNV VPg 1-124. All VPg 
proteins produced a single peak by SEC (Fig. 5-2 and Fig. 5-3), however, filtration of highly 
concentrated LDV VPg 11-94 protein (approximately 2.5 mM), resulted in a significant decrease 
in the elution volume and substantial increase in the peak width (data not shown). This suggests 
that LDV VPg may self-associate at very high protein concentration. The MNV VPg 1-124 protein 
could be, at least partially, purified from the lower molecular weight contaminates by SEC (Fig 
5-2.).  
 
A B C 
Figure 5-1: Wild type MNV VPg purification  
Purification was performed by, firstly, poly-histidine tag purification using TALON resin, then cleavage 
of the poly-histidine tag by TEV NIa protease. The TEV NIa protease was purified away by re-
application of the protein to TALON resin. Finally, the protein was further purified by size exclusion 
chromatography (SEC) using a Superdex S75 16/60 Highload column. A. Initial TALON resin purification 
monitored by SDS-PAGE. 1) Whole cell lyste pre-sonication, 2) whole cell lysate post-sonication, 3) 
soluble fraction post 30,000xg centrifugation, 4) soluble fraction post 1 mg/ml protamine sulphate 
addition and 30,000xg centrifugation, 5) flow fraction following application of protein to TALON resin, 
6) 0 mM imidazole wash 1, 7) 0 mM imidazole wash 2, 8) 5 mM imidazole wash, 9) 10 mM imidazole 
wash 1, 9) 10 mM imidazole wash 2, 11) 100 mM imidazole wash 1, 12) 100 mM imidzole wash 2, 13) 
500 mM imidzole wash. B. Monitoring TEV NIa cleavage of the poly-histidine tag by SDS-PAGE. 1) Pre 
TEV NIa cleavage, 2) post-TEV NIa cleavage. C. Re-application of the protein to TALON resin monitored 
by SDS-PAGE. 1) Flow through following re-application of the protein to TALON resin, 2) 0 mM 
imidazole wash, 3) 5 mM imidazole wash, 4) 100 mM imidazole wash, 5) 500 mM imidazole wash.  
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Figure 5-2: Size exclusion chromatography of MNV VPg proteins  
SEC purification monitored by absorbance at 280nm. Peak fractions were analysed by SDS-PAGE. A 
MNV VPg full length (1-124), B MNV VPg 11-85, C MNV VPg 11-62.  
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Figure 5-3: Size exclusion chromatography of LDV VPg proteins 
SEC purification monitored by absorbance at 280nm. Peak fractions were analysed by SDS-PAGE. A 
LDV VPg full length (1-133), B LDV VPg 11-94, C LDV VPg 11-80. 
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Protein samples to be used for 1D NMR analysis were purified by primary TALON resin 
purification only. MNV VPg 1-124 protein for SPR and MNV VPg 11-62 and 1-124 proteins for 
1H-15N HSQC NMR experiments (comparison of truncated constructs with 1-124) was purified 
by primary and secondary TALON resin purification. Protein for all other applications was 
purified by both TALON steps and SEC.  
Typical yields of WT MNV VPg, purified for multidimensional NMR and BIAcore, were 5-10 mg 
of protein per 250 ml of minimal media and 5-10 mg per litre of rich media. The higher yields 
achieved in minimal media expression reflect the higher OD600 values observed in minimal 
media expression. In the case of LDV the yields varied from 2.5 mg (VPg 1-133), to 12.5 mg (VPg 
11-94), per 250 ml of minimal media. The expression and purification of NS7pol is discussed in 
Section 4.1. 
 
5.2. Choice of construct for MNV VPg solution structure determination 
 
An amino acid sequence alignment of MNV VPg and FCV VPg shows that these two proteins 
share approximately 27% amino acid identity and 62% amino acid similarity (Fig. 5-4). The 
structured region of FCV VPg is between residues 14 and 76.  The equivalent residues of MNV 
VPg, based on the sequence alignment, are 11 to 82. An MNV VPg expression construct was 
made for MNV VPg 11-85. The protein expressed with this construct was soluble and was 
folded, as determined by the presence of an aromatic shifted methyl and dispersed backbone 
amide peaks in a 1D NMR spectrum (data not shown). Because of the relatively high level of 
sequence identity between MNV VPg and FCV VPg, and the fact that a MNV VPg construct, 
similar to that used to solve the FCV structure, was folded, MNV VPg 11-85 was chosen as the 
construct  to solve the solution structure of MNV VPg.  
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5.3. MNV VPg 11-85 backbone resonance assignment 
The key experiment for backbone resonance assignment is the 1H-15N HSQC spectroscopy. This 
experiment correlates amide nitrogen atoms with their covalently attached protons.  Each 
backbone amide group, with the exception of proline, gives rise to a 1H-15N HSQC peak. Side 
chain amide and amino groups also give rise to peaks in a 1H-15N HSQC spectrum. Because the 
1H-15N HSQC spectrum has at least one peak per residue, with exception of proline, it is often 
used to monitor changes in protein structure. Backbone amide resonance assignment was 
completed using the 1H-15N HSQC spectrum in combination with four triple resonance 
experiments. These experiments were the 3D HNCO, HN(CA)CO, CBCA(CO)NH, and the HNCACB 
spectra. The names of the experiments indicate the atoms that participate in the magnetisation 
transfer implemented by the NMR pulse sequence (atoms in brackets participate in the 
magnetisation transfer but do not have their chemical shifts recorded in the experiment). How 
backbone NMR assignments are derived is briefly outlined below. 
For each residue the HNCO spectrum correlates the chemical shifts of the amide of residue i and 
the backbone carbonyl carbon of the preceding residue (i-1). The HN(CA)CO spectrum 
correlates the chemical shifts of the amide residue i and backbone carbonyl carbon of both i and 
i-1. Similarly the CBCA(CO)NH experiment correlates the chemical shifts of amide i and the Cα 
and Cβ of i-1, while the HNCACB experiment records the chemical shifts of amide i and the Cα 
FCV_VPg    -AKGKTKLKIG---TYRGRGVALTDDEYDEWREHNASRKLDLSVEDFLMLRHR--AALGA 54 
MNV_VPg    GKKGKNKKGRGRPGVFRTRG--LTDEEYDEFKKRRESRGGKYSIDDYLADREREEELLER 58 
             ***.*   *   .:* **  ***:****::::. **  . *::*:*  *.*    *   
 
FCV_VPg    DDNDAVKFRSWWNSRTKMAN--DYEDVTVIGKGGVKHEK-IRTNTLKA--VDRGYDVSFA 109 
MNV_VPg    DEEEAIFGDGFGLKATRRSRKAERAKLGLVSGGDIRARKPIDWNVVGPSWADDDRQVDYG 118 
           *:::*:   .:  . *: :.  :  .: ::. *.:: .* *  *.: .  .* . :*.:. 
 
FCV_VPg    EE---- 111 
MNV_VPg    EKINFE 124 
          *:     
 Figure 5-4: Amino acid sequence alignment of FCV and MNV VPg proteins  
Alignment was performed with clustalW using the FCV F9 strain VPg sequence (NCBI accession number 
P27409) and MNV CW1 strain VPg sequence (NCBI accession number DQ285629.1). The FCV VPg 
helical regions are underlined.  
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and Cβ carbons of i and i-1. This set of experiments correlates the Cα, Cβ and CO backbone 
nuclei to a particular amide group NH in the protein. The HNCO, HN(CA)CO, and CBCA(CO)NH, 
HNCACB are treated as two pairs of “coupled” experiments. Matching up the chemical shift 
values of the i and i-1 cross peaks in each pair of experiments allows ordering of backbone spin 
systems.  Ordering of spin systems using representative strips from CBCA(CO)NH and HNCACB 
spectra for  MNV VPg 11-85 is shown in Figure 5-5.  In order to assign the backbone spin 
systems to a particular residue another piece of information is used. This is that particular 
amino acid types have very characteristic Cα and Cβ chemical shifts. These residues include 
alanine, serine, threonine, and glycine. By ordering spin systems, and assigning them based on 
characteristic chemical shifts to the protein sequence it should be possible to assign almost 
every backbone NH, CO, Cα and Cβ resonance.  This was performed for MNV VPg 11-85, at least 
in part, in an automated fashion using the MARS software (Jung and Zwekstetter, 2004).  
Assignment of the backbone resonances of MNV VPg 11-85 was not as straightforward as 
proteins of similar size due to the nature of the protein sequence.  Approximately 32% of the 
amino acids in MNV VPg 11-85 are glutamic acid or arginine. Another 17% are aspartic acid or 
lysine. In addition, these charged residues often occur in low complexity sequences such as the 
highly charged 48DREREEELLERDEEE63 sequence. The consequence of the unusual amino acid 
composition and sequence of MNV VPg was a high degree of resonance overlap in all 
experiments. Due to this resonance overlap only approximately 60% of the NH, CO, Cα and Cβ 
nuclei were assigned by MARS. Most of the remaining residues were assigned through visual 
examination of Cα, Cβ and carbonyl carbon shifts. Two regions of the protein sequence were 
particularly difficult to assign. These regions are residues 31 to 36 and 47 to 57, both of which 
are very rich in glutamic acid and arginine. Ultimately the 1H-15N NOESY HSQC spectrum 
(NOESY experiments are introduced in Section 4.6) was used to assign these regions,  by 
manually analysing the NH(i)-NH(i-1) NOE profile. In helical regions neighbouring residues 
have intense NH-NH NOE cross peaks.  Using both MARS and NOESY experiments all nuclei in 
the backbone of the MNV VPg 11-85 were assigned. The backbone nuclei of methionine in the 
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GAM sequence of the cleaved His tag were also assigned. The assigned 1H-15N HSQC spectrum is 
shown in Figure 5-6. 
The Hα and Hβ nuclei were subsequently assigned, for all residues except those preceding 
proline using the HBHA(CO)NH which correlates Hα and Hβ groups to the assigned amide NH 
groups. 
 
 
 
 
 
 
Figure 5-5: Backbone assignment of MNV VPg 11-85. 
Shown above is representative strips from the HNCACB and the CBCA(CO)NH experiments used in 
backbone assignments. The HNCACB strips are marked H while the CBCA(CO)NH strips are marked C. 
Neighboring  strips with matching Cα shifts are joined by a black box. Neighboring  strips with matching Cβ 
shifts are joined by a red box.  
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Figure 5-6: Backbone amide NH group assignment of MNV VPg 11-85 
The backbone amide NH peaks of MNV VPg 11-85 are labelled with their residue number. 
PPM 
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5.4. MNV VPg 11-85 side chain assignment 
 
The aliphatic side chain nuclei were assigned primarily using four experiments. These are the 
(H)CC(CO)NH TOCSY, H(CCCO)NH TOSCY, H(C)CH TOCSY and the (H)CCH TOCSY experiments. 
The H(C)CH TOCSY correlates each aliphatic 13CH group with the proton of potentially every 
other CH group in the side chain.  The (H)CCH TOCSY correlates each 13CH group with the 
carbon of every other 13CH group in the side chain. These non-amide correlated TOCSY 
experiments (i.e. the H(C)CH TOCSY and the (H)CCH TOCSY) record the carbon and proton 
frequencies of a 13CH group in direct carbon and proton dimensions respectively. In addition, 
TOCSY experiments can have a third dimension which records the chemical shift of all the 
protons (H(C)CH TOCSY) or carbon atoms ((H)CCH TOCSY) in 13CH groups in the side chain. In 
practice this allows correlation of the previously assigned Cα, Cβ, Hα, and Hβ shifts to other 
aliphatic nuclei in the side chain. Each aliphatic 13CH group in a side chain of residue i can be 
correlated to the amide group NH of i+1 using the amide NH-correlated TOCSY experiments 
(H)CC(CO)NH TOCSY and H(CCCO)NH TOCSY. Both sets of TOCSY experiments are 
complementary and are used together with the NOESY experiments for side chain assignments.  
These experiments were used to successfully assign the majority of aliphatic side chain 
resonances in MNV VPg 11-85. A table of resonance assignments for MNV VPg 11-85 is given in 
the Appendix 9-1. Most of the side chain assignment was performed using the amide-correlated 
TOCSY experiments as these suffered less from spectral overlap. All side chain assignments 
were checked for their correlation to the NOESY experiments. The correlation was very good 
despite the slight differences in buffer conditions used for the amide correlated TOCSY and the 
1H-13C NOESY experiment (see Table 3-4 for details of the buffer conditions). An illustration of 
side chain assignment using H(C)CH TOCSY and NOESY spectra is shown in Figure 5-7.  
The aromatic resonances were assigned primarily using two experiments: the 
(HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE spectra. These correlate the aromatic Hδ and Hε 
 Results and discussion: VPg 
 
 113 
 
resonances to the Cβ carbon resonance. These assignments were confirmed and extended using 
the 1H-13C NOESY HMQC experiment. The Cδ and Cε resonances were assigned using the Hδ and 
Hε chemical shift values and the 1H-13C NOESY experiment. The Hζ and Cζ resonances were 
assigned using the 1H-13C NOESY experiment and the aromatic 1H-13C HSQC experiment. There 
are 64 aromatic atoms assignable by this strategy in MNV VPg 11-85. Of these, 50 could be 
confidently assigned. The Cζ, Hζ, Cε and Hε groups of F69 and F16 and the Cζ and Hζ groups of 
F65 could not be assigned due to overlap in the (HB)CB(CGCD)HD, (HB)CB(CGCDCE)HE and 
NOESY spectra.  
Only one side chain amino or amide group could be confidently assigned: this was the Hε and Nε 
of arginine 49. This was assigned based on NOEs from NHε to the δ and γ protons in the 1H-15N 
NOESY. The remaining 12 arginine side chains groups and six lysine side chain groups could not 
be assigned as they did not give rise to 1H-15N NOESY cross peaks (data not shown).  
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Figure 5-7: H(C)CH TOCSY and NOESY strips for I42 of MNV VPg 11-85 
Strips from the H(C)CH TOCSY and nitrogen and carbon NOESY experiments for I42. These strips are at 
the chemical shift values of the protons listed below the strip. Assignments were made using the H(C)CH 
TOCSY and checked with the NOESY experiments prior to structure calculation.  
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5.5. Chemical shift indexing and TALOS  
 
Some nuclei in regions of regular secondary structure have chemical shifts which tend to 
deviate from the same groups in random coil structure. Cβ and Hα shifts are upfield-shifted in 
helical regions and downfield-shifted in strand regions, relative to Cβ and Hα shifts in random 
coil (Wishart et al., 1991; Wishart and Sykes, 1994). Conversely CO and Cα shifts are downfield-
shifted in helical regions and upfield-shifted in strand regions relative to random coil (Wishart 
et al., 1991; Wishart and Sykes, 1994). This information has been used to produce a 
bioinformatic tool, called the chemical shift index (CSI), which predicts the position of 
secondary structure elements of proteins based upon assigned chemical shift patterns (Wishart 
and Sykes, 1994). The CSI prediction given for MNV VPg 11-85 is shown in Figure 5-8. 
Surprisingly, the secondary structure prediction did not correspond well with the known 
secondary structure of FCV VPg. Three helical regions were predicted, the first region aligns 
well to helix-1of FCV VPg. The second predicted helical region aligns well to helix-2of FCV VPg. 
One helical turn is predicted in the region that aligns to the third FCV helix (Fig. 5-8).  
TALOS+ is a program used for both for secondary structure prediction and determining phi and 
psi angles which can be used as torsion angle restraints in an NMR structure calculation (Shen 
et al., 2009). It uses a database of 200 proteins which have had chemical shift assignments 
deposited in the Biological Magnetic Resonance Bank (BMRB) and have X-ray structures solved 
with data better than 2.4 Å resolution deposited in the Protein Data Bank (Shen and Bax, 2007). 
This program uses the amide nitrogen, amide proton, carbonyl carbon, Cα, Cβ, and the Hα 
chemical shift values to predict phi and psi angles. It achieves this by comparing the chemical 
shifts of each tripeptide sequence in the protein to the BMRB database. If consistent tripeptide 
chemical shifts are found in the database the program searches the protein data bank for the 
corresponding phi and psi angles for the central residue in the tripeptide. Its prediction has an 
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error rate of 2.48% when a consistent prediction is made (Shan et al., 2009).   A total of 36 phi 
and psi angle predictions were made for MNV VPg 11-85 (data not shown). 
 
Figure 5-8: Chemical shift index of MNV VPg 11-85 
Functional groups which have higher than consensus random coil chemical shift are shown in red; 
those with lower than average are shown in blue.  Those with average chemical shift are shown in 
grey. The consensus secondary structure prediction based on the chemical shifts is shown 
schematically below the chemical shift data. The predicted position of helix-3 based on the FCV VPg 
structure is shown as a black bar below the sequence. The GAM sequence at the N-terminus is not 
part of the native sequence.  The “true” sequence starts at G11; underlined in the above sequence.  
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5.6. ARIA structure calculation 
The primary experimental restraints used in NMR structure calculation are distance restraints 
between protons. These inter-proton distances are derived from the nuclear Overhauser effect 
(NOE). This is a phenomenon in NMR spectroscopy whereby nuclear spin polarisation can be 
transferred through space, e.g. from one proton to other nearby protons. Protons which can 
transfer nuclear spin magnetisation to each other are said to be NOE-coupled.  
Nuclear Overhauser effect spectroscopy (NOESY) can be used to correlate one proton to all 
other protons to which it is NOE-coupled. In the NOESY experiment the NOE-coupled proton 
signals appear as cross peaks. Because the intensity of these cross peaks is (to first 
approximation) inversely proportional to the sixth power of distance between the two NOE-
coupled protons, the intensity can be used to derive a distance restraint between these protons. 
Typically the longest distance restraints which can be determined using the NOESY experiment 
is approximately 5 Å, which means that NMR structures are primarily calculated with a large 
number of short range distance restraints.  
One obstacle to implementing these distance restraints in the structure calculation is cross peak 
assignment. This is the determination of the identity of the two NOE-coupled protons which 
gave rise to the cross peak. In theory this should be easy as the cross peaks have the direct 
proton and direct carbon or nitrogen chemical shift values of one of the partners in the NOE 
couple. In addition, the indirect proton chemical shift value of the cross peak is the same as the 
second partner in the couple. Thus, by cross referencing the cross peak chemical shift values 
with the side chain and backbone assignments it should be possible to manually assign each 
cross peak.  In practice, however, manual assignment is a very difficult task, primarily due to the 
fact that the chemical shift value is not a unique identifier of a particular proton or nucleus; 
many protons and nuclei share similar or identical chemical shift values. For this reason cross 
peaks were assigned using an automated assignment program called ARIA (Rieping et al., 2007; 
Habeck et al., 2004). ARIA acts as a restraint manager for a structure calculation program; in 
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this case CNS. ARIA can use ambiguously assigned cross peaks in the structure calculation. It 
does this by taking into account all cross peak assignment possibilities. Initially ARIA submits 
the unambiguously assigned cross peaks to CNS for structure calculation. The structures from 
this first iteration are then analysed by ARIA. Part of the analysis is determining the 
contribution of each possible assignment to ambiguous cross peaks based on the distance 
between protons of the assignment candidates from the initial structures.  Based on the 
contribution, each assignment possibility is given a weighting. A maximum cumulative 
weighting value is applied to each cross peak. If the cumulative weighting is greater than this 
maximum value, possible assignments with the lowest contribution weighting are excluded 
until the cumulative weighting factor is below the maximum threshold. This has the effect of 
reducing the number of assignment possibilities for each-cross peak. This process is repeated 
for eight more iterations with the exception that ambiguously assigned peaks are also submitted 
from the second iteration onwards. As assignment possibilities are excluded, the structures 
become more reliable, allowing the maximum cumulative weighting to be reduced which 
further reduces the number of assignment possibilities for ambiguous peaks. While it is unlikely 
that all cross peaks can be unambiguously assigned using this process a significant proportion 
of cross peaks which could not be assigned unambiguously in iteration zero will be assigned 
unambiguously by iteration eight. In addition to this, cross-peak assignments which do not 
match the calculated structures consistently are removed from the structure calculation.   
CNS calculates structures using simulated annealing and molecular dynamics (Brunger et al., 
1998). This is a computational method which optimises a target function by heating and then 
slowly cooling a system. The target function in the case of macromolecular structure calculation 
is energy reduction of the structure. This energy function has both a real energy component and 
a pseudo energy component (Brunger and Rice, 1997). The real component models the energy 
of the structures based on the van der Waals interactions, electrostatic interactions as well as 
the protein geometry and stereochemistry. The pseudo energy component introduces an energy 
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penalty when cross peak or dihedral restraints used to calculate the structure do not fit the 
structures (Brunger and Rice, 1997).   
The data used in the structure calculation of MNV VPg were: cross peaks from nitrogen and 1H-
13C NOESY experiments and TALOS derived torsion angle restraints for regions predicted to be 
in regular secondary structure. All data used in the structure calculation were derived using the 
MNV VPg 11-85 protein and structures were calculated for this entire region. The 1H-1 3C NOESY 
and 1H-15N NOESY data used to generate distance restraints for structure calculation were of 
good quality. Representative strips of  1H-13C NOESY and 1H-15N NOESY data are shown in Fig 5-
9. 
 
 
Figure 5-9: Representative MNV VPg 11-85 1H-13C NOESY and 1H-15N NOESY data 
Representative strips of 1H-15N NOESY and 1H-13C NOESY data are shown in panals A and B 
respectively. Both data sets were recorded on a Bruker Avance II 800 MHz spectrometer at 303 
K. 
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5.7.MNV VPg structure  
As predicted by both the chemical shift index and TALOS, the core of MNV VPg has only two 
helices. The first helix extends from residue 21 to 37, and includes the nucleotide accepting 
tyrosine, Y26. Helix 2 extends from residue 42 to 55 and includes the highly charged EREEE 
motif (Fig. 5-10).  At the N-terminus of helix-1 is a loop structure, which is poorly restrained and 
thus adopts a range of conformations. The C-terminus of this loop structure packs into helix-1 
but is very flexible at the extreme N-terminus (Fig. 5-10). At the C-terminus of helix-2 the 
structure is very poorly defined due to an absence of NOE restraints, which is likely due to 
flexibility in this region of the protein. The helices are separated by a short loop which allows 
them to pack together at an angle of approximately 45° (Fig. 5-10).  This packing is primarily 
mediated by a small hydrophobic core composed of residues of helix-1, the N-terminus of helix-
2 and the loop separating the two helices. This hydrophobic core is made up primarily by 
residues L21, F29, Y40, I42, Y45 and L46.  In addition R17, T18, and Y26 also appear to have 
roles in stabilisation of the core, but are very much at the periphery of the core and are largely 
surface exposed. The hydrophobic core is shown schematically in Figure 5-11. In addition to the 
hydrophobic core the fold appears to be stabilised by electrostatic interactions between the two 
helices. In almost all calculated conformers a terminal amide of the R32 guanidinium group 
forms a salt bridge with a carboxylate of D48; in some conformers R32 also appears to interact 
with D52.  R32 is also stabilised by interaction with the hydroxyl of Y40 (Fig. 5-11).   
Presented in Figure 5-10 are the 20 “water-refined” MNV VPg conformers. None of these 
conformers have NOE distance violations greater than 0.5 Å or dihedral violations greater than 
5°. The core structure, between residues 21 and 55, is well defined, with a backbone RMSD of 
0.3 Å in this region over the 20 conformers (Figure 5-10). The side chains in the hydrophobic 
core are also well defined in the structure, while the positions of the many charged side chains 
in the core are less so.  The stereochemistry of all models in the 21 to 55 region is good. 99.6% 
of residues are in the most favoured region of the Ramachandran plot and no residues are in 
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disallowed regions (Fig. 5-12). Within the core domain the chi1/chi2 angle values are also, in 
general, good; the chi1/chi2 plot for MNV VPg 11-85 is given in Appendix 9.3. The refinement 
and model statistics are given in Table 5-1.  
Broadly speaking, comparison of the MNV VPg structure with that of FCV shows that the core 
domain of MNV VPg overlays well with FCV VPg (Fig. 5-13). The backbone RMSD between the 
two core domains is approximately 2 Å. Helix 1 in particular overlays very well between the two 
structures, which results in the nucleotide accepting tyrosine occupying very similar positions 
in both structures (Fig. 5-13). Helix 2 does not overlay as well, since the orientation of this helix 
appears to be slightly different between the two structures (Fig. 5-13). In addition to the 
similarities in the backbone atoms of the core, the positions of side chains involved in the MNV 
VPg hydrophobic core align very well to equivalent hydrophobic core residues in the FCV VPg 
core (data not shown).  The primary difference between the two structures is, however, the 
absence of a third helix in MNV VPg. This was unexpected given that the two proteins share 
approximately 27% amino acid identity (Fig. 5-4). However, the sequence identity over the 
third helical region is just 14%. In addition, the predicted third helical region of MNV VPg 
contains a GxGxG motif not present in helix-3 of FCV VPg. This sequence is likely to confer quite 
a lot of structural flexibility to this region and maybe is the reason for the deviation between the 
two structures. One thing to note, however, is that while this helix-3 region is poorly conserved 
between FCV VPg and MNV VPg, two out of three aromatic residues in the FCV helix-3 are 
conserved in the MNV VPg sequence. All three of these FCV aromatic residues (F62, W65 and 
W66) are tightly packed in the hydrophobic core. The significance of this conservation is 
difficult to determine. However, it does suggest that the two helix model of MNV VPg requires 
significant structural validation. This is performed in Section 5.8.  
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Figure 5-10: Solution NMR structure of MNV VPg 11-85 
Two views of the MNV VPg structure. A-B. Backbone line representation of the overlaid 20 water 
refined structures. The nucleotide accepting tyrosine Y26 side chain is shownas lines. The C and N -
terminii are marked C and N respectivly. C-D. Same views as A and B but this time a representative 
conformer shown as a cartoon. The side chain of Y26 is shown as sticks. 
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Restraints   
Total number of restraints 1250 
NOE-derived 1176 
Unambiguous NOE restraints 618 
Ambiguous NOE restraints 558 
Intra-residual NOE restraints (|i-j|= 0) 226 
Sequential  NOE restraints (|i-j|= 1) 106 
Medium range NOE restraints (1<|i-j|≤ 4) 140 
Long range NOE restraints (|i-j|>4) 110 
Ψ/Φ dihedral angle restraints 74 
 
 RMSD from experimental restraintsA 
 Distance (Å) 0.032 +/-  0.001 
Dihedral angle (°) 0.1669 +/-  0.0734 
 
 
RMSD from idealised covalent geometryA 
 Bond (Å) 0.0038 +/- 0.0001 
Angle (°) 0.48 +/- 0.014 
Impropers (°) 1.15 +/- 0.06 
  
EnergiesA (kcal/mol) 
ENOE 59.9803 +/- 1.84 
Etotal -2673.45 +/- 86.02 
Ebond 17.74 +/- 1.38 
Eangle 78.53 +/- 4.10 
Evdw -626.53 +/- 6.15 
Eelectrostatic -2642.19 +/- 82.68 
Edihed 364.714 +/- 4.72  
Eimpr 134.284 +/-15.11 
 
 Coordinate RMSD A B (Å) 
Backbone atoms in secondary structure 0.3 
All heavy atoms in secondary structure 0.8 
All backbone atoms 6.7 
All heavy atoms  7.0 
  
 Ramachandran plot B, C  (%) 
Most favoured  99.6 
Allowed  0.4 
Disallowed  0.0 
Table 5-1: Refinement and model statistics for the NMR solution structure of MNV VPg 
A.  Calculated using the lowest energy 25 structures (MNV VPg 11-71) with no dihedral violations 
greater than 5° or distance restraint violations greater than 0.5Å. Values are given +/- one standard 
deviation of the data set. B. Generated using MolProbity (Chen et al., 2010). C. Determined using the 
core region of MNV VPg defined as residues 21-55. 
 Results and discussion: VPg 
 
 124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-11: Hydrophobic and electrostatic interactions in the MNV VPg core 
Representative structure of MNV VPg showing both a cartoon representation of the protein 
backbone and sticks representation of hydrophobic core side chains A, and charged/polar side 
chains B, which play a role in stabilisation of the MNV VPg  core.  
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Figure 5-12: Ramachandran plot for the solution NMR structure of MNV VPg 
All 20 water refined structures of MNV VPg 11-85 were analysed using MolProbity (Chen et al., 
2010). The numbering in the submitted structures is that used throughout the structure calculation 
rather than the true numbering. Thus numbers in the above figure are 7 less than their true residue 
number. 
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Figure 5-13: Comparison of the MNV and FCV VPg structures. 
A. MNV VPg core domain is shown in green B. Same view as A FCV VPg is shown in orange. The side 
chains of nucleotide accepting tyrosines of MNV VPg (Y26) and FCV VPg (Y24) are shown as sticks. 
Helices 1, 2 and 3 are marked α1, α2, α3 respectively. 
 
5.8.MNV VPg structure validation 
 
In order to confirm that the absence of a third helix in MNV VPg was not an artefact of the 
structure calculation, construct choice or solution conditions, a number of structure validation 
experiments were performed. The first experiment performed was to record 1H-15N HSQC 
spectra for MNV VPg 11-62 (truncated 7 residues after the end of helix-2) and full length MNV 
VPg (1-124) and to compare these to the previously recorded HSQC spectrum of MNV VPg 11-
85. All HSQC experiments were recorded in identical solution conditions (see Section 3.5.3).   
The three spectra overlay well, particularly in regions which are dispersed from the centre of 
spectra in the proton dimension (Fig. 5-14). Peaks outside the centre of the spectrum in the 
proton dimension are typically indicative of amide NH groups in structured regions of the 
protein.  Full length MNV VPg does not have any backbone amide NH peaks outside the centre of 
the spectrum that are not present in the MNV VPg 11-85 or MNV VPg 11-62 spectra (Fig. 5-14). 
In addition, all amide NH peaks assigned to residues in the core of the protein overlap very well. 
These data suggest that the core of MNV VPg does not extend beyond the residue 11-62 
construct and that this core is the same in all three constructs.  
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Figure 5-14: 1H-15N HQSC spectra of MNV VPg proteins 
The HSQC spectra presented above are of the following proteins: A. MNV VPg 11-85, B. MNV VPg full 
length (1-124), C. MNV VPg 11-62. D. is an overlay of all three spectra; 1-124, 11-85 and 11-62 are 
shown in black, blue and red respectively. Each spectrum was recorded with protein in identical 
buffer conditions. These were 300 mM NaCl, 50 mM sodium phosphate pH 6.5, 1 mM DTT. 
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To further validate the lack of structured regions outside the 11-62 core, a 1H-15N heteronuclear 
NOE (hetNOE) analysis was performed. This records the steady state intensities of 1H-15N 
signals with and without 1H saturation, which affects the nitrogen spin population due to NOE 
enhancement. The hetNOE value for any residue is the ratio of peak intensities in the saturated 
and unsaturated experiments.  This value conveys important information about the dynamics of 
the protein on the ns-ps timescale. The maximum hetNOE value is dependent upon field 
strength of the spectrometer. In the case of the Bruker Avance III spectrometer (1H frequency 
600.05 MHz) used to record the hetNOE data the maximum possible value is 0.833.  Amide NH 
groups in very structured parts of proteins will have hetNOE values close to this maximum 
value. Amides in unstructured regions which are highly dynamic have ratios of saturated to 
unsaturated peak intensities which are negative due to the saturated peak intensity being 
negative. In some intrinsically disordered proteins nearly every backbone amide NH group in 
the protein has a negative hetNOE value (Benison et al., 2006). 
Amide hetNOE experiments were performed using full length MNV VPg and MNV VPg 11-85 
samples. However, due to the fact that amide NH groups were only assigned for MNV VPg 11-85 
both experiments were only analysed for the 11-85 region. The hetNOE values for both 
experiments correspond very well, suggesting that both the full length and 11-85 constructs 
have similar dynamics on ns-ps timescales, as would be expected if both proteins contain the 
same core domain (Fig. 5-15). The hetNOE values plateau at approximately 0.65-0.75 for helix-1 
and the first half of helix-2. This suggests that the core of the protein is quite stable, even though 
values of 0.8 or more are observed in highly structured proteins. The value decreases from 0.64 
to 0.58 in the second half of helix-2 indicating that this part of helix-2is more mobile than the 
preceding part of the domain. This fits with the model in that the second part of this helix does 
not pack into the core of the protein. The decrease in hetNOE values continues after helix-2 
down to another plateau of hetNOE values in the range of 0.05-0.2. This is where helix-3 would 
be, based on the FCV VPg structure. HetNOE values of this magnitude indicate that this region is 
not completely dynamic but is very unlikely to be in stable secondary structure, suggesting that 
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the MNV VPg core is made up of two helices, and not three like FCV VPg. The plateauing of the 
values rather than a monotonic drop could indicate some residual structural propensity, or 
partial association with the core domain. However, the absence of 1H-15N chemical shift 
differences between full length MNV VPg and the 11-62 protein suggest that any residual 
structure in this region is likely to be transient.  
Finally, using 1H-1 5N HSQC experiments, the effect of the solution conditions and temperature on 
the structure of MNV VPg was determined. This was done to verify that the conditions at which 
the NOESY or assignment experiments were recorded do not disrupt helix-3 packing. The 1H-15N 
HSQC spectrum of full length MNV VPg is nearly identical in 50, 150 and 300 mM NaCl 
concentrations, suggesting that ionic strength has little effect on structure (Fig. 5-16).  Changing 
the pH from 8 down to 6 similarly had little effect on the 1H-15N HSQC spectrum (Fig. 5-17). 
Small changes in the spectrum become apparent at pH 5. At pH 4 all of the structured signals are 
absent indicating that the protein is unfolded (Fig. 5-17).  
  
 
 
 
 
 
 
 
 
Figure 5-15: Amide hetNOE data for MNV VPg  
hetNOE experiments were performed using MNV VPg full length (1-124) and MNV VPg 11-85. 
Intensities determined using MNV VPg full length are shown as grey boxes, while those determined 
using MNV VPg 11-85 are shown as black squares. Relative intensity is plotted against residue 
number. Backbone amides of residues 86-124 have not been assigned, thus the hetNOE values could 
not be plotted against residue number for this region in the full length construct.  Positions of helix-1 
and helix-2 are marked by black lines. The predicted position of helix-3 is marked by a blue line. 
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Figure 5-16: Effect of ionic strength on MNV VPg 1-124 structure 
The effect of NaCl concentration on protein structure was monitored by 1H-15N HQSC experiments. 
Spectra recorded in 50 mM NaCl, 150 mM NaCl, and 300 mM NaCl are shown in that order in panels 
A-C. An overlay of these spectra is shown in panel D. 50 mM NaCl, 150 mM NaCl, and 300 mM NaCl 
spectra are shown in red, green, and black respectivly. Each spectrum was recorded with protein in 
identical buffer conditions apart from the NaCl concentration. The buffer conditions were as follows:  
50 mM sodium phosphate pH 6.5, 1 mM DTT.  
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Figure 5-17: Effect of pH on MNV VPg 1-124 structure  
The effect of pH on protein structure was monitored by 1H-15N HQSC experiments. Spectra recorded 
in pH 4, 5, 6, 7, and 8 are shown in that order in panels A-E. An overlay of these spectra is shown in 
panel E. pH 4, 5, 6, 7, and 8 spectra are shown in black, red, green, blue and cyan respectivly. Each 
spectrum was recorded with protein in identical buffer conditions except the pH was titrated to a 
different value. The buffer conditions were as follows: 300 mM NaCl, 50 mM MMT buffer, 1 mM 
DTT.  
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The determination of the solution structure of FCV VPg suffered from issues of dynamics at 
intermediate time scales causing amide peaks to be absent at ambient to physiological 
temperatures. Thus the structure was solved at 283 K, 20 K below the temperature at which the 
MNV VPg structure was solved. Therefore, it was important to characterise the effect of 
temperature on the structure of MNV VPg.  1H-15N HSQC spectra were recorded at 5 K intervals 
from 278 K to 303 K inclusive.  The spectrum of MNV VPg, recorded at 303 K, is quite different 
to the spectrum recorded at 278 K; this is due to a well documented dependence of the amide 1H 
chemical shift on temperature (Ohnish and Urry, 1969). However only one additional peak is 
present (at approximate PPM coordinates H: 8.5, N: 125) in the structured part of the spectrum 
at 278 K which is absent at 303 K (Fig. 5-18). Given that several structured peaks are absent at 
278 this may represent movement of structured peaks. It is therefore very unlikely that the 
MNV VPg core is larger at lower temperatures than it is at 303 K.  
In summary the chemical shift index, TALOS, an NMR structure calculation, HSQC spectra of full 
length and truncated constructs as well as dynamic experiments all suggest that the MNV VPg 
core is smaller than the FCV core, and that the difference between the two structures is the 
absence of a third helix in MNV VPg. In addition, it is unlikely that the deviation between the two 
structures is due to the solution conditions or temperature at which the MNV VPg 11-85 
structure calculations were recorded.  
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Figure 5-18: Effect of temperature on MNV VPg 11-85 1H-15N HSQC spectrum 
The effect of temperature on protein structure was monitored by 1H-15N HQSC experiments. 
Spectra recorded at 278 K, 283 K, 288 K, 293 K, 298 K and 303 K are shown in that order in panels 
A-E. The buffer conditions were as follows: 300 mM NaCl, 50 mM sodium phosphate, 1 mM 
DTT.The extra peak present at lower temperatures is indicated with an arrow in panel A. 
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5.9.LDV VPg initial NMR characterisation 
 
Due to the differences between FCV and MNV VPg it was decided to extend the investigation 
into HuNV VPg proteins. LDV was chosen as the virus strain to investigate as it is a member of 
the pandemic-causing GII.4 genotype. Given that MNV VPg and LDV VPg share approximately 
51% amino acid identity they should be very structurally similar (Fig. 5-19).  One intriguing 
aspect which can be observed by sequence alignment is that there a YY insertion into helix-2 
and a KIRQRI insertion into helix-3. 
Before any experiments were performed to define the core of the LDV VPg protein, solution 
condition screens were performed using full length LDV VPg (1-133) and a temperature 
titration was performed using LDV VPg 11-94.  1H-15N HSQC spectra were recorded at pH 7.5, 
pH 6.5 and pH 5.5. pH affects the spectrum, but, peak shifts are modest and are very unlikely to 
represent large structural rearrangements within the protein (Fig. 5-20).  The structure also 
does not appear to change with temperature at least for LDV VPg 11-94 (data not shown). 
However, at lower temperatures the dispersed amide NH peaks in the 1H-1 5N HSQC spectrum 
broaden substantially suggesting that the protein may self-associate and this self-association is 
more evident at lower temperatures (data not shown). NaCl concentration appears to have little 
effect on structure as 1H-15N HSQC spectra recorded with both 100 mM and 300 mM NaCl are 
almost identical (Fig. 5-21).  Thus, as with MNV VPg, the core of LDV VPg is folded, and this fold 
is stable across a variety of solution conditions.   
The first experiment to define the core of LDV VPg was a comparison of the 1H-15N HSQC spectra 
of different truncated LDV VPg constructs. A prediction based on the MNV VPg structure would 
suggest that the structure of the LDV VPg core should extend from residue 13 to residue 60. 
Therefore, the 1H-15N HSQC of full length LDV VPg was compared to that of LDV VPg 11-80 and 
LDV VPg 11-66. Initial protein expression and acquisition of the HSQC spectrum of LDV VPg 11-
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66 were performed by Ms Xenia Snetkov, under my supervision. All HSQC spectra were 
acquired with identical solution conditions and temperatures. What was immediately apparent 
is that, unlike the case for different MNV VPg constructs, the 1H-15N HSQC spectra do not overlay 
very well outside the proton centre of spectrum. This suggests that the core of the protein 
extends beyond the 11-80 construct (Fig. 5-22).   
 
MNV_VPg     GKKGKNKKGRGR-PGVFRTRGLTDEEYDEFKKRRESRGGKYSIDDYLADRER--EEELLE 57 
LDV_VPg     GKKGKNKTGRGKKHTAFSSKGLSDEEYDEYKRIREERNGKYSIEEYLQDRDKYYEEVAIA 60 
            *******.***:   .* ::**:******:*: **.*.*****::** **::  **  :  
 
MNV_VPg     RDEEEAIFGDGFG------LKATRRSRKAERAKLGLVSGGDIRARKPIDWNVVGPSWADD 111 
LDV_VPg     RATEEDFCEEEEAKIRQRIFRPTRKQRKEERASLGLVTGSEIRKRNPDDFKPKGKLWADD 120 
            *  ** :  :  .      ::.**:.** ***.****:*.:** *:* *::  *  **** 
 
MNV_VPg     DRQVDYGEKINFE 124 
LDV_VPg     DRSVDYNEKLDFE 133 
            **.***.**::** 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-19: Amino acid sequence alignment of LDV and MNV VPg proteins  
Alignment was performed using clustalW using the LDV VPg sequence (NCBI accession number 
CAA60254.1) and MNV CW1 strain VPg sequence (NCBI accession number DQ285629.1). The 
positions of MNV VPg helix 1 and helix 2 are marked by bold lettering and underlined in the MNV 
VPg sequence. The region of the MNV VPg sequence which aligns to helix 3 of FCV VPg is shown in 
red. The equivalent region for LDV VPg is shown in blue. 
 Results and discussion: VPg 
 
 136 
 
 
 
 
 
Figure 5-20: The effect of pH on LDV VPg 1-133. 
The effect of pH on protein structure was monitored by 1H-15N HQSC experiments. Spectra recorded 
at pH 7.5, 6.5, and 5.5 are shown in that order in panels A-C. An overlay of these spectra is shown in 
panel D. pH 5.5, 6.5, and 7.5 spectra are shown in black, red, and green respectively. Each spectrum 
was recorded with protein in identical buffer conditions, except the pH was titrated to a different 
value. The buffer conditions were as follows: 300 mM NaCl, 50 mM sodium phosphate buffer, 1 mM 
DTT, 2 mM NaN3. 
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Figure 5-21: The effect of NaCl concentration on LDV VPg 1-133. 
The effect of NaCl concentration on protein structure was monitored by 1H-15N HQSC experiments. 
Spectra recorded in 300 mM NaCl and 100 mM NaCl are shown in that order in panels A-B. An 
overlay of these spectra is shown in panel C. 300 mM NaCl and 100 mM NaCl spectra are shown in 
black and red respectively. Each spectrum was recorded with protein in identical  buffer conditions, 
except the NaCl concentration. The buffer conditions were as follows: 50 mM sodium phosphate pH 
6.5, 1 mM DTT, 2 mM NaN3. 
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While the LDV VPg 1H-15N HSQC spectra suggest that the core of the LDV VPg protein is larger 
than its MNV counterpart, it did not define the full extent of the LDV VPg core. In order to do 
this, the strategy that was chosen was to assign the protein backbone resonances and use a 
hetNOE experiment to characterise the dynamics of the protein on a ns-ps timescale. Backbone 
resonance assignment experiments HNCO, HN(CA)CO, CBCA(CO)NH and HNCACB were 
Figure 5-22: HSQC spectra of LDV VPg protein constructs. 
The HSQC spectra presented above are of the following proteins: A) full length LDV VPg (1-133), B) 
LDV VPg 11-94, C) LDV VPg 11-66. D) is an overlay of all three proteins; 1-133, 11-94 and 11-66 are 
shown in black, green and red respectively. Each spectrum was recorded with protein in identical 
buffer conditions. These were 300 mM NaCl, 50 mM sodium phosphate pH 6.5, 1 mM DTT. 
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performed using full length LDV VPg (1-133). The data acquired for the structured region of the 
protein were significantly impaired by peak broadening in the core of the protein. This is due to 
the slow tumbling of the LDV VPg core, which may be due to flexible termini retarding protein 
tumbling or possibly protein self association. Consequently only the C and N-termini of the 
protein could be assigned; with the notable exception of G39. The regions which could be 
assigned were residues 1-19, 39, 82-86, 91-103, 107-113 and 116-133 inclusive. Using the 
assigned nuclei chemical shift indexing was performed as per MNV VPg 11-85, however, no 
regular secondary structure was predicted in the assigned regions (data not shown).  
The hetNOE experiment shows that the extreme C-terminus of the protein, residues 130-133, is 
completely unstructured with negative hetNOE values (Fig. 5-23 B). Residues 95-98, inclusive, 
also have negative hetNOE values, however, residues between these two unstructured regions, 
have hetNOE values around zero indicating that the C-terminus is not completely unstructured 
but does not have stable secondary structure. The hetNOE value decreases in a stepwise manner 
from 0.5 to 0.0 between residues 83-88. At the N-terminus the hetNOE value increases gradually 
from -0.9 at the extreme N-terminus to 0.4 at residue 23. Thus, residues 23 and 88 are quite 
stable and it likely that these residues flank the LDV VPg structured core. Residue 39 has a 
hetNOE value of 0.69 which fits with it being part of a structured core. 
To characterise the core domain further, the backbone resonances of LDV VPg 11-94 was 
assigned and a hetNOE performed. The only residue for which no nucleus could be assigned was 
residue 40. Some nuclei also could not be assigned for residues 35, 36, 15, 16 and 75.  
The chemical shift index predicts that LDV VPg 11-94 has three helices (Fig. 5-23 A).  The first 
helix is predicted to be between residues 24 and 38, which corresponds well to the prediction 
based on the MNV VPg structure. The second helix is predicted to be between residues 44 and 
57, which again corresponds well to the prediction based on the MNV VPg structure. The third 
helix is predicted to be between residues 69 and 78. This is close to the predicted helix position, 
resides 72-84, based on alignment of the LDV VPg with the FCV equivalent.  This helix has, at its 
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N-terminus, the unusual EEEEA motif. This is followed by a five residue sequence, KIRQR, which 
is part of the helix three insertion sequence present in LDV VPg but absent in MNV VPg.  
The hetNOE values of LDV VPg 11-94 plateau at 0.70-0.85 between residues 23 and 80, with the 
exception of residues 65, 68 and 69 which have hetNOE values of 0.32-0.66 (Fig. 5-22 B). These 
hetNOE values fit with the chemical shift index prediction that LDV VPg has three helices which 
are located between residues 24 and 78.  
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Figure 5-23:  Chemical shift index for LDV VPg 11-94 and 1H-15N hetNOE data for LDV 1-133 
and 11-94 
A) Chemical shift index Functional groups which have higher than consensus random coil 
chemical shift are shown in red; those with lower than average are shown in blue.  Those with 
average chemical shift are shown in grey. The consensus secondary structure prediction based 
on the chemical shifts is shown schematically below the chemical shift data. B) HetNOE 
experiments were performed using LDV VPg full length (1-133) and LDV VPg 11-94. Intensities 
determined using LDV VPg full length (1-133) are shown in orange, while those determined 
using LDV VPg 11-94 are shown in black. Relative intensity is plotted against residue number. 
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The differences in structure of MNV and LDV VPg are quite unexpected given the level of 
identity between the sequences of the two proteins. However, the structural deviation, 
suggested by the NMR analysis, between the two structures appears to be in a region which is 
highly divergent in sequence between the two proteins.  
The fact that there is a structural deviation in the VPg protein between these two closely related 
norovirus genogroups raises the question: how conserved is helix three as a structural element 
of VPg proteins across the five norovirus genogroups? This question is difficult to answer 
without structural characterisation of the VPg protein of at least one member of each 
genogroup. However in order to understand the potential for structural variability it was 
decided to characterise the amino acid sequence conservation for the VPg protein across 
genogroups. One VPg sequence per genogroup was chosen for sequence analysis. However, a 
sequence for genogroup IV VPg has not been deposited in GenBank so genogroup IV was not 
used in the analysis. The sequences chosen were: genogroup I, represented by Norwalk virus 
(NCBI accession number AAC64602.1); genogroup II, LDV (NCBI accession number 
CAA60254.1); genogroup III, Bo/GIII/B309/2003/BEL (NCBI accession number ACJ04905.1); 
and genogroup V, MNV 1 CW1 (NCBI accession DQ285629.1). Pairwise alignments of genogroup 
I, III, and IV VPg sequences to that of genogroup II shows that LDV VPg shares approximately 
50% amino acid identity with the VPg protein of each of the other genogroups. In addition it 
shows that the KIRQRI insertion sequence in LDV VPg can be aligned to very similar sequences 
in genogroups I and III. Therefore, it may be that helix three is well conserved across 
genogroups I, II and III.  Further structural characterisation will be required to confirm this 
hypothesis. 
Interestingly, alignment of all four sequences shows that they share 32% amino acid identity 
over the first 60 residues, and 55% amino acid identity over the final 18 residues of the 
sequence alignment. However, they only share 5% amino acid identity in the intervening region 
between residues 60 and 120 (Fig. 5-24). Therefore, the sequence variability of the helix-3 
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region is much greater than the region containing helices-1 and 2. So while it is difficult to 
determine the conservation of helix-3 across genotypes it is very likely that helix-1 and 2 are 
conserved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Norwalk_GI         GKNKGKTKKGRGRKANYNAFSRRGLNDEEYEESRRLEKEKGGNYSIQEYLEDRQRYEEEM 60 
Lordsdale_GII      GK-KGKNKTGRGKK--HTAFSSKGLSDEEYDEYKRIREERNGKYSIEEYLQDRDKYYEEV 57 
MNV1_GV            GK-KGKNKKGRGRP---GVFRTRGLTDEEYDEFKKRRESRGGKYSIDDYLADRER--EEE 54 
Bovine_GIII        APVQLESKKGRRKT---NAFSRRGLSDEEYDEYKKIREERGGNYSIQEYLEDRERYEREL 57 
                   .  : :.*.** :     .*  :**.****:* :: .:.:.*:***::** **::  .*  
 
Norwalk_GI         AEVQAGGDGGIGETEMEIRHRVFFKSKTKRNRQEERRQLGLVTGSEIRKRKPIDWTPPKN 120 
Lordsdale_GII      AIARATEEDFCEEEEAKIRQRIFRP--TRKQRKEERASLGLVTGSEIRKRNPDDFKPKGK 115 
MNV1_GV            LLERDEEEAIFGDG--------FGLKATRRSRKAERAKLGLVSGGDIRARKPIDWNVVGP 106 
Bovine_GIII        AERQAGDEAYDDS--------------SIRQKYFGRGKAAKAQ------RKKIDWNPVGP 97 
                      :   :    .              : :.:   * . . .       *:  *:.     
Norwalk_GI         EWADDDREVDYTEKINFE 138 
Lordsdale_GII      LWADDDRSVDYNEKLDFE 133 
MNV1_GV            SWADDDRQVDYGEKINFE 124 
Bovine_GIII        SWADDEREVDYNEVIEFQ 115 
                    ****:*.*** * ::*: 
 
Figure 5-24: Comparison of VPg sequences across norovirus genogroups 
Alignment was performed using clustalW using the following sequences: Norwalk virus (Genogroup I 
NCBI accession number AAC64602.1), LDV (genogroup II NCBI accession number CAA60254.1), bovine 
norovirus (GIII NCBI accession: ACJ04905.1) and MNV CW1 strain (Genogroup V NCBI accession 
number DQ285629.1). The KIRQR pentapeptide sequence, which is part of the predicted helix 3 in LDV 
VPg, is underlined, as are the sequences in Norwalk virus VPg and bovine norovirus VPg which align to 
it by pairwise alignment. The sequences of MNV VPg helix 1 and helix 2 are underlined and shown in 
red. 
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5.10. The role of VPg structure  
Our structural biology studies of caliciviral VPg proteins have been fruitful in that we now have 
a structure of an important caliciviral protein. While this is a valuable step forward, ultimately it 
would be desirable to have a functional understanding of calicivirus translation initiation and 
protein priming, preferably at atomic resolution.  The structures determined thus far have told 
us very little about VPg function either in translation initiation or as a protein primer.  One 
interesting observation, however, is that the nucleotide accepting tyrosine is in a helical region 
of the protein. In order to be nucleotidylated the tyrosine hydroxyl group must interact with the 
active site of the polymerase, which is located deep within the polymerase RNA binding cleft 
(Fig. 5-25). As has been discussed in the Introduction, a co-crystal structure of the FMDV VPg 
with the 3Dpol protein has been determined. The FMDV VPg traverses the RNA binding cleft of 
the polymerase as an extended peptide with no regular secondary structure. Despite the lack of 
secondary structure, VPg occupies almost all the space in the RNA binding cleft.  The MNV NS7 pol 
RNA binding cleft is more open than the picornaviral equivalent, as is shown in Figure 5-25. 
However, it is highly unlikely that it can accommodate an α-helix. Therefore, it was postulated 
that VPg must unfold, at least  partially, in order to be nucleotidylated by the polymerase.  
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Initial support for this hypothesis came from HuNV nucleotidylation assays which 
demonstrated that mutations Y30A, Y41A and Y46A increase the rate of VPg nucleotidylation in 
vitro (Belliot et al., 2008). The equivalent positions in MNV VPg are F29, Y40 and Y45. 
Inspection of the solution structure determined here suggests that all of these residues play a 
role in forming the hydrophobic core of MNV VPg. Thus it is very likely that the Y to A mutations 
would destabilise the hydrophobic core of HuNV VPg. In order to characterise the effect of 
mutation on MNV VPg, a series of substations was made which, based on the structure, would be 
expected to destabilise the protein. We also decided that we would extend this work to FCV VPg 
and also make a series of mutations which would be expected to destabilise the FCV core. The 
MNV VPg mutants analysed were Y26A, Y26F, R32D, Y40A, Y40F, Y45A, Y45F, D48R and a  
R32D/D48R double mutant. The FCV VPg mutants analysed were Y24A, F43A, R47E, F62A and 
R69E. The role of these residues in stabilising the core domain in shown in Figure 5-26; which is 
similar to Figure 5-11 for MNV VPg. 
Figure 5-25: Surface representation of RNA binding clefts of PV and MNV polymerase proteins 
The active site Asp residues in both proteins are shown in red. The poliovirus 3Dpol structure shown 
on the left is from Thompson and Peerson, 2004 (PDB 1RA6). The MNV NS7pol structure presented 
on the right is the unpublished structure presented in this thesis. 
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These mutant VPg proteins were analysed by 1D NMR to assess their foldedness. The effect of 
these mutations on VPg nucleotidylation was then determined as was the effect of the mutations 
on virus recovery and growth using the MNV reverse genetics system.  The nucleotidylation 
assays and reverse genetics work were performed by collaborators Dr Ian Goodfellow (Imperial 
College London) and colleagues as well as Professor Cheng Kao and colleagues (University of 
Indiana).  
Typically ring current-shifted methyl signals are used as markers of globular protein structure 
in 1D NMR. However, since some of the mutations are aromatic to aliphatic substitutions, 
dispersed amide NH groups with high proton chemical shift values (~8.5-10 ppm) are used as 
markers instead. Therefore, 1D spectra were recorded for WT and mutant proteins and the 
Figure 5-26: Hydrophobic and electrostatic interactions in the FCV VPg core 
Representative structure of FCV VPg showing both a cartoon representation of the protein backbone 
and sticks representation of hydrophobic side chains A. Charged/polar side chains which play a role 
in stabilisation of the FCV VPg core  B. Helices 1, 2, and 3 are marked α1, α2, and α3 respectivly. The 
structure represented above is a representative structure from the NMR strucrture determination of 
FCV VPg 11-76 
. 
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spectra compared between chemical shift values of 8.5 to 10 ppm.  MNV Y40A and Y45A appear 
to be largely unstructured proteins, based on an absence of dispersed amide NH groups with 
high proton chemical shift values in the 1D NMR spectra (Fig. 5-27).  Y40F and Y45F were 
predicted to have WT-like structures as the phenylalanine should play a similar role to tyrosine 
in stabilisation of the hydrophobic core.  However, while the Y45F spectrum is WT like, the 
Y40F spectra is missing several dispersed amide NH peaks suggesting it has a smaller 
structured core (Fig. 5-27). In many of the calculated MNV VPg conformers Y40 forms a 
hydrogen bond with the R32 guanidinium group which, as previously discussed, forms an inter-
helical salt bridge with D48. Like Y40F, both D48R and R32D mutant VPg proteins are missing 
some dispersed amide NH peaks indicating a truncated structured core (Fig. 5-27). The 
R32D/D48R double mutant also has a disrupted core, indicating that the attempt to rebuild the 
salt bridge in the opposite orientation did not work. This is likely due to the fact that R32 is 
coordinated by more than one residue. The Y26A mutant appears to be structurally similar to 
WT (Fig. 5-27). This was not unexpected given that Y26 is at the periphery of the hydrophobic 
core and is quite surface exposed.  
In the case of FCV VPg the structured amide region of the spectrum has only 5 amide peaks as 
markers of structure. However the F43A and R47E mutants do not have any of these peaks, 
strongly indicative of a very large disruption to the protein structure. The F62A and R69E 
mutants retain only one of these peaks suggestive of a disrupted core with some residual 
structure (Fig 5-27). Again the nucleotide accepting tyrosine Y24 appears to contribute little to 
protein stability as mutation to alanine resulted in a spectrum that looks similar to WT (Fig 5-
27). 
Each of the above mutations was introduced into the viral genome using the reverse genetics 
system (Chaudry et al., 2007; Sosnovstev and Green, 1995).  In the case of MNV live virus could 
not be recovered from any of the Y26A, Y26F, Y40A, Y45A, and Y45F VPg mutants introduced 
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into the reverse genetic system indicating that these residues are very important in the virus life 
cycle (Table 5-2). The R32D VPg mutant virus could be recovered but the TCID50 (50% tissue 
culture infective dose) was significantly lower per ml of culture than that of WT (Table 5-2). The 
D48R and Y40F VPg mutant viruses recovered with a TCID50 equivalent to that of WT (Table 5-
2). Attempting to correlate these data with the unfolding data could be potentially misleading 
given that residues may have roles in interacting with binding partners in addition to 
stabilisation of the core domain of MNV VPg. However, it is clear from the NMR and reverse 
genetics studies that the core of the VPg protein can be significantly disrupted without inducing 
lethality in the virus.  The fact that neither Y40A nor Y45A were viable, tentatively suggests that 
some residual structure is required for VPg function.  However, as mentioned previously these 
mutations may be negatively affecting VPg interactions as well as destabilising the structure. 
Indeed it is likely that Y45 has a role beyond VPg stability, as the Y45F mutant was not 
recoverable from the reverse genetics system, despite the Y45F mutant protein having a similar 
1D spectrum to WT. 
In the case of FCV the data appears to be much more clear cut. F43A, R47E, F62A, and R69E 
destabilisation mutants, when introduced into the reverse genetics system, did not produce live 
virus. In addition, other mutations H30A, W65A and W66A which are also likely to destabilise 
VPg structure also could not be recovered using reverse genetics (Table 5-2). This suggests that 
FCV is more sensitive to VPg destabilisation than MNV.  
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Figure 5-27: Effects of core mutations on the structure of MNV and FCV VPg 
The effect of mutation in the core of the protein was probed using 1D NMR. The region of the 
spectrum shown is the structured amide region of a 1D protein spectrum which is not overlapped by 
aromatic signals. The peaks at ~9.9-10.2 PPM are that of Trp NHε. The position of Trp  NHε are not 
good markers of structure.  
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MNV VPg core stabilityA virus recoveryB NS7pol enhancement c Nucleotidylation of NS7pol D 
Wild type + +++ + + 
Y26A + - - - 
R32D +/- ++ + + 
Y40A - - - - 
Y40F + +++ + + 
Y45A - - +/- + 
Y45F + - - - 
D48R +/- +++ - - 
D48R/R32D +/- ++ ND ND 
     FCV VPg 
    Wild type + +++ ND ND 
F43A +/- - ND ND 
R47E +/- - ND ND 
F62A +/- - ND ND 
R69E +/- - ND ND 
 Table 5-2: The effect of mutation on VPg stability, tissue culture infectivity and nucleotidylation 
capacity. 
A) Core stability was determined using 1D NMR. In the case of WT MNV VPg the spectrum contains 
nine distinct dispersed amide peaks. Samples with more than 7 peaks are denoted with a +.  Samples 
with between 3 and 5 peaks are denoted with a +/-, and samples with less than 3 peaks are denoted 
with a –. In the case of WT FCV VPg the sample contains 5 dispersed amide peaks. Samples with 
more than 4 peaks are denoted with a +.  Samples with between 2 and 4 peaks are denoted with a 
+/-, and samples with less than 1 peak are denoted with a –. B) Virus recovery is expressed as the 
yield post transfection relative to wild-type (+++) as assayed by >3 independent experiments. Typical 
yields of wild-type virus were 1-5 x 104 TCID50 units. - no virus detected, + up to 100 TCID50 detected, 
++  up to 1000 TCID50, +++ up to WT levels of virus detected These data were generated by our 
collaborators Ian Goodfellow and colleagues. The virus strain used in the MNV and FCV analysis were 
MNV VPg CW1 and FCV Urbana strains respectively. The reverse genetic systems are described in 
Chaudry et al., 2007 and Sosnovstev and Green, 1995. C) NS7pol enhancement was measured by an 
in-cell assay which monitored RIG-I activity using firefly luciferase under the control of a type 1 IFN 
promoter. NS7pol enhancement is defined as + when the luciferase activity is statistically significantly 
greater (P >0.05 in the Student t-test) than NS7pol alone in cells. D) Nucleotidylation of MNV VPg WT 
and mutant proteins was determined using the same cell based assay as in C.  Nucleotidylation by 
NS7pol was defined as being + when a larger migrating species of VPg was observed in cells by 
western blot analysis. The NS7pol enhancement data and nucleotidylation data were generated by 
collaborators Cheng Kao and colleagues. The assays are described in detail in Subba-Reddy et al., 
2011). ND indicates not determined. 
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Finally Y26A, Y40A, Y45A, and D48R MNV VPg mutants were all used in cell based 
nucleotidylation assays. These assays involve the cotransfection of MNV VPg and MNV NS7pol 
into HEK 293T cells. This enables VPg nucleotidylation to occur in cells. VPg nucleotidylation is 
monitored in two ways. Firstly by determining if a population of the VPg in cells migrate on an 
SDS-PAGE gel as a higher molecular weight species. This higher molecular weight species has 
been shown to be RNA-linked VPg (Subba-Reddy et al., 2011). This is a direct measure of VPg 
nucleotidylation in cells.  
The second method by which VPg nucleotidylation is monitored is by using RIG-I activation as a 
surrogate marker for VPg nucleotidylation. RIG-I is a protein which upon ligand binding starts a 
signal cascade which ends in cytokine and type I interferon gene transcription (reviewed in 
Takeuchi and Akira, 2009). The reported ligands for RIG-I include poly U/UC RNA as well as 
RNA with either a 5ʹ  triphosphate or a 3ʹ  monophosphate (reviewed in Loo and Gale, 2011). 
The level of RIG-I induced transcription is increased by VPg nucleotidylation and 
nucleotidylated VPg extension (Subba-Reddy et al., 2011). In this assay MNV VPg and NS7pol are 
co-transfected into cells along with a plasmid encoding firefly luciferase under the control of a 
type I interferon promoter. The level of firefly luciferase activity of the cell can then be used as 
marker of RIG-I activity and therefore VPg nucleotidylation. This is a very indirect measure of 
VPg nucleotidylation in cells.  
Data generated using this assay demonstrates that, as expected, Y26A mutant VPg cannot be 
nucleotidylated by the viral polymerase (Table 5.2). In addition it demonstrates that Y40A, 
Y45A and D48R mutant VPg proteins are all deficient in their capacity for nucleotidylation 
(Table 5.2). While it is tempting to speculate from these data that the VPg core structure is 
required for nucleotidylation it must be noted that Y45F which has a WT-like 1H-15N HSQC 
spectrum was also deficient in nucleotidylation. In addition, R32D which has a D48R-like 1H-15N 
HSQC spectrum had a WT-like capacity for nucleotidylation in cells (Table 5.2). Thus in the case 
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of MNV VPg, it is difficult to correlate the folded state of VPg with firstly, viral recovery/growth 
using the reverse genetic system and secondly, VPg nucleotidylation in cells. This is at odds with 
the work of Belliot and colleagues who, using an in vitro assay demonstrated that large to small 
mutations in the core of the protein actually increases VPg nucleotidylation (Belliot et al., 2008).  
 It may be that VPg structure is required for interaction with components of the viral replication 
complex which are not present in the Belliot in vitro assay; this suggestion, however, is highly 
speculative. In addition it may be that in the context of the cell the structure of VPg is altered 
due to the presence of chaperone proteins or binding partners which are not present in our 
NMR assays or in the Belliot in vitro assay. What is clear is that despite a significant amount of 
work we do not yet know if VPg unfolding is a requirement for nucleotidylation. 
It may be that a VPg-NS7pol co-crystal structure will be required to determine if our hypothesis 
of unfolding is correct. Due to the largely unstructured nature of VPg, defining a minimal VPg 
region which interacts with NS7pol is likely to be very important for successful co-crystallisation.  
In order to define this minimal region the first approach we used was NMR. Titrating an 
unlabelled ligand into a 15N labelled protein and monitoring the interaction by 1H-15N HSQC can 
allow identification of residues which significantly change chemical environment during the 
interaction, through chemical shift perturbation mapping.  Two NMR titrations were performed: 
in each case unlabelled MNV NS7po l was titrated into 15N labelled MNV VPg. The two different 
VPg constructs used in the titrations were MNV VPg full length (1-124), and MNV VPg 11-62. 
Both constructs interact with MNV NS7pol as, in both titrations, differential peak broadening 
occurs whereby the structured signals broaden significantly more than the unstructured signals 
(Fig. 5-28). This is likely due to the core of the protein interacting with the polymerase and 
increasing the tumbling time, thus decreasing the apparent NMR intensity from the core 
domain.  The unstructured region tumbles semi-independently and therefore the signals from 
are less affected by the interaction. The 1H-15N HSQC spectra following the titration of MNV 
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NS7pol into MNV VPg 11-62 are shown in Figure 5-28. Despite the addition of large molar 
excesses of NS7po l and recording the 1H-15N HSQC spectrum overnight specific peak shifts were 
not observed in any of the titrations. Thus while this approach showed that the core domain 
alone could interact with NS7pol, no specific residues involved in the interaction could be 
identified by chemical shift mapping. 
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Figure 5-28: Titration of MNV NS7pol into 15N labelled MNV VPg 
The titration was followed by 1H-15N HSQC. A HSQC spectrum was recorded for a 100 µM reference 
sample of MNV VPg 11-62. This spectrum is shown in panel A. The HSQC spectrum of this sample 
plus 0.94 and 3.76 molar equivalents of NS7pol are shown in panels B and C respectively. The HSQC  
spectrumof the reference sample plus 3.82 molar equivalents but concentrated back down to the 
original reference VPg volume is shown in panel D. Panel E shows the HSQC spectrum of the 
reference VPg sample plus 11.82 molar equivalents of NS7pol.This HSQC spectrum was recorded 
overnight to increase the signal to noise ratio. An overlay of the reference HSQC spectrum (green) 
with that of panel E (black) is shown in panel F. 
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While NMR analysis demonstrated that the core domain of MNV VPg could interact with NS7pol, 
it did not show that the core domain alone is entirely responsible for the interaction. In order to 
show that the core domain alone was responsible for the interaction, and to define the minimal 
VPg region required for VPg interaction another strategy was devised based on determining the 
affinity of the VPg-NS7pol complex. By comparing the affinity of full length MNV VPg and MNV 
VPg 11-62 for NS7pol it should be possible to determine whether the 11-62 region alone binds to 
NS7pol. In addition an alanine scanning approach coupled with affinity measurements should 
allow determination of the minimal NS7pol interacting regions of VPg. 
Surface plasmon resonance (SPR) using a BIAcore instrument was chosen as a method to 
determine the affinity of the VPg-NS7pol interaction. In these experiments, one protein, termed 
ligand, is fixed to a carboxy methyl surface on a BIAcore chip. Its binding partner, known as the 
analyte, is then passed over the chip surface. Binding is monitored by measuring changes in the 
refractive index at the chip surface upon interaction of analyte with ligand. Theoretical aspects 
of BIAcore-based SPR analysis of macromolecular interaction are reviewed in Malmqvist and 
Karlsson, 1997. 
In order to determine affinity it is important to measure changes in the refractive index using a 
wide range of analyte concentrations below saturation levels, requiring multiple analyte runs 
using the same chip surface. This in turn requires complete analyte removal between runs, a 
process which is termed regeneration. MNV VPg NS7po l was used as the ligand and MNV VPg 
(both full length and 11-62) was used as the analyte. It was found that using MNV VPg full 
length as analyte the chip could be regenerated by allowing the running buffer to flow over the 
chip surface at 30 µl/min for 13 minutes post sample injection. Unfortunately, an adequate 
regeneration condition could not be found when using MNV VPg 11-62 as analyte. The following 
were tried as regeneration conditions: 1) 1 M NaCl, 10 mM Hepes pH 7, 2) 3.6 M KCl, 10 mM 
Hepes pH 7, 3) 5 mM NaOH, 4) 50 mM NaOH, 5) 0.0014% triethylamine, 6) a two-step 
regeneration scheme using 1 M NaCl, 10 mM Hepes pH 7, then 5 mM NaOH, 7) a two-step 
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regeneration scheme using 3.33 mM HCl followed by 5 mM HCl.  Conditions 4 and 7 reduced the 
level of immobilisation of the NS7pol protein on the chip surface. All other conditions failed to 
adequately regenerate the chip surface. Because of the inability to regenerate the chip surface 
for MNV VPg 11-62, the relative affinities of the core domain and full length VPg for NS7 pol could 
not be determined. However, the interaction of full length VPg with NS7pol could be 
characterised. This interaction has fast on and off kinetics meaning that kinetic analysis could 
not be performed (Fig. 5-29).  Instead the KD of the interaction was determined by plotting the 
average equilibrium response units against analyte concentration. The KD  is the concentration 
of analyte at 50% ligand saturation, for the VPg-NS7pol interaction this is approximately 160 µM 
(Fig. 5-29). An affinity of 160 µM is quite low. However, given that both VPg and NS7pol co-
localise to a membranous vesicle during infection, the local concentration of both partners may 
be quite high (Hyde et al., 2009). This result is very preliminary; repeats with VPg as ligand and 
NS7pol as analyte should be performed to confirm the result. The result does show that SPR 
analysis could be used to characterise the effect of mutation on the VPg-NS7po l interaction. 
However, given our inability to characterise the VPg 11-62 NS7po l interaction it is likely that 
other techniques such as isothermal calorimetry could be attempted in order to further 
characterise the interaction.   
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Figure 5-29: BIAcore analysis of the MNV VPg-NS7pol interaction 
A. Raw sensograms for the MNV VPg-NS7pol interaction. These sensograms plot the response units of 
the analyte flowing over the NS7pol bound surface minus the response units of the analyte flowing 
over a control surface. An average equilibrium response unit value was determined for each curve 
and this was plotted against the protein concentration. A cubic polynomial function was used to fit 
the data. This curve is shown in panel B. 
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5.11. VPg research: future perspectives  
Many questions remain to be answered about the role of VPg in caliciviral infection. The main 
question that arises from the structural work is: what is the role of VPg structure? It is likely 
that we will only begin to understand the role of structure when we have structurally 
characterised VPg in complex with its binding partners. As has been discussed in the previous 
section, work is on-going to determine the structure of the VPg-NS7pol complex.  
One aspect which the VPg structural work has not yet addressed is whether having a viral 
genome attached to the VPg protein alters the structure in any way, or whether the VPg in some 
way influences RNA structure. This may be a difficult question to answer for two reasons. 
Firstly, genome-linked VPg would have to be harvested from cells infected with the virus. This 
may present problems in obtaining the kinds of yield required for structural analysis. It would 
also make the NMR labelling process very expensive as 15N enriched eukaryotic NMR labelled 
media would be required. Secondly the material, once obtained, is likely to behave poorly in the 
NMR machine due to its overall size. The alternative may be to determine if VPg binds RNA by 
titrating the genomic RNA from the 5′ end of the genome into VPg, and monitoring it by 1H-15N 
HSQC spectroscopy. 
In addition to the VPg-NS7po l work, preliminary work has been performed on the VPg-eIF4G 
interaction. It has been demonstrated that VPg interacts with the central HEAT domain of eIF4G 
and that a single mutation, F123A, at the C-terminus of VPg is enough to abrogate the 
interaction. This suggests that VPg interacts with eIF4G via an unstructured peptide at the C-
terminus. Given that a structure of eIF4G has been determined, a co-crystal structure of eIF4G 
with a C-terminal VPg peptide maybe achievable in the near future (Marcotrigano et al., 2001). 
Little or no work has been performed to characterise the reported interactions between VPg 
and eIF4E, eIF3d and 40S ribosomal protein S6 (Daughenbaugh et al., 2003; Chaudhry et al., 
2006; Goodfellow et al., 2005). It remains to be determined if the core domain is responsible for 
interaction with any of these molecules.  Ultimately the goal is to structurally characterise the 
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caliciviral mechanism of translation initiation. In order to do this a structure of  the 48S 
ribosomal subunit with a VPg linked message may be required. This would show how VPg 
interacts with all its binding partners and how it presents the viral message to the catalytic 
centre of the ribosome.  This may be quite ambitious, but, as has been discussed previously an 
EM structure has been determined of the 40S ribosomal subunit bound to HCV IRES and eIF3. 
Therefore this approach may be possible.  
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6. Summary 
 
This PhD thesis has described structural work on the murine norovirus polymerase as well as 
the murine and human norovirus VPg proteins. MNV NS7po l structure is very similar to that of 
other caliciviral polymerases which have been published. Indeed subsequent to the work 
presented in this thesis the MNV NS7pol structure was published by another group (Lee et al., 
2011). Thus the MNV NS7pol structure in itself adds little to the current body of knowledge on 
MNV replication. However, our structural studies of the high fidelity NS7po l mutant P72S has 
shown that S72 contributes an extra hydrogen bond in a network of interactions which connects 
a remote site in the thumb of the polymerase to motif A of the active site.  The G64S mutation in 
PV 3Dpol also increases polymerase fidelity (Pfeiffer and Kirkegaard, 2003; Arnold et al., 2005). 
This mutation is in a very similar position in the poliovirus 3Dpol as P72S of MNV NS7pol. In 
addition S64 forms an extra hydrogen bond that connects the thumb domain, the N-terminus 
and motif A of the polymerase (Marcotte et al., 2007). It is thus likely that the P72S mutant of 
MNV NS7pol and the G64S of PV 3Dpol are acting through similar mechanisms. Based on the work 
of Cameron and colleagues on PV 3Dpol, this mechanism, is likely to operate though increased 
conformational rigidity of the polymerase, leading to a decrease in the rate of polymerase 
closure (Moustafa et al., 2011; Arnold et al., 2005). The structure of a second MNV NS7pol high 
fidelity mutant (E75S) appears to be identical to WT even in the hydrogen bond network 
connecting the thumb and motif A.  
Structural studies presented in this thesis on the MNV VPg has revealed it have two helices 
which pack together at approximately 45°. These helices and the loop connecting them are 
between residue 21 and 55 in the protein which is 123 residues in length. The two helix bundle 
is very similar to the first two helices of the previously determined FCV VPg structure (Kwok et 
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al., unpublished).  While this outcome was expected given that FCV and MNV VPg share 27% 
amino acid identity the absence of a third helix in the MNV VPg structure was not. However, the 
level of sequence identity between these proteins in this third helix region is much lower than in 
the first and second helical regions.  The absence of this third helix is supported by the 
calculated MNV VPg structure, chemical shift data, dynamics profile and characterisation of 
truncated MNV VPg constructs by amide HQSC spectroscopy. Thus, while unexpected, the 
absence of helix-3 from MNV VPg represents a real difference between the two VPg structures 
determined thus far.  
In addition to MNV VPg this thesis also presents initial structural work on the LDV VPg protein. 
MNV and LDV VPg proteins share 57% amino acid identity and thus were expected to be 
identical in structure. However, the chemical shift index and dynamics data suggest that the 
core of the LDV VPg protein is significantly larger than that of the MNV VPg protein and contains 
three helices much like FCV VPg. More than 50% of the LDV VPg predicted helix region is made 
up of an insertion that is absent from the MNV VPg sequence (Fig. 5-19). These observations 
have yet to be confirmed by calculation of an NMR structure of LDV VPg. 
While the VPg structures are interesting, they do not reveal much about VPg nucleotidylation or 
protein priming. One interesting feature of the structure is, however, that the nucleotide 
accepting tyrosine is in a helical region of the protein. Given that this tyrosine must interact 
with the active site of the polymerase which is located deep inside a closed RNA binding cleft we 
postulated that VPg must unfold to become nucleotidylated. Mutations were made in the VPg 
which fully or partially unfold the protein as determined by 1D NMR. When these mutations 
were introduced into the reverse genetics system Ian Goodfellow and colleagues demonstrated 
that while VPg proteins which are partially unfolded could support virus replication those 
which are completely unfolded could not.  In addition, Cheng Kao and colleagues demonstrated 
that mutant VPg which has been shown to be unfolded, has a reduced capacity to be 
nucleotidylated. This suggests that our initial hypothesis of VPg unfolding being a requirement 
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for productive nucleotidylation is likely to be incorrect or a gross oversimplification of a more 
process in the cell. 
Finally this thesis presents very preliminary NMR titration data which demonstrates MNV VPg 
11-62 is capable of interaction with the MNV NS7pol. In addition SPR experiments have shown 
that the VPg-NS7pol interaction is low affinity; approximately 160 µM. 
As has been discussed in chapters 4 and 5, a lot of work is still required to fully characterise 
both NS7pol and VPg. In particular, the structural basis of protein priming, translation initiation, 
replication complex formation and genome replication remain to be determined. However, 
hopefully the work presented in this thesis will contribute in some way to better understanding 
these processes in the future. 
 
  
 
 Acknoweldgements 
 
 163 
 
7. Acknowledgements 
 
I have to acknowledge the help of a great many people who have helped me in these past three 
and a half years. Firstly thanks to Stephen for taking me on as a PhD student and giving the 
space and time to manage my project (with mixed results!). While also regularly taking time out 
regularly to give advice and direction. This has been a very good learning experience.  
All my NMR work was supervised by Pete Simpson. Pete has been great. His knowledge, ever 
eagerness to help and patience with NMR idiots like me has been essential to this PhD. Jan 
Marchant also helped me quite a lot not least because he developed backbone assignment, side  
chain assignment and NOE violation analysis tools based on NMRVIEW. This was an enormous 
help throughout my PhD. In addition to Pete and Jan I must also thank Steve Matthews and the 
rest of the macromolecular NMR group for helping me out repeatedly. 
I also have to thank my supervisor during my masters in the lab and guru during my PhD Trevor 
Sweeney. Trevor was remorseless in his mockery.  This man called me Eileen every day for 
about two years! Despite this bastardy behaviour I must thank Trev for being tough in the 
lab…making sure I reached certain technical standards. I also learned from Trev that results 
should be contemplated thoroughly before moving on to the next phase of the work.  Trev was 
also always buzzing around the lab with his latest idea on how all his work might fit together…I 
have yet to be able to mimic Trev’s creative insights into his experiments. I am, however, wiser 
for just having witnessed them. 
I must thank Amar! Amar was a masters student and PhD student at the same as me in the Curry 
lab. There has always been (very) friendly rivalry throughout this time. This certainly benefited 
me throughout my time in the lab as Amar is both a very knowledgeable and competent 
scientist.  He has also been very helpful.  
 Acknoweldgements 
 
 164 
 
Many thanks to Peter Brick for the many times he helped me with crystallographic software and 
for the practical advice he gave me on writing the thesis.  
Other members of the Curry/Hohenester/Brick lab must also be thanked these include: 
Jan Gebauer (or as Gebauer-power as Trev called him). Jan is very knowledgeable and great fun 
(despite him being German!).  
Federico Carafoli (or Fedex as Trev called him). Fedex has helped keep law and order in the lab 
for as long as I can remember. While this has not been appreciated by many a messy masters 
student it has been by me. 
Saffi Hussain (or Safferella as Trev called her). Saffi has been the life and soul of the biophysics 
crystallography group for nearly a decade. She has definitely helped me to keep sane during the 
PhD. 
Mewesh Islam. Helped me with BIAcore. Both performing the experiments and analysis. Cheers!  
I also have to thank the students I have supervised: 
Robert Harrington, Xenia Snetkov, Joanna Young, Matthew Keen, Stephen Jameison, Ben 
Krishna, Gabriela Baeza Sam Correia, Hamlet Cromwell Jr, and Mark Pheil. Many of these have 
made very big contributions to the norovirus structural biology project. All of these made large 
contributions to my approach to science; particularly with regards to planning and organisation.  
I have to acknowledge collaborators on the project. Especially Prof. Ian Goodfellow and Lucy 
Thorne for ideas plasmids and generally being good collaborators. 
I have to thank Stephen Holland, Nick Peters, Sonja Tattermusch, as well as the rest of the ‘Up 
your bingo’ table quiz team for helping me stay sane!  
Finally I must thank my family for supporting me and putting me up while I wrote my thesis 
(and generally!). Thanks Mom and Dad. 
 Bibliography 
 
 165 
 
 
8. Bibliography 
 
 
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, 
Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson 
JS, Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta crystallographica Section D, Biological crystallography 
66: 213-221 
 
Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS (1973) Acute infectious nonbacterial 
gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness 
produced by the Norwalk agent in man. Ann Intern Med 79: 18-25 
 
Ambros V, Baltimore D (1978) Protein is linked to the 5' end of poliovirus RNA by a 
phosphodiester linkage to tyrosine. The Journal of biological chemistry 253: 5263-5266 
 
Anindya R, Chittori S, Savithri HS (2005) Tyrosine 66 of Pepper vein banding virus genome-
linked protein is uridylylated by RNA-dependent RNA polymerase. Virology 336: 154-162 
 
Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE (2008) Determinants of 
RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase 
encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J Virol 
82: 12346-12355 
 
Arnold JJ, Cameron CE (2004) Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-
state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. Biochemistry 43: 
5126-5137 
 
Arnold JJ, Gohara DW, Cameron CE (2004) Poliovirus RNA-dependent RNA polymerase (3Dpol): 
pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mn2+. 
Biochemistry 43: 5138-5148 
 
Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE (2005) Remote site control of an active 
site fidelity checkpoint in a viral RNA-dependent RNA polymerase. The Journal of biological 
chemistry 280: 25706-25716 
 
Bailey D, Kaiser WJ, Hollinshead M, Moffat K, Chaudhry Y, Wileman T, Sosnovtsev SV, 
Goodfellow IG (2010) Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic 
reticulum to initiate replication complex formation. J Gen Virol 91: 739-749 
 
Bailey D, Thackray LB, Goodfellow IG (2008) A single amino acid substitution in the murine 
norovirus capsid protein is sufficient for attenuation in vivo. J Virol 82: 7725-7728 
 
Belliot G, Sosnovtsev SV, Chang KO, Babu V, Uche U, Arnold JJ, Cameron CE, Green KY (2005) 
Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent 
RNA polymerase. J Virol 79: 2393-2403 
 
 Bibliography 
 
 166 
 
Belliot G, Sosnovtsev SV, Chang KO, McPhie P, Green KY (2008) Nucleotidylylation of the VPg 
protein of a human norovirus by its proteinase-polymerase precursor protein. Virology 374: 33-
49 
 
Belliot G, Sosnovtsev SV, Mitra T, Hammer C, Garfield M, Green KY (2003) In vitro proteolytic 
processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors 
and products similar to those detected in calicivirus-infected cells. J Virol 77: 10957-10974 
 
Bellsolell L, Cho-Park PF, Poulin F, Sonenberg N, Burley SK (2006) Two structurally atypical 
HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1. 
Structure 14: 913-923 
 
Benison G, Nyarko A, Barbar E (2006) Heteronuclear NMR identifies a nascent helix in 
intrinsically disordered dynein intermediate chain: implications for folding and dimerization. J 
Mol Biol 362: 1082-1093 
 
Bentham M, Holmes K, Forrest S, Rowlands DJ, Stonehouse NJ (2012) Formation of Higher-
Order Foot-and-Mouth Disease Virus 3Dpol Complexes Is Dependent on Elongation Activity. J 
Virol 86: 2371-2374 
 
Bertolotti-Ciarlet A, Crawford SE, Hutson AM, Estes MK (2003) The 3' end of Norwalk virus 
mRNA contains determinants that regulate the expression and stability of the viral capsid 
protein VP1: a novel function for the VP2 protein. J Virol 77: 11603-11615 
 
Bhella D, Gatherer D, Chaudhry Y, Pink R, Goodfellow IG (2008) Structural insights into 
calicivirus attachment and uncoating. J Virol 82: 8051-8058 
 
Bhella D, Goodfellow IG (2011) The cryo-electron microscopy structure of feline calicivirus 
bound to junctional adhesion molecule A at 9-angstrom resolution reveals receptor-induced 
flexibility and two distinct conformational changes in the capsid protein VP1. J Virol 85: 11381-
11390 
 
Bienz K, Egger D, Rasser Y, Bossart W (1980) Kinetics and location of poliovirus 
macromolecular synthesis in correlation to virus-induced cytopathology. Virology 100: 390-399 
 
Boettiger D, Love DN, Weiss RA (1975) Virus envelope markers in mammalian tropism of avian 
RNA tumor viruses. J Virol 15: 108-114 
 
Brautigam CA, Aschheim K, Steitz TA (1999) Structural elucidation of the binding and inhibitory 
properties of lanthanide (III) ions at the 3'-5' exonucleolytic active site of the Klenow fragment. 
Chem Biol 6: 901-908 
 
Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski 
J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL (1998) Crystallography & NMR 
system: A new software suite for macromolecular structure determination. Acta 
crystallographica Section D, Biological crystallography 54: 905-921 
 
Brunger AT, Rice LM (1997) Crystallographic refinement by simulated annealing: methods and 
applications. Methods Enzymol 277: 243-269 
 
Bull RA, Hyde J, Mackenzie JM, Hansman GS, Oka T, Takeda N, White PA (2011) Comparison of 
the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. 
Virus Genes 42: 16-27 
 
 Bibliography 
 
 167 
 
Burroughs JN, Brown F (1978) Presence of a covalently linked protein on calicivirus RNA. J Gen 
Virol 41: 443-446 
 
Castro C, Arnold JA, Cameron CE (2005) Incorporation fidelity of the viral RNA-dependent RNA 
polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 107: 141-149 
 
Castro C, Smidansky E, Maksimchuk KR, Arnold JA, Korneeva VS, Götte M, Konigsberg W, 
Cameron CE (2007) Two proton transfers in the transition state for nucleotidyl transfer 
catalyzed by RNA- and DNA-dependent RNA and DNA polymerases. PNAS 104: 4267-4272 
 
Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Jiang X, Li X, Rao Z (2007) Structural basis 
for the recognition of blood group trisaccharides by norovirus. J Virol 81: 5949-5957 
 
Cao X, Wimmer E (1995) Intragenomic complementation of a 3AB mutant in dicistronic 
polioviruses. Virology 209: 315-326 
 
Chang KO, Sosnovtsev SS, Belliot G, Wang Q, Saif LJ, Green KY (2005) Reverse genetics system 
for porcine enteric calicivirus, a prototype sapovirus in the Caliciviridae. J Virol 79: 1409-1416 
 
Chaudhry Y, Nayak A, Bordeleau ME, Tanaka J, Pelletier J, Belsham GJ, Roberts LO, Goodfellow IG 
(2006) Caliciviruses differ in their functional requirements for eIF4F components. The Journal 
of biological chemistry 281: 25315-25325 
 
Chaudhry Y, Skinner MA, Goodfellow IG (2007) Recovery of genetically defined murine 
norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol 
88: 2091-2100 
 
Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, 
Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for 
macromolecular crystallography. Acta crystallographica Section D, Biological crystallography 
66: 12-21 
 
Chen Y, Tan M, Xia M, Hao N, Zhang XC, Huang P, Jiang X, Li X, Rao Z (2011) Crystallography of a 
Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood 
group antigens. PLoS Pathog 7: e1002152 
 
Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by 
using ribavirin. Proc Natl Acad Sci U S A 98: 6895-6900 
 
Daughenbaugh KF, Fraser CS, Hershey JW, Hardy ME (2003) The genome-linked protein VPg of 
the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. 
EMBO J 22: 2852-2859 
 
Daughenbaugh KF, Wobus CE, Hardy ME (2006) VPg of murine norovirus binds translation 
initiation factors in infected cells. Virol J 3: 33 
 
Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional 
spectral processing system based on UNIX pipes. Journal of biomolecular NMR 6: 277-293 
 
Emanuilov I, Sabatini DD, Lake JA, Freienstein C (1978) Localization of eukaryotic initiation 
factor 3 on native small ribosomal subunits. Proc Natl Acad Sci U S A 75: 1389-1393 
 
Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta 
crystallographica Section D, Biological crystallography 66: 486-501 
 Bibliography 
 
 168 
 
 
Ettayebi K, Hardy ME (2003) Norwalk virus nonstructural protein p48 forms a complex with the 
SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G 
protein. J Virol 77: 11790-11797 
 
Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N (2006) 
The structure of a protein primer-polymerase complex in the initiation of genome replication. 
EMBO J 25: 880-888 
 
Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N (2004) Structure of 
foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a 
template-primer RNA. The Journal of biological chemistry 279: 47212-47221 
 
Ferrer-Orta C, Sierra M, Agudo R, de la Higuera I, Arias A, Perez-Luque R, Escarmis C, Domingo E, 
Verdaguer N (2010) Structure of foot-and-mouth disease virus mutant polymerases with 
reduced sensitivity to ribavirin. J Virol 84: 6188-6199 
 
Flynn WT, Saif LJ (1988) Serial propagation of porcine enteric calicivirus-like virus in primary 
porcine kidney cell cultures. J Clin Microbiol 26: 206-212 
 
Fukushi S, Kojima S, Takai R, Hoshino FB, Oka T, Takeda N, Katayama K, Kageyama T (2004) 
Poly(A)- and primer-independent RNA polymerase of Norovirus. J Virol 78: 3889-3896 
 
Fullerton SW, Blaschke M, Coutard B, Gebhardt J, Gorbalenya A, Canard B, Tucker PA, Rohayem J 
(2007) Structural and functional characterization of sapovirus RNA-dependent RNA 
polymerase. J Virol 81: 1858-1871 
 
Gallie DR (1991) The cap and poly(A) tail function synergistically to regulate mRNA 
translational efficiency. Genes Dev 5: 2108-2116 
 
Gallie DR (1998) A tale of two termini: a functional interaction between the termini of an mRNA 
is a prerequisite for efficient translation initiation. Gene 216: 1-11 
 
Gerondopoulos A, Jackson T, Monaghan P, Doyle N, Roberts LO (2010) Murine norovirus-1 cell 
entry is mediated through a non-clathrin-, non-caveolae-, dynamin- and cholesterol-dependent 
pathway. J Gen Virol 91: 1428-1438 
 
Glass PJ, White LJ, Ball JM, Leparc-Goffart I, Hardy ME, Estes MK (2000) Norwalk virus open 
reading frame 3 encodes a minor structural protein. J Virol 74: 6581-6591 
 
Glass PJ, Zeng CQ, Estes MK (2003) Two nonoverlapping domains on the Norwalk virus open 
reading frame 3 (ORF3) protein are involved in the formation of the phosphorylated 35K 
protein and in ORF3-capsid protein interactions. J Virol 77: 3569-3577 
 
Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361: 1776-1785 
 
Gohara DW, Arnold JJ, Cameron CE (2004) Poliovirus RNA-dependent RNA polymerase (3Dpol): 
kinetic, thermodynamic, and structural analysis of ribonucleotide selection. Biochemistry 43: 
5149-5158 
 
Gohara DW, Crotty S, Arnold JJ, Yoder JD, Andino R, Cameron CE (2000) Poliovirus RNA-
dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of 
conserved structural motifs A and B. The Journal of biological chemistry 275: 25523-25532 
 
 Bibliography 
 
 169 
 
Gong P, Peersen OB (2010) Structural basis for active site closure by the poliovirus RNA-
dependent RNA polymerase. Proc Natl Acad Sci U S A 107: 22505-22510 
 
Goodfellow I, Chaudhry Y, Gioldasi I, Gerondopoulos A, Natoni A, Labrie L, Laliberte JF, Roberts L 
(2005) Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO 
Rep 6: 968-972 
 
Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, Barclay W, Evans DJ (2000) 
Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74: 
4590-4600 
 
Goodfellow IG, Polacek C, Andino R, Evans DJ (2003) The poliovirus 2C cis-acting replication 
element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. 
J Gen Virol 84: 2359-2363 
 
Gradi A, Svitkin YV, Imataka H, Sonenberg N (1998) Proteolysis of human eukaryotic translation 
initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after 
poliovirus infection. Proc Natl Acad Sci U S A 95: 11089-11094 
 
Green KY (2006) Caliciviridae: The Noroviruses. In Fields Virology, Knipe DM, Howly PM (eds), 
5 edn, Caliciviridae: The Noroviruses, pp 949-979. Lippincott Williams & Wilkins 
 
Gruez A, Selisko B, Roberts M, Bricogne G, Bussetta C, Jabafi I, Coutard B, De Palma AM, Neyts J, 
Canard B (2008) The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in 
complex with its protein primer VPg confirms the existence of a second VPg binding site on 
Picornaviridae polymerases. J Virol 82: 9577-9590 
 
Guo M, Hayes J, Cho KO, Parwani AV, Lucas LM, Saif LJ (2001) Comparative pathogenesis of 
tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic 
pigs and induction of diarrhea by intravenous inoculation of wild-type PEC. J Virol 75: 9239-
9251 
 
Habeck M, Rieping W, Linge JP, Nilges M (2004) NOE assignment with ARIA 2.0: the nuts and 
bolts. Methods Mol Biol 278: 379-402 
 
Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, 
Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart 
C, DeGruttola V, Mellors JW (2002) Dual vs single protease inhibitor therapy following 
antiretroviral treatment failure: a randomized trial. JAMA 288: 169-180 
 
Hansen JL, Long AM, Schultz SC (1997) Structure of the RNA-dependent RNA polymerase of 
poliovirus. Structure 5: 1109-1122 
 
Hansman GS, Biertumpfel C, Georgiev I, McLellan JS, Chen L, Zhou T, Katayama K, Kwong PD 
(2011) Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with 
histo-blood group antigens reveal details for a potential site of vulnerability. J Virol 85: 6687-
6701 
 
Harmon SA, Richards OC, Summers DF, Ehrenfeld E (1991) The 5'-terminal nucleotides of 
hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol 65: 2757-2760 
 
Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA (2008) Deaths from norovirus among 
the elderly, England and Wales. Emerg Infect Dis 14: 1546-1552 
 
 Bibliography 
 
 170 
 
Herbert TP, Brierley I, Brown TD (1997) Identification of a protein linked to the genomic and 
subgenomic mRNAs of feline calicivirus and its role in translation. J Gen Virol 78 ( Pt 5): 1033-
1040 
 
Hinnebusch AG (2006) eIF3: a versatile scaffold for translation initiation complexes. Trends 
Biochem Sci 31: 553-562 
 
Hobson SD, Rosenblum ES, Richards OC, Richmond K, Kirkegaard K, Schultz SC (2001) 
Oligomeric structures of poliovirus polymerase are important for function. EMBO J 20: 1153-
1163 
 
Hogbom M, Jager K, Robel I, Unge T, Rohayem J (2009) The active form of the norovirus RNA-
dependent RNA polymerase is a homodimer with cooperative activity. J Gen Virol 90: 281-291 
 
Holland JJ, Domingo E, de la Torre JC, Steinhauer DA (1990) Mutation frequencies at defined 
single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by 
chemical mutagenesis. J Virol 64: 3960-3962 
 
Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, Altaye M, Pickering 
LK, Newburg DS, LePendu J, Jiang X (2003) Noroviruses bind to human ABO, Lewis, and secretor 
histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188: 
19-31 
 
Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, Jiang X (2005) Norovirus and 
histo-blood group antigens: demonstration of a wide spectrum of strain specificities and 
classification of two major binding groups among multiple binding patterns. J Virol 79: 6714-
6722 
 
Hyde JL, Mackenzie JM (2010) Subcellular localization of the MNV-1 ORF1 proteins and their 
potential roles in the formation of the MNV-1 replication complex. Virology 406: 138-148 
 
Hyde JL, Sosnovtsev SV, Green KY, Wobus C, Virgin HW, Mackenzie JM (2009) Mouse norovirus 
replication is associated with virus-induced vesicle clusters originating from membranes 
derived from the secretory pathway. J Virol 83: 9709-9719 
 
Imataka H, Sonenberg N (1997) Human eukaryotic translation initiation factor 4G (eIF4G) 
possesses two separate and independent binding sites for eIF4A. Mol Cell Biol 17: 6940-6947 
 
Jackson RJ, Hellen CU, Pestova TV (2010) The mechanism of eukaryotic translation initiation 
and principles of its regulation. Nat Rev Mol Cell Biol 11: 113-127 
 
Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E (1988) A segment of 
the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of 
ribosomes during in vitro translation. J Virol 62: 2636-2643 
 
Jiang X, Wang M, Graham DY, Estes MK (1992) Expression, self-assembly, and antigenicity of the 
Norwalk virus capsid protein. J Virol 66: 6527-6532 
 
Joachims M, Van Breugel PC, Lloyd RE (1999) Cleavage of poly(A)-binding protein by 
enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73: 718-727 
 
Johnson BA (2004) Using NMRView to visualize and analyze the NMR spectra of 
macromolecules. Methods Mol Biol 278: 313-352 
 
 Bibliography 
 
 171 
 
Jones TA, Zou JY, Cowan SW, Kjeldgaard M (1991) Improved methods for building protein 
models in electron density maps and the location of errors in these models. Acta 
crystallographica Section A, Foundations of crystallography 47 ( Pt 2): 110-119 
 
Joyce CM, Benkovic SJ (2004) DNA polymerase fidelity: kinetics, structure, and checkpoints. 
Biochemistry 43: 14317-14324 
 
Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM (2011) Comparative murine 
norovirus studies reveal a lack of correlation between intestinal virus titers and enteric 
pathology. Virology 421: 202-210 
 
Kaiser WJ, Chaudhry Y, Sosnovtsev SV, Goodfellow IG (2006) Analysis of protein-protein 
interactions in the feline calicivirus replication complex. J Gen Virol 87: 363-368 
 
Karst SM, Wobus CE, Lay M, Davidson J, Virgin HWt (2003) STAT1-dependent innate immunity 
to a Norwalk-like virus. Science 299: 1575-1578 
 
Kay LE, Torchia DA, Bax A (1989) Backbone dynamics of proteins as studied by 15N inverse 
detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. 
Biochemistry 28: 8972-8979 
 
Korneeva VS, Cameron CE (2007) Structure-function relationships of the viral RNA-dependent 
RNA polymerase: fidelity, replication speed, and initiation mechanism determined by a residue 
in the ribose-binding pocket. The Journal of biological chemistry 282: 16135-16145 
 
Kuyumcu-Martinez M, Belliot G, Sosnovtsev SV, Chang KO, Green KY, Lloyd RE (2004) Calicivirus 
3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. J Virol 78: 
8172-8182 
 
Laurila MR, Salgado PS, Stuart DI, Grimes JM, Bamford DH (2005) Back-priming mode of phi6 
RNA-dependent RNA polymerase. J Gen Virol 86: 521-526 
 
Lee CH, Gilbertson DL, Novella IS, Huerta R, Domingo E, Holland JJ (1997) Negative effects of 
chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol 71: 3636-
3640 
 
Lee JH, Alam I, Han KR, Cho S, Shin S, Kang S, Yang JM, Kim KH (2011) Crystal structures of 
murine norovirus-1 RNA-dependent RNA polymerase. J Gen Virol 92: 1607-1616 
 
Lee YF, Nomoto A, Detjen BM, Wimmer E (1977) A protein covalently linked to poliovirus 
genome RNA. Proc Natl Acad Sci U S A 74: 59-63 
 
Leen EN, Baeza G, Curry S (2012) Structure of a Murine Norovirus NS6 Protease-Product 
Complex Revealed by Adventitious Crystallisation. PLoS ONE 7: e38723.  
LeFebvre AK, Korneeva NL, Trutschl M, Cvek U, Duzan RD, Bradley CA, Hershey JW, Rhoads RE 
(2006) Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit. The 
Journal of biological chemistry 281: 22917-22932 
 
Leonard S, Plante D, Wittmann S, Daigneault N, Fortin MG, Laliberte JF (2000) Complex 
formation between potyvirus VPg and translation eukaryotic initiation factor 4E correlates with 
virus infectivity. J Virol 74: 7730-7737 
 
 Bibliography 
 
 172 
 
Leslie AGW (2006) The integration of macromolecular diffraction data. Acta Crystallogr D 62: 
48-57 
 
Liu BL, Viljoen GJ, Clarke IN, Lambden PR (1999) Identification of further proteolytic cleavage 
sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli. J 
Gen Virol 80 ( Pt 2): 291-296 
 
Liu G, Ni Z, Yun T, Yu B, Chen L, Zhao W, Hua J, Chen J (2008) A DNA-launched reverse genetics 
system for rabbit hemorrhagic disease virus reveals that the VP2 protein is not essential for 
virus infectivity. J Gen Virol 89: 3080-3085 
 
Loo YM, Gale M, Jr. (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680-692 
 
Love DN, Sabine M (1975) Electron microscopic observation of feline kidney cells infected with 
a feline calicivirus. Arch Virol 48: 213-228 
 
Lovenetskii AN, Kiselev FL, Zaretskii IZ, Irlin IS, Bykovskii AF (1975) [Biochemical and 
physiocochemical characteristics of a type C virus isolated from spontaneous lymphosarcoma of 
CC57Br strain mice]. Vopr Virusol: 14-20 
 
Lyle JM, Bullitt E, Bienz K, Kirkegaard K (2002) Visualization and functional analysis of RNA-
dependent RNA polymerase lattices. Science 296: 2218-2222 
 
Makino A, Shimojima M, Miyazawa T, Kato K, Tohya Y, Akashi H (2006) Junctional adhesion 
molecule 1 is a functional receptor for feline calicivirus. J Virol 80: 4482-4490 
 
Mann R, Baltimore D (1985) Varying the position of a retrovirus packaging sequence results in 
the encapsidation of both unspliced and spliced RNAs. J Virol 54: 401-407 
 
Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its 
use to produce helper-free defective retrovirus. Cell 33: 153-159 
 
Marcotrigiano J, Gingras AC, Sonenberg N, Burley SK (1997) Cocrystal structure of the 
messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89: 951-961 
 
Marcotrigiano J, Gingras AC, Sonenberg N, Burley SK (1999) Cap-dependent translation 
initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell 3: 707-716 
 
Marcotrigiano J, Lomakin IB, Sonenberg N, Pestova TV, Hellen CU, Burley SK (2001) A conserved 
HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol Cell 7: 
193-203 
 
Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, Filman DJ, Cameron CE, Hogle JM 
(2007) Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to 
the RNA-dependent RNA polymerase. J Virol 81: 3583-3596 
 
Marionneau S, Ruvoen N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A, Ruiz-Palacois G, 
Huang P, Jiang X, Le Pendu J (2002) Norwalk virus binds to histo-blood group antigens present 
on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122: 1967-1977 
 
Martella V, Lorusso E, Decaro N, Elia G, Radogna A, D'Abramo M, Desario C, Cavalli A, Corrente 
M, Camero M, Germinario CA, Banyai K, Di Martino B, Marsilio F, Carmichael LE, Buonavoglia C 
(2008) Detection and molecular characterization of a canine norovirus. Emerg Infect Dis 14: 
1306-1308 
 Bibliography 
 
 173 
 
 
Mattern CF, Daniel WA (1965) Replication of poliovirus in HeLa cells: electron microscopic 
observations. Virology 26: 646-663 
 
McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser 
crystallographic software. Journal of applied crystallography 40: 658-674 
 
Meeroff JC, Schreiber DS, Trier JS, Blacklow NR (1980) Abnormal gastric motor function in viral 
gastroenteritis. Ann Intern Med 92: 370-373 
 
Meyers G, Wirblich C, Thiel HJ (1991) Genomic and subgenomic RNAs of rabbit hemorrhagic 
disease virus are both protein-linked and packaged into particles. Virology 184: 677-686 
 
Mitra T, Sosnovtsev SV, Green KY (2004) Mutagenesis of tyrosine 24 in the VPg protein is lethal 
for feline calicivirus. J Virol 78: 4931-4935 
 
Miyoshi H, Suehiro N, Tomoo K, Muto S, Takahashi T, Tsukamoto T, Ohmori T, Natsuaki T (2006) 
Binding analyses for the interaction between plant virus genome-linked protein (VPg) and plant 
translational initiation factors. Biochimie 88: 329-340 
 
Moustafa IM, Shen H, Morton B, Colina CM, Cameron CE (2011) Molecular dynamics simulations 
of viral RNA polymerases link conserved and correlated motions of functional elements to 
fidelity. J Mol Biol 410: 159-181 
 
Murphy JF, Klein PG, Hunt AG, Shaw JG (1996) Replacement of the tyrosine residue that links a 
potyviral VPg to the viral RNA is lethal. Virology 220: 535-538 
 
Murphy JF, Rychlik W, Rhoads RE, Hunt AG, Shaw JG (1991) A tyrosine residue in the small 
nuclear inclusion protein of tobacco vein mottling virus links the VPg to the viral RNA. J Virol 65: 
511-513 
 
Nakamura K, Someya Y, Kumasaka T, Ueno G, Yamamoto M, Sato T, Takeda N, Miyamura T, 
Tanaka N (2005) A norovirus protease structure provides insights into active and substrate 
binding site integrity. J Virol 79: 13685-13693 
 
Ng KK, Cherney MM, Vazquez AL, Machin A, Alonso JM, Parra F, James MN (2002) Crystal 
structures of active and inactive conformations of a caliciviral RNA-dependent RNA polymerase. 
The Journal of biological chemistry 277: 1381-1387 
 
Ng KK, Pendas-Franco N, Rojo J, Boga JA, Machin A, Alonso JM, Parra F (2004) Crystal structure 
of norwalk virus polymerase reveals the carboxyl terminus in the active site cleft. The Journal of 
biological chemistry 279: 16638-16645 
 
Nomoto A, Kitamura N, Golini F, Wimmer E (1977) The 5'-terminal structures of poliovirion 
RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S 
A 74: 5345-5349 
 
Oliver SL, Dastjerdi AM, Wong S, El-Attar L, Gallimore C, Brown DW, Green J, Bridger JC (2003) 
Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of 
noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J Virol 77: 2789-2798 
 
Ossiboff RJ, Zhou Y, Lightfoot PJ, Prasad BV, Parker JS (2010) Conformational changes in the 
capsid of a calicivirus upon interaction with its functional receptor. J Virol 84: 5550-5564 
 
 Bibliography 
 
 174 
 
Parwani AV, Flynn WT, Gadfield KL, Saif LJ (1991) Serial propagation of porcine enteric 
calicivirus in a continuous cell line. Effect of medium supplementation with intestinal contents 
or enzymes. Arch Virol 120: 115-122 
 
Paul AV, Peters J, Mugavero J, Yin J, van Boom JH, Wimmer E (2003) Biochemical and genetic 
studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol 
77: 891-904 
 
Paul AV, van Boom JH, Filippov D, Wimmer E (1998) Protein-primed RNA synthesis by purified 
poliovirus RNA polymerase. Nature 393: 280-284 
 
Paul AV, Yin J, Mugavero J, Rieder E, Liu Y, Wimmer E (2003) A "slide-back" mechanism for the 
initiation of protein-primed RNA synthesis by the RNA polymerase of poliovirus. The Journal of 
biological chemistry 278: 43951-43960 
 
Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by 
a sequence derived from poliovirus RNA. Nature 334: 320-325 
 
Perez L, Carrasco L (1993) Entry of poliovirus into cells does not require a low-pH step. J Virol 
67: 4543-4548 
 
Perry JW, Taube S, Wobus CE (2009) Murine norovirus-1 entry into permissive macrophages 
and dendritic cells is pH-independent. Virus Res 143: 125-129 
 
Perry JW, Wobus CE (2010) Endocytosis of murine norovirus 1 into murine macrophages is 
dependent on dynamin II and cholesterol. J Virol 84: 6163-6176 
 
Pestova TV, Hellen CU (2003) Translation elongation after assembly of ribosomes on the Cricket 
paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. Genes 
Dev 17: 181-186 
 
Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU (1998) A prokaryotic-like mode of 
cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation 
initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 12: 67-83 
 
Pfeiffer JK, Kirkegaard K (2003) A single mutation in poliovirus RNA-dependent RNA 
polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl 
Acad Sci U S A 100: 7289-7294 
 
Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK (1999) X-ray crystallographic 
structure of the Norwalk virus capsid. Science 286: 287-290 
 
Racaniello VR (2006) Picornaviridae: The Viruses and Their Replication. In Fields Virology, 
Knipe DM, Howly PM (eds), 5 edn, Picornaviridae: The Viruses and Their Replication, pp 796-
938. Lippincott Williams & Wilkins 
 
Rieping W, Habeck M, Bardiaux B, Bernard A, Malliavin TE, Nilges M (2007) ARIA2: automated  
NOE assignment and data integration in NMR structure calculation. Bioinformatics 23: 381-382 
 
Rohayem J, Jager K, Robel I, Scheffler U, Temme A, Rudolph W (2006) Characterization of 
norovirus 3Dpol RNA-dependent RNA polymerase activity and initiation of RNA synthesis. J Gen 
Virol 87: 2621-2630 
 
 Bibliography 
 
 175 
 
Rohayem J, Robel I, Jager K, Scheffler U, Rudolph W (2006) Protein-primed and de novo 
initiation of RNA synthesis by norovirus 3Dpol. J Virol 80: 7060-7069 
 
Rothberg PG, Harris TJ, Nomoto A, Wimmer E (1978) O4-(5'-uridylyl)tyrosine is the bond 
between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A 75: 
4868-4872 
 
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM 
(2011) Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis 17: 
7-15 
 
Schaffer FL, Ehresmann DW, Fretz MK, Soergel MI (1980) A protein, VPg, covalently linked to 
36S calicivirus RNA. J Gen Virol 47: 215-220 
 
Schein CH, Oezguen N, Volk DE, Garimella R, Paul A, Braun W (2006) NMR structure of the viral 
peptide linked to the genome (VPg) of poliovirus. Peptides 27: 1676-1684 
 
Schuler M, Connell SR, Lescoute A, Giesebrecht J, Dabrowski M, Schroeer B, Mielke T, Penczek 
PA, Westhof E, Spahn CM (2006) Structure of the ribosome-bound cricket paralysis virus IRES 
RNA. Nat Struct Mol Biol 13: 1092-1096 
 
Schutz P, Bumann M, Oberholzer AE, Bieniossek C, Trachsel H, Altmann M, Baumann U (2008) 
Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase controlled by protein-
protein interactions. Proc Natl Acad Sci U S A 105: 9564-9569 
 
Seah EL, Marshall JA, Wright PJ (2003) Trans activity of the norovirus Camberwell proteinase 
and cleavage of the N-terminal protein encoded by ORF1. J Virol 77: 7150-7155 
 
Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, Prasad BV (2011) Structural analysis of 
histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications 
for epochal evolution. J Virol 85: 8635-8645 
 
Sharp TM, Guix S, Katayama K, Crawford SE, Estes MK (2010) Inhibition of cellular protein 
secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic 
reticulum export signal. PLoS One 5: e13130 
 
Shen Y, Delaglio F, Cornilescu G, Bax A (2009) TALOS+: a hybrid method for predicting protein 
backbone torsion angles from NMR chemical shifts. Journal of biomolecular NMR 44: 213-223 
 
Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E (2005) Structural roles for human 
translation factor eIF3 in initiation of protein synthesis. Science 310: 1513-1515 
 
Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CU (1998) Specific interaction of 
eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus 
and classical swine fever virus RNAs. J Virol 72: 4775-4782 
 
Smerdon SJ, Jager J, Wang J, Kohlstaedt LA, Chirino AJ, Friedman JM, Rice PA, Steitz TA (1994) 
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human 
immunodeficiency virus type 1. Proc Natl Acad Sci U S A 91: 3911-3915 
 
Sosnovtsev S, Green KY (1995) RNA transcripts derived from a cloned full-length copy of the 
feline calicivirus genome do not require VpG for infectivity. Virology 210: 383-390 
 
 Bibliography 
 
 176 
 
Sosnovtsev SV, Belliot G, Chang KO, Prikhodko VG, Thackray LB, Wobus CE, Karst SM, Virgin HW, 
Green KY (2006) Cleavage map and proteolytic processing of the murine norovirus 
nonstructural polyprotein in infected cells. J Virol 80: 7816-7831 
 
Sosnovtsev SV, Garfield M, Green KY (2002) Processing map and essential cleavage sites of the 
nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J Virol 76: 7060-
7072 
 
Sosnovtsev SV, Green KY (2000) Identification and genomic mapping of the ORF3 and VPg 
proteins in feline calicivirus virions. Virology 277: 193-203 
 
Sosnovtseva SA, Sosnovtsev SV, Green KY (1999) Mapping of the feline calicivirus proteinase 
responsible for autocatalytic processing of the nonstructural polyprotein and identification of a 
stable proteinase-polymerase precursor protein. J Virol 73: 6626-6633 
 
Spagnolo JF, Rossignol E, Bullitt E, Kirkegaard K (2010) Enzymatic and nonenzymatic functions 
of viral RNA-dependent RNA polymerases within oligomeric arrays. RNA 16: 382-393 
 
Steitz TA (1993) DNA-Dependent and Rna-Dependent DNA-Polymerases. Curr Opin Struct Biol 
3: 31-38 
 
Stohlman SA, Wisseman CL, Jr., Eylar OR, Silverman DJ (1975) Dengue virus-induced 
modifications of host cell membranes. J Virol 16: 1017-1026 
 
Stuart AD, Brown TD (2006) Entry of feline calicivirus is dependent on clathrin-mediated 
endocytosis and acidification in endosomes. J Virol 80: 7500-7509 
 
Stuart AD, Brown TD (2007) Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus. J 
Gen Virol 88: 177-186 
 
Subba-Reddy CV, Goodfellow I, Kao CC (2011) VPg-primed RNA synthesis of norovirus RNA-
dependent RNA polymerases by using a novel cell-based assay. J Virol 85: 13027-13037 
 
Sugieda M, Nakajima S (2002) Viruses detected in the caecum contents of healthy pigs 
representing a new genetic cluster in genogroup II of the genus "Norwalk-like viruses". Virus 
Res 87: 165-172 
 
Suzuki T, Yamaya M, Sekizawa K, Hosoda M, Yamada N, Ishizuka S, Nakayama K, Yanai M, 
Numazaki Y, Sasaki H (2001) Bafilomycin A(1) inhibits rhinovirus infection in human airway 
epithelium: effects on endosome and ICAM-1. Am J Physiol Lung Cell Mol Physiol 280: L1115-
1127 
 
Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227: 75-86 
 
Tan M, Huang P, Meller J, Zhong W, Farkas T, Jiang X (2003) Mutations within the P2 domain of 
norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding 
pocket. J Virol 77: 12562-12571 
 
Tarun SZ, Jr., Sachs AB (1996) Association of the yeast poly(A) tail binding protein with 
translation initiation factor eIF-4G. EMBO J 15: 7168-7177 
 
Taube S, Rubin JR, Katpally U, Smith TJ, Kendall A, Stuckey JA, Wobus CE (2010) High-resolution 
x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding 
domain. J Virol 84: 5695-5705 
 Bibliography 
 
 177 
 
 
Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL (2008) 
Norwalk virus: how infectious is it? J Med Virol 80: 1468-1476 
 
Thompson AA, Peersen OB (2004) Structural basis for proteolysis-dependent activation of the 
poliovirus RNA-dependent RNA polymerase. EMBO J 23: 3462-3471 
 
Troeger H, Loddenkemper C, Schneider T, Schreier E, Epple HJ, Zeitz M, Fromm M, Schulzke JD 
(2009) Structural and functional changes of the duodenum in human norovirus infection. Gut 
58: 1070-1077 
 
van Dijk AA, Makeyev EV, Bamford DH (2004) Initiation of viral RNA-dependent RNA 
polymerization. Journal of General Virology 85: 1077-1093 
 
Vazquez AL, Alonso JMM, Parra F (2001) Characterisation of the RNA-dependent RNA 
polymerase from Rabbit hemorrhagic disease virus produced in Escherichia coli. Arch Virol 146: 
59-69 
 
Vignuzzi M, Wendt E, Andino R (2008) Engineering attenuated virus vaccines by controlling 
replication fidelity. Nat Med 14: 154-161 
 
Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Belliot G, Barron EL, Sosnovtsev SV, 
Green KY (2006) Pathology of immunodeficient mice with naturally occurring murine norovirus 
infection. Toxicol Pathol 34: 708-715 
 
Ward VK, McCormick CJ, Clarke IN, Salim O, Wobus CE, Thackray LB, Virgin HWt, Lambden PR 
(2007) Recovery of infectious murine norovirus using pol II-driven expression of full-length 
cDNA. Proc Natl Acad Sci U S A 104: 11050-11055 
 
Weiss RA, Boettiger D, Love DN (1975) Phenotypic mixing between vesicular stomatitis virus 
and avian RNA tumor viruses. Cold Spring Harb Symp Quant Biol 39 Pt 2: 913-918 
 
Wells SE, Hillner PE, Vale RD, Sachs AB (1998) Circularization of mRNA by eukaryotic 
translation initiation factors. Mol Cell 2: 135-140 
 
Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, Walther P, Fuller SD, Antony C, Krijnse-
Locker J, Bartenschlager R (2009) Composition and three-dimensional architecture of the 
dengue virus replication and assembly sites. Cell Host Microbe 5: 365-375 
 
Willcocks MM, Carter MJ, Roberts LO (2004) Cleavage of eukaryotic initiation factor eIF4G and 
inhibition of host-cell protein synthesis during feline calicivirus infection. J Gen Virol 85: 1125-
1130 
 
Wilson JE, Pestova TV, Hellen CU, Sarnow P (2000) Initiation of protein synthesis from the A site 
of the ribosome. Cell 102: 511-520 
 
Wishart DS, Sykes BD (1994) The 13C chemical-shift index: a simple method for the 
identification of protein secondary structure using 13C chemical-shift data. Journal of 
biomolecular NMR 4: 171-180 
 
Wishart DS, Sykes BD, Richards FM (1991) Relationship between nuclear magnetic resonance 
chemical shift and protein secondary structure. J Mol Biol 222: 311-333 
 
 Bibliography 
 
 178 
 
Wittmann S, Chatel H, Fortin MG, Laliberte JF (1997) Interaction of the viral protein genome 
linked of turnip mosaic potyvirus with the translational eukaryotic initiation factor (iso) 4E of 
Arabidopsis thaliana using the yeast two-hybrid system. Virology 234: 84-92 
 
Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, 
Green KY, Virgin HW (2004) Replication of Norovirus in cell culture reveals a tropism for 
dendritic cells and macrophages. PLoS Biol 2: e432 
 
Wobus CE, Thackray LB, Virgin HWt (2006) Murine norovirus: a model system to study 
norovirus biology and pathogenesis. J Virol 80: 5104-5112 
 
Yunus MA, Chung LM, Chaudhry Y, Bailey D, Goodfellow I (2010) Development of an optimized 
RNA-based murine norovirus reverse genetics system. J Virol Methods 169: 112-118 
 
Zamyatkin DF, Parra F, Alonso JM, Harki DA, Peterson BR, Grochulski P, Ng KK (2008) Structural 
insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase. The Journal 
of biological chemistry 283: 7705-7712 
 
Zamyatkin DF, Parra F, Machin A, Grochulski P, Ng KK (2009) Binding of 2'-amino-2'-
deoxycytidine-5'-triphosphate to norovirus polymerase induces rearrangement of the active 
site. J Mol Biol 390: 10-16 
Zeitler CE, Estes MK, Venkataram Prasad BV (2006) X-ray crystallographic structure of the 
Norwalk virus protease at 1.5-A resolution. J Virol 80: 5050-5058 
 
Zou P, Gautel M, Geerlof A, Wilmanns M, Koch MH, Svergun DI (2003) Solution scattering 
suggests cross-linking function of telethonin in the complex with titin. The Journal of biological 
chemistry 278: 2636-2644 
 
 
 
 
 
 Appendix 
 
 179 
 
 
9. Appendix 
 
9.1.Chemical shift values for MNV VPg 11-85 
 
The following are the chemical shift values for MNV VPg 11-85. The numbering is that of the 11-85 
construct. Residues 2 and 3 are the a and m of the residual affinity tag respectively. Residue 4 in 
column 2 is in fact residue 11 of MNV VPg. The sequence of the construct is given below. 
 1  GAMGRPGVFR TRGLTDEEYD EFKKRRESRG GKYSIDDYLA DREREEELLE 
51  RDEEEAIFGD GFGLKATRRS RKAERAKL 
 
 
Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
2.CA 52.668 12 5.CB 30.4
2.HA 4.386 12 5.HB2 1.74
2.CB 19.435 12 5.HB1 1.84
2.HB1 1.433 12 5.CG 26.8
2.C 177.827 12 5.HG2 1.66
3.N 119.607 12 5.HG1 1.66
3.HN 8.519 12 5.CD 43.6
3.CA 55.676 12 5.HD2 3.17
3.HA 4.51 12 5.HD1 3.17
3.CB 32.559 12 5.C 174.242
3.HB2 2.074 13 6.CA 63.259
3.HB1 2.133 13 6.HA 4.457
3.CG 32.4 13 6.CB 32.067
3.HG2 2.65 13 6.HB2 1.951
3.HG1 2.58 13 6.HB1 2.328
3.C 176.694 13 6.CG 27.553
11 4.N 110.122 13 6.HG2 2.041
11 4.HN 8.383 13 6.HG1 2.059
11 4.CA 45.664 13 6.CD 50.67
11 4.HA2 3.942 13 6.HD2 3.834
11 4.HA1 3.988 13 6.HD1 3.647
11 4.C 173.672 13 6.C 177.524
12 5.N 121.4 14 7.N 109.192
12 5.HN 8.14 14 7.HN 8.467
12 5.CA 53.9 14 7.CA 45.497
12 5.HA 4.64 14 7.HA2 3.936
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
14 7.HA1 3.943 17 10.HD2 3.144
14 7.C 174.227 17 10.HD1 3.144
15 8.N 119.157 17 10.C 176.452
15 8.HN 7.837 18 11.N 114.223
15 8.CA 62.529 18 11.HN 8.015
15 8.HA 4.081 18 11.CA 62.41
15 8.CB 32.491 18 11.HA 4.231
15 8.HB 2.012 18 11.CB 69.509
15 8.CG2 20.668 18 11.HB 4.194
15 8.HG21 0.85 18 11.CG2 21.728
15 8.CG1 21.064 18 11.HG21 1.173
15 8.HG11 0.842 18 11.C 174.348
15 8.C 175.986 19 12.N 120.957
16 9.N 123.11 19 12.HN 8.08
16 9.HN 8.265 19 12.CA 56.093
16 9.CA 58.398 19 12.HA 4.323
16 9.HA 4.614 19 12.CB 30.48
16 9.CB 39.475 19 12.HB2 1.824
16 9.HB2 3.01 19 12.HB1 1.972
16 9.HB1 3.139 19 12.CG 26.773
16 9.CD1 61.9 19 12.HG2 1.65
16 9.HD1 7.24 19 12.HG1 1.63
16 9.CD2 61.9 19 12.CD 43.453
16 9.HD2 7.24 19 12.HD2 3.15
16 9.C 175.804 19 12.HD1 3.15
17 10.N 122.074 19 12.C 175.986
17 10.HN 8.155 20 13.N 107.963
17 10.CA 56.71 20 13.HN 8.241
17 10.HA 4.323 20 13.CA 45.273
17 10.CB 30.937 20 13.HA2 3.965
17 10.HB2 1.756 20 13.HA1 3.942
17 10.HB1 1.813 20 13.C 173.802
17 10.CG 27.047 21 14.N 121.181
17 10.HG2 1.548 21 14.HN 7.967
17 10.HG1 1.554 21 14.CA 54.677
17 10.CD 43.367 21 14.HA 4.77
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
21 14.CB 43.142 24 17.HG1 2.45
21 14.HB2 1.639 24 17.C 179.911
21 14.HB1 1.74 25 18.N 121.151
21 14.CG 27.556 25 18.HN 7.801
21 14.HG 1.764 25 18.CA 59.178
21 14.CD1 23.717 25 18.HA 4.2
21 14.HD11 0.833 25 18.CB 30.873
21 14.CD2 25.545 25 18.HB2 2.23
21 14.HD21 0.781 25 18.HB1 2.465
21 14.C 178.414 25 18.CG 37.564
22 15.N 114.494 25 18.HG2 2.466
22 15.HN 9.075 25 18.HG1 2.54
22 15.CA 61.316 25 18.C 178.394
22 15.HA 4.558 26 19.N 120.692
22 15.CB 71.015 26 19.HN 8.897
22 15.HB 4.831 26 19.CA 61.924
22 15.CG2 21.942 26 19.HA 4.184
22 15.HG21 1.414 26 19.CB 37.837
22 15.C 175.359 26 19.HB2 3.011
23 16.N 121.204 26 19.HB1 3.175
23 16.HN 8.943 26 19.CD1 62.873
23 16.CA 58.315 26 19.HD1 7.122
23 16.HA 4.485 26 19.CE1 48.09
23 16.CB 39.931 26 19.HE1 6.862
23 16.HB2 2.702 26 19.CE2 48.09
23 16.HB1 2.849 26 19.HE2 6.862
23 16.C 178.697 26 19.CD2 62.873
24 17.N 119.241 26 19.HD2 7.122
24 17.HN 8.741 26 19.C 177.483
24 17.CA 59.973 27 20.N 118.898
24 17.HA 4.199 27 20.HN 8.135
24 17.CB 29.306 27 20.CA 57.864
24 17.HB2 2.046 27 20.HA 4.338
24 17.HB1 2.129 27 20.CB 40.797
24 17.CG 37.039 27 20.HB2 2.686
24 17.HG2 2.43 27 20.HB1 2.859
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
27 20.C 178.535 30 23.HB1 1.732
28 21.N 121.02 30 23.CG 25.271
28 21.HN 7.655 30 23.HG2 1.165
28 21.CA 59.45 30 23.HG1 1.349
28 21.HA 4.101 30 23.CD 29.475
28 21.CB 29.231 30 23.HD2 1.64
28 21.HB2 2.252 30 23.HD1 1.6
28 21.HB1 2.391 30 23.CE 41.539
28 21.CG 36.329 30 23.HE2 2.89
28 21.HG2 2.377 30 23.HE1 2.79
28 21.HG1 2.548 30 23.C 179.445
28 21.C 178.394 31 24.N 120.113
29 22.N 121.567 31 24.HN 7.69
29 22.HN 8.471 31 24.CA 59.7
29 22.CA 61.371 31 24.HA 4.018
29 22.HA 3.765 31 24.CB 32.3
29 22.CB 37.588 31 24.HB2 1.934
29 22.HB2 2.207 31 24.HB1 1.915
29 22.HB1 2.883 31 24.CG 25.187
29 22.CD1 61.993 31 24.HG2 1.579
29 22.HD1 6.855 31 24.HG1 1.405
29 22.CE1 60.8 31 24.CD 29.1
29 22.HE1 7.1 31 24.HD2 1.696
29 22.CZ 59.4 31 24.HD1 1.688
29 22.HZ 7.33 31 24.CE 41.933
29 22.CE2 60.8 31 24.HE2 2.959
29 22.HE2 7.101 31 24.HE1 2.595
29 22.CD2 61.993 31 24.C 179.918
29 22.HD2 6.855 32 25.N 121.2
29 22.C 176.169 32 25.HN 8.299
30 23.N 118.916 32 25.CA 59.452
30 23.HN 8.287 32 25.HA 3.893
30 23.CA 60.346 32 25.CB 31.284
30 23.HA 3.137 32 25.HB2 1.308
30 23.CB 31.992 32 25.HB1 1.929
30 23.HB2 1.657 32 25.CG 27.83
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
32 25.HG2 1.523 35 28.HB2 3.958
32 25.HG1 2.003 35 28.HB1 4.005
32 25.CD 44.555 35 28.C 175.339
32 25.HD2 3.238 36 29.N 119.557
32 25.HD1 3.272 36 29.HN 7.459
32 25.C 178.99 36 29.CA 55.794
33 26.N 120.223 36 29.HA 4.439
33 26.HN 8.704 36 29.CB 30.276
33 26.CA 59.607 36 29.HB2 1.359
33 26.HA 3.698 36 29.HB1 2.157
33 26.CB 29.57 36 29.CG 27.046
33 26.HB2 1.279 36 29.HG2 1.513
33 26.HB1 1.694 36 29.HG1 1.46
33 26.CG 27.099 36 29.CD 43.271
33 26.HG2 1.518 36 29.HD2 2.88
33 26.HG1 1.618 36 29.HD1 2.549
33 26.CD 44.189 36 29.C 177.524
33 26.HD2 3.287 37 30.N 109.722
33 26.HD1 2.994 37 30.HN 7.981
33 26.C 178.697 37 30.CA 46.691
34 27.N 119.86 37 30.HA2 3.999
34 27.HN 7.941 37 30.HA1 4.034
34 27.CA 59.21 37 30.C 175.117
34 27.HA 4.046 38 31.N 104.904
34 27.CB 29.38 38 31.HN 8.271
34 27.HB2 2.094 38 31.CA 45.012
34 27.HB1 2.127 38 31.HA2 3.571
34 27.CG 36.329 38 31.HA1 4.324
34 27.HG2 2.278 38 31.C 174.489
34 27.HG1 2.332 39 32.N 122.169
34 27.C 179.85 39 32.HN 7.471
35 28.N 115.261 39 32.CA 55.622
35 28.HN 7.813 39 32.HA 4.515
35 28.CA 60.068 39 32.CB 30.846
35 28.HA 4.378 39 32.HB2 1.886
35 28.CB 63.321 39 32.HB1 2.022
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
39 32.CG 24.631 42 35.CA 63.317
39 32.HG2 1.458 42 35.HA 3.384
39 32.HG1 1.5 42 35.CB 37.29
39 32.CD 29.018 42 35.HB 1.573
39 32.HD2 1.76 42 35.CG1 28.961
39 32.HD1 1.774 42 35.HG12 0.68
39 32.CE 42.27 42 35.HG11 1.09
39 32.HE2 3.063 42 35.CD1 12.645
39 32.HE1 3.077 42 35.HD11 0.46
39 32.C 174.995 42 35.CG2 17.658
40 33.N 123.749 42 35.HG21 0.795
40 33.HN 7.687 42 35.C 176.573
40 33.CA 58.629 43 36.N 118.987
40 33.HA 4.893 43 36.HN 7.673
40 33.CB 40.871 43 36.CA 57.809
40 33.HB2 2.692 43 36.HA 4.317
40 33.HB1 2.944 43 36.CB 40.722
40 33.CD1 62.849 43 36.HB2 2.423
40 33.HD1 7.105 43 36.HB1 2.586
40 33.CE1 48.087 43 36.C 178.94
40 33.HE1 6.975 44 37.N 121.961
40 33.CE2 48.087 44 37.HN 7.61
40 33.HE2 6.975 44 37.CA 57.624
40 33.CD2 62.849 44 37.HA 4.259
40 33.HD2 7.105 44 37.CB 41.244
40 33.C 173.883 44 37.HB2 2.436
41 34.N 124.561 44 37.HB1 2.554
41 34.HN 9.246 44 37.C 177.564
41 34.CA 56.913 45 38.N 121.352
41 34.HA 5.061 45 38.HN 7.75
41 34.CB 67.136 45 38.CA 60.703
41 34.HB2 4.001 45 38.HA 4.676
41 34.HB1 4.377 45 38.CB 38.747
41 34.C 175.258 45 38.HB2 3.085
42 35.N 122.298 45 38.HB1 3.249
42 35.HN 8.848 45 38.CD1 62.85
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
45 38.HD1 7.236 48 41.C 178.596
45 38.CE1 48.09 49 42.N 120.274
45 38.HE1 6.696 49 42.HN 8.459
45 38.CE2 48.09 49 42.CA 58.133
45 38.HE2 6.696 49 42.HA 3.952
45 38.CD2 62.85 49 42.CB 29.231
45 38.HD2 7.236 49 42.HB2 1.589
45 38.C 177.362 49 42.HB1 1.688
46 39.N 118.65 49 42.CG 26.408
46 39.HN 8.544 49 42.HG2 1.305
46 39.CA 57.807 49 42.HG1 1.336
46 39.HA 3.697 49 42.CD 42.818
46 39.CB 41.205 49 42.HD2 2.956
46 39.HB2 1.417 49 42.HD1 3.168
46 39.HB1 1.843 49 42.NE 117.3
46 39.CG 26.916 49 42.HE 7.45
46 39.HG 1.935 49 42.C 178.454
46 39.CD1 25.824 50 43.N 118.834
46 39.HD11 0.879 50 43.HN 7.734
46 39.CD2 22.365 50 43.CA 58.928
46 39.HD21 0.819 50 43.HA 4.101
46 39.C 179.85 50 43.CB 29.53
47 40.N 121.991 50 43.HB2 2.101
47 40.HN 7.716 50 43.HB1 2.133
47 40.CA 55.048 50 43.CG 36.435
47 40.HA 4.19 50 43.HG2 2.283
47 40.CB 18.337 50 43.HG1 2.42
47 40.HB1 1.543 50 43.C 178.353
47 40.C 180.457 51 44.N 119.239
48 41.N 120.788 51 44.HN 7.694
48 41.HN 8.316 51 44.CA 58.105
48 41.CA 57.361 51 44.HA 4.24
48 41.HA 4.505 51 44.CB 30.649
48 41.CB 40.076 51 44.HB2 2.02
48 41.HB2 2.732 51 44.HB1 2.031
48 41.HB1 2.929 51 44.CG 27.647
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
51 44.HG2 1.738 54 47.HG2 2.314
51 44.HG1 1.812 54 47.HG1 2.428
51 44.CD 43.458 54 47.C 177.443
51 44.HD2 3.297 55 48.N 120.563
51 44.HD1 3.314 55 48.HN 7.905
51 44.C 178.37 55 48.CA 56.07
52 45.N 119.667 55 48.HA 4.288
52 45.HN 8.299 55 48.CB 42.062
52 45.CA 58.538 55 48.HB2 1.623
52 45.HA 4.099 55 48.HB1 1.78
52 45.CB 29.661 55 48.CG 27.007
52 45.HB2 2.128 55 48.HG 1.744
52 45.HB1 2.128 55 48.CD1 25.048
52 45.CG 36.512 55 48.HD11 0.955
52 45.HG2 2.327 55 48.CD2 23.4
52 45.HG1 2.51 55 48.HD21 0.906
52 45.C 178.37 55 48.C 177.735
53 46.N 119.152 56 49.N 121.25
53 46.HN 8.098 56 49.HN 7.859
53 46.CA 58.172 56 49.CA 55.979
53 46.HA 4.21 56 49.HA 4.312
53 46.CB 29.53 56 49.CB 42.635
53 46.HB2 2.13 56 49.HB2 1.615
53 46.HB1 2.136 56 49.HB1 1.773
53 46.CG 36.421 56 49.CG 27.099
53 46.HG2 2.337 56 49.HG 1.741
53 46.HG1 2.432 56 49.CD1 25.088
53 46.C 177.74 56 49.HD11 0.948
54 47.N 120.097 56 49.CD2 23.534
54 47.HN 7.968 56 49.HD21 0.895
54 47.CA 58.081 56 49.C 177.726
54 47.HA 4.212 57 50.N 120.632
54 47.CB 29.788 57 50.HN 8.153
54 47.HB2 2.131 57 50.CA 57.076
54 47.HB1 2.131 57 50.HA 4.283
54 47.CG 36.512 57 50.CB 30.052
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
57 50.HB2 1.995 60 53.HG2 2.261
57 50.HB1 2.13 60 53.HG1 2.329
57 50.CG 36.477 60 53.C 176.876
57 50.HG2 2.276 61 54.N 121.077
57 50.HG1 2.326 61 54.HN 8.384
57 50.C 176.553 61 54.CA 57.734
58 51.N 121.282 61 54.HA 4.21
58 51.HN 8.146 61 54.CB 30.425
58 51.CA 56.344 61 54.HB2 2.093
58 51.HA 4.372 61 54.HB1 2.005
58 51.CB 31.102 61 54.CG 36.6
58 51.HB2 1.81 61 54.HG2 2.31
58 51.HB1 1.899 61 54.HG1 1.648
58 51.CG 27.098 61 54.C 176.832
58 51.HG2 1.66 62 55.N 121.155
58 51.HG1 1.68 62 55.HN 8.3
58 51.CD 43.653 62 55.CA 57.137
58 51.HD2 3.21 62 55.HA 4.249
58 51.HD1 3.216 62 55.CB 30.425
58 51.C 176.169 62 55.HB2 1.993
59 52.N 121.619 62 55.HB1 2.101
59 52.HN 8.386 62 55.CG 36.344
59 52.CA 54.768 62 55.HG2 2.277
59 52.HA 4.639 62 55.HG1 2.326
59 52.CB 41.256 62 55.C 176.432
59 52.HB2 2.649 63 56.N 124.607
59 52.HB1 2.755 63 56.HN 8.178
59 52.C 176.553 63 56.CA 52.915
60 53.N 121.214 63 56.HA 4.293
60 53.HN 8.372 63 56.CB 19.07
60 53.CA 57.361 63 56.HB1 1.356
60 53.HA 4.273 63 56.C 177.483
60 53.CB 30.425 64 57.N 118.941
60 53.HB2 1.99 64 57.HN 7.872
60 53.HB1 2.103 64 57.CA 61.342
60 53.CG 36.511 64 57.HA 4.076
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
64 57.CB 38.7 67 60.CB 41.265
64 57.HB 1.753 67 60.HB2 2.664
64 57.CG1 27.107 67 60.HB1 2.72
64 57.HG12 1.088 67 60.C 176.897
64 57.HG11 1.34 68 61.N 108.789
64 57.CD1 13 68 61.HN 8.342
64 57.HD11 0.805 68 61.CA 46.02
64 57.CG2 17.393 68 61.HA2 3.91
64 57.HG21 0.706 68 61.HA1 3.94
64 57.C 176.047 68 61.C 174.307
65 58.N 122.809 69 62.N 119.903
65 58.HN 8.188 69 62.HN 8.178
65 58.CA 57.807 69 62.CA 58.146
65 58.HA 4.615 69 62.HA 4.599
65 58.CB 39.827 69 62.CB 39.339
65 58.HB2 3.008 69 62.HB2 3.041
65 58.HB1 3.189 69 62.HB1 3.199
65 58.CD1 61.7 69 62.CD1 62.2
65 58.HD1 7.261 69 62.HD1 7.25
65 58.CE1 61.21 69 62.CD2 62.2
65 58.HE1 7.34 69 62.HD2 7.25
65 58.CE2 61.21 69 62.C 176.432
65 58.HE2 7.34 70 63.N 110.089
65 58.CD2 61.7 70 63.HN 8.382
65 58.HD2 7.26 70 63.CA 45.628
65 58.C 176.27 70 63.HA2 3.864
66 59.N 110.278 70 63.HA1 3.962
66 59.HN 8.213 70 63.C 174.227
66 59.CA 45.391 71 64.N 121.6
66 59.HA2 3.946 71 64.HN 8.069
66 59.HA1 3.977 71 64.CA 55.5
66 59.C 173.802 71 64.HA 4.29
67 60.N 120.51 71 64.CB 42.4
67 60.HN 8.254 71 64.HB2 1.681
67 60.CA 54.425 71 64.HB1 1.615
67 60.HA 4.599 71 64.CG 27.007
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
71 64.HG 1.621 74 67.CG2 21.76
71 64.CD1 25 74 67.HG21 1.235
71 64.HD11 0.957 74 67.C 174.753
71 64.CD2 23.6 75 68.N 123.112
71 64.HD21 0.901 75 68.HN 8.296
71 64.C 177.645 75 68.CA 56.801
72 65.N 121.214 75 68.HA 4.371
72 65.HN 8.372 75 68.CB 30.798
72 65.CA 56.594 75 68.HB2 1.827
72 65.HA 4.283 75 68.HB1 1.916
72 65.CB 32.765 75 68.CG 27.046
72 65.HB2 1.788 75 68.HG2 1.644
72 65.HB1 1.86 75 68.HG1 1.679
72 65.CG 24.961 75 68.CD 43.362
72 65.HG2 1.424 75 68.HD2 3.208
72 65.HG1 1.475 75 68.HD1 3.216
72 65.CD 29.109 75 68.C 176.411
72 65.HD2 1.701 76 69.N 121.977
72 65.HD1 1.712 76 69.HN 8.36
72 65.CE 42.27 76 69.CA 56.689
72 65.HE2 2.978 76 69.HA 4.362
72 65.HE1 3.02 76 69.CB 30.873
72 65.C 176.553 76 69.HB2 1.809
73 66.N 124.187 76 69.HB1 1.899
73 66.HN 8.188 76 69.CG 26.916
73 66.CA 52.597 76 69.HG2 1.658
73 66.HA 4.347 76 69.HG1 1.677
73 66.CB 19.239 76 69.CD 43.367
73 66.HB1 1.411 76 69.HD2 3.209
73 66.C 178.009 76 69.HD1 3.217
74 67.N 112.973 76 69.C 176.411
74 67.HN 8.054 77 70.N 116.981
74 67.CA 62.046 77 70.HN 8.325
74 67.HA 4.339 77 70.CA 58.497
74 67.CB 69.779 77 70.HA 4.483
74 67.HB 4.26 77 70.CB 63.839
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Real residue number Nuclei Chemical shift Real residue number Nuclei Chemical shift
77 70.HB2 3.889 80 73.CA 52.597
77 70.HB1 3.938 80 73.HA 4.308
77 70.C 174.672 80 73.CB 19.18
78 71.N 123.324 80 73.HB1 1.429
78 71.HN 8.421 80 73.C 177.787
78 71.CA 56.619 81 74.N 120.243
78 71.HA 4.377 81 74.HN 8.283
78 71.CB 30.873 81 74.CA 56.893
78 71.HB2 1.805 81 74.HA 4.278
78 71.HB1 1.925 81 74.CB 30.374
78 71.CG 27.007 81 74.HB2 2.019
78 71.HG2 1.666 81 74.HB1 2.1
78 71.HG1 1.681 81 74.CG 36.344
78 71.CD 43.367 81 74.HG2 2.284
78 71.HD2 3.224 81 74.HG1 2.355
78 71.HD1 3.224 81 74.C 176.614
78 71.C 176.492 82 75.N 121.743
79 72.N 122.352 82 75.HN 8.256
79 72.HN 8.3 82 75.CA 56.047
79 72.CA 57.076 82 75.HA 4.378
79 72.HA 4.266 82 75.CB 30.757
79 72.CB 33.186 82 75.HB2 1.923
79 72.HB2 1.788 82 75.HB1 1.8
79 72.HB1 1.881 82 75.CG 26.864
79 72.CG 24.782 82 75.HG2 1.663
79 72.HG2 1.438 82 75.HG1 1.685
79 72.HG1 1.497 82 75.CD 43.453
79 72.CD 29.201 82 75.HD2 3.224
79 72.HD2 1.715 82 75.HD1 3.224
79 72.HD1 1.714 82 75.C 175.946
79 72.CE 42.27 83 76.N 125.049
79 72.HE2 3.049 83 76.HN 8.241
79 72.HE1 3.049 83 76.CA 52.872
79 72.C 176.472 83 76.HA 4.313
80 73.N 124.816 83 76.CB 19.239
80 73.HN 8.269 83 76.HB1 1.415
 Appendix 
 
 191 
 
 
 
 
 
 
 
 
 
 
Real residue number Nuclei Chemical shift
83 76.C 177.322
84 77.N 121.088
84 77.HN 8.186
84 77.CA 56.316
84 77.HA 4.286
84 77.CB 32.923
84 77.HB2 1.794
84 77.HB1 1.877
84 77.CG 24.768
84 77.HG2 1.46
84 77.HG1 1.497
84 77.CD 29.052
84 77.HD2 1.663
84 77.HD1 1.685
84 77.CE 42.268
84 77.HE2 3.038
84 77.HE1 3.033
84 77.C 175.46
85 78.N 129.503
85 78.HN 7.829
85 78.CA 56.286
85 78.HA 4.346
85 78.CB 42.9
85 78.HB2 1.681
85 78.HB1 1.773
85 78.CG 26.67
85 78.HG 0.894
85 78.CD1 24.677
85 78.HD11 0.945
85 78.CD2 23.583
85 78.HD21 0.891
85 78.C 182.419
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9.2.Magnetisation transfer in assignment experiments  
 
Atoms for which chemical shift values were recorded in the experiment are shown in pink. 
Atoms which participate in the pulse sequence but for which chemical shift values are not 
recorded are shown in light blue. These schematics were taken from www.protein-
nmr.org.uk/spectra.html. 
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9.3.Chi1/Chi2 plots for MNV VPg 11-85 
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